BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 691362 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H26ClFN4O3/c1-32-24-13-18(27(34)35)6-8-23(24)30-25(32)15-33-11-9-17(10-12-33)22-3-2-4-26(31-22)36-16-19-5-7-20(28)14-21(19)29/h2-8,13-14,17H,9-12,15-16H2,1H3,(H,34,35) GVBZZYXNJYZMGA-UHFFFAOYSA-N 349654 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 1A-01 Glucagon-like peptide 1 receptor Human 81.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349654&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611157 386051414 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691363 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H26ClFN4O3/c1-32-24-13-18(27(34)35)6-8-23(24)30-25(32)15-33-11-9-17(10-12-33)22-3-2-4-26(31-22)36-16-19-5-7-20(28)14-21(19)29/h2-8,13-14,17H,9-12,15-16H2,1H3,(H,34,35) GVBZZYXNJYZMGA-UHFFFAOYSA-N 349654 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 1A-01 Glucagon-like peptide 1 receptor Human 910 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349654&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611157 386051414 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691364 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30ClFN4O4/c1-38-14-13-35-26-15-20(29(36)37)6-8-25(26)32-27(35)17-34-11-9-19(10-12-34)24-3-2-4-28(33-24)39-18-21-5-7-22(30)16-23(21)31/h2-8,15-16,19H,9-14,17-18H2,1H3,(H,36,37) UZWPHEBZMXBQBX-UHFFFAOYSA-N 349655 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-02 Glucagon-like peptide 1 receptor Human 16.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349655&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611182 386051415 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691365 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30ClFN4O4/c1-38-14-13-35-26-15-20(29(36)37)6-8-25(26)32-27(35)17-34-11-9-19(10-12-34)24-3-2-4-28(33-24)39-18-21-5-7-22(30)16-23(21)31/h2-8,15-16,19H,9-14,17-18H2,1H3,(H,36,37) UZWPHEBZMXBQBX-UHFFFAOYSA-N 349655 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-02 Glucagon-like peptide 1 receptor Human 320 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349655&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611182 386051415 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691366 COCCn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H31FN6O4/c1-20-17-36(27-4-3-5-29(34-27)41-19-23-7-6-21(16-32)14-24(23)31)11-10-35(20)18-28-33-25-9-8-22(30(38)39)15-26(25)37(28)12-13-40-2/h3-9,14-15,20H,10-13,17-19H2,1-2H3,(H,38,39)/t20-/m0/s1 BPLIDKHPZRJBCQ-FQEVSTJZSA-N 349656 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-03 Glucagon-like peptide 1 receptor Human 4.30 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349656&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611117 386051416 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691367 COCCn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H31FN6O4/c1-20-17-36(27-4-3-5-29(34-27)41-19-23-7-6-21(16-32)14-24(23)31)11-10-35(20)18-28-33-25-9-8-22(30(38)39)15-26(25)37(28)12-13-40-2/h3-9,14-15,20H,10-13,17-19H2,1-2H3,(H,38,39)/t20-/m0/s1 BPLIDKHPZRJBCQ-FQEVSTJZSA-N 349656 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-03 Glucagon-like peptide 1 receptor Human 92.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349656&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611117 386051416 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691368 COCCn1c(CN2CCC(CC2)c2ccc(F)c(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H29ClF2N4O4/c1-39-13-12-36-26-14-19(29(37)38)3-6-25(26)33-27(36)16-35-10-8-18(9-11-35)24-7-5-22(31)28(34-24)40-17-20-2-4-21(30)15-23(20)32/h2-7,14-15,18H,8-13,16-17H2,1H3,(H,37,38) MXGGSJCZZAVYEM-UHFFFAOYSA-N 349657 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-04 Glucagon-like peptide 1 receptor Human 21.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349657&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208495 386051417 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691369 COCCn1c(CN2CCC(CC2)c2ccc(F)c(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H29ClF2N4O4/c1-39-13-12-36-26-14-19(29(37)38)3-6-25(26)33-27(36)16-35-10-8-18(9-11-35)24-7-5-22(31)28(34-24)40-17-20-2-4-21(30)15-23(20)32/h2-7,14-15,18H,8-13,16-17H2,1H3,(H,37,38) MXGGSJCZZAVYEM-UHFFFAOYSA-N 349657 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-04 Glucagon-like peptide 1 receptor Human 350 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349657&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208495 386051417 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691370 COCCn1c(CN2CCN(CC2)c2nc(OCc3ccc(Cl)cc3F)ccc2F)nc2ccc(cc12)C(O)=O InChI=1S/C28H28ClF2N5O4/c1-39-13-12-36-24-14-18(28(37)38)3-6-23(24)32-25(36)16-34-8-10-35(11-9-34)27-21(30)5-7-26(33-27)40-17-19-2-4-20(29)15-22(19)31/h2-7,14-15H,8-13,16-17H2,1H3,(H,37,38) WJMZSTOUDJICMA-UHFFFAOYSA-N 349658 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]-3-fluoropyridin-2-yl}piperazin-1-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-05 Glucagon-like peptide 1 receptor Human 42.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349658&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208496 386051418 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691371 COCCn1c(CN2CCN(CC2)c2nc(OCc3ccc(Cl)cc3F)ccc2F)nc2ccc(cc12)C(O)=O InChI=1S/C28H28ClF2N5O4/c1-39-13-12-36-24-14-18(28(37)38)3-6-23(24)32-25(36)16-34-8-10-35(11-9-34)27-21(30)5-7-26(33-27)40-17-19-2-4-20(29)15-22(19)31/h2-7,14-15H,8-13,16-17H2,1H3,(H,37,38) WJMZSTOUDJICMA-UHFFFAOYSA-N 349658 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]-3-fluoropyridin-2-yl}piperazin-1-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-05 Glucagon-like peptide 1 receptor Human 530 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349658&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208496 386051418 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691372 COCCn1c(CN2CCN(C[C@@H]2C)c2nc(OCc3ccc(Cl)cc3F)ccc2F)nc2ccc(cc12)C(O)=O InChI=1S/C29H30ClF2N5O4/c1-18-15-36(28-22(31)6-8-27(34-28)41-17-20-3-5-21(30)14-23(20)32)10-9-35(18)16-26-33-24-7-4-19(29(38)39)13-25(24)37(26)11-12-40-2/h3-8,13-14,18H,9-12,15-17H2,1-2H3,(H,38,39)/t18-/m0/s1 CTZAOBIEDBZYHZ-SFHVURJKSA-N 349659 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]-3-fluoropyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-06 Glucagon-like peptide 1 receptor Human 29.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349659&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208497 386051419 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691373 COCCn1c(CN2CCN(C[C@@H]2C)c2nc(OCc3ccc(Cl)cc3F)ccc2F)nc2ccc(cc12)C(O)=O InChI=1S/C29H30ClF2N5O4/c1-18-15-36(28-22(31)6-8-27(34-28)41-17-20-3-5-21(30)14-23(20)32)10-9-35(18)16-26-33-24-7-4-19(29(38)39)13-25(24)37(26)11-12-40-2/h3-8,13-14,18H,9-12,15-17H2,1-2H3,(H,38,39)/t18-/m0/s1 CTZAOBIEDBZYHZ-SFHVURJKSA-N 349659 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]-3-fluoropyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-06 Glucagon-like peptide 1 receptor Human 350 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349659&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208497 386051419 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691374 COCCn1c(CN2CCN(C[C@@H]2C)c2ccc(F)c(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30ClF2N5O4/c1-18-15-36(26-8-6-22(31)28(34-26)41-17-20-3-5-21(30)14-23(20)32)10-9-35(18)16-27-33-24-7-4-19(29(38)39)13-25(24)37(27)11-12-40-2/h3-8,13-14,18H,9-12,15-17H2,1-2H3,(H,38,39)/t18-/m0/s1 GGNJOIUGWVJWGJ-SFHVURJKSA-N 349660 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]-5-fluoropyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-07 Glucagon-like peptide 1 receptor Human 3.90 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349660&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611174 386051420 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691375 COCCn1c(CN2CCN(C[C@@H]2C)c2ccc(F)c(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30ClF2N5O4/c1-18-15-36(26-8-6-22(31)28(34-26)41-17-20-3-5-21(30)14-23(20)32)10-9-35(18)16-27-33-24-7-4-19(29(38)39)13-25(24)37(27)11-12-40-2/h3-8,13-14,18H,9-12,15-17H2,1-2H3,(H,38,39)/t18-/m0/s1 GGNJOIUGWVJWGJ-SFHVURJKSA-N 349660 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]-5-fluoropyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-07 Glucagon-like peptide 1 receptor Human 45.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349660&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611174 386051420 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691376 COCCn1c(CN2CCN(C[C@@H]2C)c2ccc(F)c(OCc3ccc(cc3)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H31FN6O4/c1-20-17-36(27-10-8-24(31)29(34-27)41-19-22-5-3-21(16-32)4-6-22)12-11-35(20)18-28-33-25-9-7-23(30(38)39)15-26(25)37(28)13-14-40-2/h3-10,15,20H,11-14,17-19H2,1-2H3,(H,38,39)/t20-/m0/s1 UBOFEEKFCBBZCC-FQEVSTJZSA-N 349661 2-{[(2S)-4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-08 Glucagon-like peptide 1 receptor Human 7.10 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349661&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611071 386051421 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691377 COCCn1c(CN2CCN(C[C@@H]2C)c2ccc(F)c(OCc3ccc(cc3)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H31FN6O4/c1-20-17-36(27-10-8-24(31)29(34-27)41-19-22-5-3-21(16-32)4-6-22)12-11-35(20)18-28-33-25-9-7-23(30(38)39)15-26(25)37(28)13-14-40-2/h3-10,15,20H,11-14,17-19H2,1-2H3,(H,38,39)/t20-/m0/s1 UBOFEEKFCBBZCC-FQEVSTJZSA-N 349661 2-{[(2S)-4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-08 Glucagon-like peptide 1 receptor Human 120 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349661&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611071 386051421 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691378 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1 HYBAKUMPISVZQP-DEOSSOPVSA-N 349662 2-{[4-(6-{[(4-cyano-2-fluorophenyl)(methyl-d2)]oxy}pyridin-2-yl)piperidin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-09::US10208019, Example 4A-01 Glucagon-like peptide 1 receptor Human 0.950 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349662&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search UK4 6X1A,7LCI,7LCJ,7LCK 134611040 386051422 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691379 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1 HYBAKUMPISVZQP-DEOSSOPVSA-N 349662 2-{[4-(6-{[(4-cyano-2-fluorophenyl)(methyl-d2)]oxy}pyridin-2-yl)piperidin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-09::US10208019, Example 4A-01 Glucagon-like peptide 1 receptor Human 17.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349662&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search UK4 6X1A,7LCI,7LCJ,7LCK 134611040 386051422 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691380 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccccc3)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H32N4O4/c1-36-17-16-33-26-18-23(29(34)35)10-11-25(26)30-27(33)19-32-14-12-22(13-15-32)24-8-5-9-28(31-24)37-20-21-6-3-2-4-7-21/h2-11,18,22H,12-17,19-20H2,1H3,(H,34,35) VFSAQXBVXGMIEK-UHFFFAOYSA-N 349663 2-({4-[6-(benzyloxy)pyridin-2-yl]piperidin-1-yl}methyl)-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-10 Glucagon-like peptide 1 receptor Human 930 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349663&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208498 386051423 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691381 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccccc3)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H32N4O4/c1-36-17-16-33-26-18-23(29(34)35)10-11-25(26)30-27(33)19-32-14-12-22(13-15-32)24-8-5-9-28(31-24)37-20-21-6-3-2-4-7-21/h2-11,18,22H,12-17,19-20H2,1H3,(H,34,35) VFSAQXBVXGMIEK-UHFFFAOYSA-N 349663 2-({4-[6-(benzyloxy)pyridin-2-yl]piperidin-1-yl}methyl)-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-10 Glucagon-like peptide 1 receptor Human 9000 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349663&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208498 386051423 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691382 COCCn1c(CN2CCN(CC2)c2cccc(OCc3ccc(cc3)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30N6O4/c1-38-16-15-35-25-17-23(29(36)37)9-10-24(25)31-27(35)19-33-11-13-34(14-12-33)26-3-2-4-28(32-26)39-20-22-7-5-21(18-30)6-8-22/h2-10,17H,11-16,19-20H2,1H3,(H,36,37) AOAGOHODWHAPQT-UHFFFAOYSA-N 349664 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-11 Glucagon-like peptide 1 receptor Human 19.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349664&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611110 386051424 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691383 COCCn1c(CN2CCN(CC2)c2cccc(OCc3ccc(cc3)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30N6O4/c1-38-16-15-35-25-17-23(29(36)37)9-10-24(25)31-27(35)19-33-11-13-34(14-12-33)26-3-2-4-28(32-26)39-20-22-7-5-21(18-30)6-8-22/h2-10,17H,11-16,19-20H2,1H3,(H,36,37) AOAGOHODWHAPQT-UHFFFAOYSA-N 349664 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-11 Glucagon-like peptide 1 receptor Human 530 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349664&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611110 386051424 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691384 COCCn1c(CN2CCN(c3cccc(OCc4ccc(Cl)cc4F)n3)C(C)(C)C2)nc2ccc(cc12)C(O)=O InChI=1S/C30H33ClFN5O4/c1-30(2)19-35(17-27-33-24-10-8-20(29(38)39)15-25(24)36(27)13-14-40-3)11-12-37(30)26-5-4-6-28(34-26)41-18-21-7-9-22(31)16-23(21)32/h4-10,15-16H,11-14,17-19H2,1-3H3,(H,38,39) HOMYQLUFDWVWIN-UHFFFAOYSA-N 349665 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3,3-dimethylpiperazin-1-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-12 Glucagon-like peptide 1 receptor Human 750 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349665&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208499 386051425 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691385 COCCn1c(CN2CCN([C@@H](C)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H31ClFN5O4/c1-19-16-34(17-27-32-24-9-7-20(29(37)38)14-25(24)36(27)12-13-39-2)10-11-35(19)26-4-3-5-28(33-26)40-18-21-6-8-22(30)15-23(21)31/h3-9,14-15,19H,10-13,16-18H2,1-2H3,(H,37,38)/t19-/m0/s1 OZWNCRKARVXORD-IBGZPJMESA-N 349666 2-{[(3S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-13 Glucagon-like peptide 1 receptor Human 210 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349666&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208500 386051426 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691386 COCCn1c(CN2CCN([C@H](C)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H31ClFN5O4/c1-19-16-34(17-27-32-24-9-7-20(29(37)38)14-25(24)36(27)12-13-39-2)10-11-35(19)26-4-3-5-28(33-26)40-18-21-6-8-22(30)15-23(21)31/h3-9,14-15,19H,10-13,16-18H2,1-2H3,(H,37,38)/t19-/m1/s1 OZWNCRKARVXORD-LJQANCHMSA-N 349667 2-{[(3R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-14 Glucagon-like peptide 1 receptor Human 47.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349667&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208501 386051427 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691387 COCCn1c(CN2CCN([C@H](C)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H31ClFN5O4/c1-19-16-34(17-27-32-24-9-7-20(29(37)38)14-25(24)36(27)12-13-39-2)10-11-35(19)26-4-3-5-28(33-26)40-18-21-6-8-22(30)15-23(21)31/h3-9,14-15,19H,10-13,16-18H2,1-2H3,(H,37,38)/t19-/m1/s1 OZWNCRKARVXORD-LJQANCHMSA-N 349667 2-{[(3R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-14 Glucagon-like peptide 1 receptor Human 1600 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349667&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208501 386051427 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691388 COCCn1c(CN2CCN([C@@H](CO)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H31ClFN5O5/c1-40-12-11-36-25-13-19(29(38)39)6-8-24(25)32-27(36)16-34-9-10-35(22(15-34)17-37)26-3-2-4-28(33-26)41-18-20-5-7-21(30)14-23(20)31/h2-8,13-14,22,37H,9-12,15-18H2,1H3,(H,38,39)/t22-/m1/s1 HYFPLHLYAZTRSX-JOCHJYFZSA-N 349668 2-{[(3R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-(hydroxymethyl)piperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-15 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349668&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208502 386051428 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691389 Cn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H30FN7O3/c1-38-20-35-16-25(38)17-40-29-14-23(32(41)42)7-8-28(29)36-30(40)18-39-11-9-22(10-12-39)27-3-2-4-31(37-27)43-19-24-6-5-21(15-34)13-26(24)33/h2-8,13-14,16,20,22H,9-12,17-19H2,1H3,(H,41,42) HUKCENNLWBEOOS-UHFFFAOYSA-N 349669 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-16 Glucagon-like peptide 1 receptor Human 1.50 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349669&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611120 386051429 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691390 Cn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H30FN7O3/c1-38-20-35-16-25(38)17-40-29-14-23(32(41)42)7-8-28(29)36-30(40)18-39-11-9-22(10-12-39)27-3-2-4-31(37-27)43-19-24-6-5-21(15-34)13-26(24)33/h2-8,13-14,16,20,22H,9-12,17-19H2,1H3,(H,41,42) HUKCENNLWBEOOS-UHFFFAOYSA-N 349669 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-16 Glucagon-like peptide 1 receptor Human 14.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349669&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611120 386051429 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691391 Cn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(F)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H30F2N6O3/c1-37-19-34-15-24(37)16-39-28-13-21(31(40)41)6-8-27(28)35-29(39)17-38-11-9-20(10-12-38)26-3-2-4-30(36-26)42-18-22-5-7-23(32)14-25(22)33/h2-8,13-15,19-20H,9-12,16-18H2,1H3,(H,40,41) IONISRGPWNLVRC-UHFFFAOYSA-N 349670 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-17 Glucagon-like peptide 1 receptor Human 2.40 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349670&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208503 386051430 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691392 Cn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(F)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H30F2N6O3/c1-37-19-34-15-24(37)16-39-28-13-21(31(40)41)6-8-27(28)35-29(39)17-38-11-9-20(10-12-38)26-3-2-4-30(36-26)42-18-22-5-7-23(32)14-25(22)33/h2-8,13-15,19-20H,9-12,16-18H2,1H3,(H,40,41) IONISRGPWNLVRC-UHFFFAOYSA-N 349670 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-17 Glucagon-like peptide 1 receptor Human 45.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349670&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208503 386051430 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691393 CCCn1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H33ClFN7O3/c1-2-12-40-20-35-38-30(40)18-41-28-15-22(32(42)43)7-9-27(28)36-29(41)17-39-13-10-21(11-14-39)26-4-3-5-31(37-26)44-19-23-6-8-24(33)16-25(23)34/h3-9,15-16,20-21H,2,10-14,17-19H2,1H3,(H,42,43) FEWIYJXTSGMYMV-UHFFFAOYSA-N 349671 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4-propyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-18 Glucagon-like peptide 1 receptor Human 6.40 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349671&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208504 386051431 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691394 CCCn1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H33ClFN7O3/c1-2-12-40-20-35-38-30(40)18-41-28-15-22(32(42)43)7-9-27(28)36-29(41)17-39-13-10-21(11-14-39)26-4-3-5-31(37-26)44-19-23-6-8-24(33)16-25(23)34/h3-9,15-16,20-21H,2,10-14,17-19H2,1H3,(H,42,43) FEWIYJXTSGMYMV-UHFFFAOYSA-N 349671 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4-propyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-18 Glucagon-like peptide 1 receptor Human 110 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349671&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208504 386051431 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691395 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H31ClFN5O4/c1-19-15-36(27-3-2-4-29(34-27)41-18-21-5-7-22(31)14-24(21)32)11-10-35(19)17-28-33-25-8-6-20(30(38)39)13-26(25)37(28)16-23-9-12-40-23/h2-8,13-14,19,23H,9-12,15-18H2,1H3,(H,38,39)/t19-,23-/m0/s1 IGXAOFNNKAUXCJ-CVDCTZTESA-N 349672 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-19 Glucagon-like peptide 1 receptor Human 0.280 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349672&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611104 386051432 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691396 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H31ClFN5O4/c1-19-15-36(27-3-2-4-29(34-27)41-18-21-5-7-22(31)14-24(21)32)11-10-35(19)17-28-33-25-8-6-20(30(38)39)13-26(25)37(28)16-23-9-12-40-23/h2-8,13-14,19,23H,9-12,15-18H2,1H3,(H,38,39)/t19-,23-/m0/s1 IGXAOFNNKAUXCJ-CVDCTZTESA-N 349672 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-19 Glucagon-like peptide 1 receptor Human 3.20 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349672&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611104 386051432 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691397 Cn1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H29FN8O3/c1-38-19-34-37-29(38)17-40-27-14-22(31(41)42)7-8-26(27)35-28(40)16-39-11-9-21(10-12-39)25-3-2-4-30(36-25)43-18-23-6-5-20(15-33)13-24(23)32/h2-8,13-14,19,21H,9-12,16-18H2,1H3,(H,41,42) DWSJKJUYKBOFCE-UHFFFAOYSA-N 349673 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4-methyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-20 Glucagon-like peptide 1 receptor Human 44.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349673&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208505 386051433 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691398 Cn1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H29FN8O3/c1-38-19-34-37-29(38)17-40-27-14-22(31(41)42)7-8-26(27)35-28(40)16-39-11-9-21(10-12-39)25-3-2-4-30(36-25)43-18-23-6-5-20(15-33)13-24(23)32/h2-8,13-14,19,21H,9-12,16-18H2,1H3,(H,41,42) DWSJKJUYKBOFCE-UHFFFAOYSA-N 349673 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4-methyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-20 Glucagon-like peptide 1 receptor Human 880 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349673&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208505 386051433 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691399 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCCO3)c2c1 InChI=1S/C32H32FN5O4/c33-26-15-21(17-34)6-7-24(26)20-42-31-5-1-4-27(36-31)22-10-12-37(13-11-22)19-30-35-28-9-8-23(32(39)40)16-29(28)38(30)18-25-3-2-14-41-25/h1,4-9,15-16,22,25H,2-3,10-14,18-20H2,(H,39,40)/t25-/m0/s1 KYAMEOCCRNSOEY-VWLOTQADSA-N 349674 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-tetrahydrofuran-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-21 Glucagon-like peptide 1 receptor Human 4.90 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349674&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611115 386051434 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691400 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCCO3)c2c1 InChI=1S/C32H32FN5O4/c33-26-15-21(17-34)6-7-24(26)20-42-31-5-1-4-27(36-31)22-10-12-37(13-11-22)19-30-35-28-9-8-23(32(39)40)16-29(28)38(30)18-25-3-2-14-41-25/h1,4-9,15-16,22,25H,2-3,10-14,18-20H2,(H,39,40)/t25-/m0/s1 KYAMEOCCRNSOEY-VWLOTQADSA-N 349674 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-tetrahydrofuran-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-21 Glucagon-like peptide 1 receptor Human 75.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349674&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611115 386051434 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691401 COCCn1c(CN2CC[C@H]([C@H](F)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H29ClF2N4O4/c1-39-12-11-36-26-13-18(29(37)38)6-8-25(26)33-27(36)16-35-10-9-21(23(32)15-35)24-3-2-4-28(34-24)40-17-19-5-7-20(30)14-22(19)31/h2-8,13-14,21,23H,9-12,15-17H2,1H3,(H,37,38)/t21-,23-/m1/s1 YQXTZOSZHYUUDQ-FYYLOGMGSA-N 349675 US10208019, Example 1A-22::rac 2-{[(3S,4S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-fluoropiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human 36.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349675&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208506 386051435 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691402 COCCn1c(CN2CC[C@H]([C@H](F)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H29ClF2N4O4/c1-39-12-11-36-26-13-18(29(37)38)6-8-25(26)33-27(36)16-35-10-9-21(23(32)15-35)24-3-2-4-28(34-24)40-17-19-5-7-20(30)14-22(19)31/h2-8,13-14,21,23H,9-12,15-17H2,1H3,(H,37,38)/t21-,23-/m1/s1 YQXTZOSZHYUUDQ-FYYLOGMGSA-N 349675 US10208019, Example 1A-22::rac 2-{[(3S,4S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-fluoropiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human 400 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349675&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208506 386051435 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691403 COCCn1c(CN2CC[C@H]([C@H](O)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30ClFN4O5/c1-39-12-11-35-25-13-18(29(37)38)6-8-24(25)32-27(35)16-34-10-9-21(26(36)15-34)23-3-2-4-28(33-23)40-17-19-5-7-20(30)14-22(19)31/h2-8,13-14,21,26,36H,9-12,15-17H2,1H3,(H,37,38)/t21-,26+/m0/s1 JMBWEJQHPLSOAE-HFZDXXHNSA-N 349676 US10208019, Example 1A-23::rac-2-{[(3S,4S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-hydroxypiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human 50.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349676&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208507 386051436 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691404 COCCn1c(CN2CC[C@H]([C@H](O)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30ClFN4O5/c1-39-12-11-35-25-13-18(29(37)38)6-8-24(25)32-27(35)16-34-10-9-21(26(36)15-34)23-3-2-4-28(33-23)40-17-19-5-7-20(30)14-22(19)31/h2-8,13-14,21,26,36H,9-12,15-17H2,1H3,(H,37,38)/t21-,26+/m0/s1 JMBWEJQHPLSOAE-HFZDXXHNSA-N 349676 US10208019, Example 1A-23::rac-2-{[(3S,4S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-hydroxypiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human 1000 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349676&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208507 386051436 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691405 COCCn1c(CN2CC[C@H]([C@@H](O)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30ClFN4O5/c1-39-12-11-35-25-13-18(29(37)38)6-8-24(25)32-27(35)16-34-10-9-21(26(36)15-34)23-3-2-4-28(33-23)40-17-19-5-7-20(30)14-22(19)31/h2-8,13-14,21,26,36H,9-12,15-17H2,1H3,(H,37,38)/t21-,26-/m0/s1 JMBWEJQHPLSOAE-LVXARBLLSA-N 349677 US10208019, Example 1A-24::rac-2-{[(3R,4S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-hydroxypiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human >11000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349677&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208508 386051437 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691406 COCCn1c(CN2CC[C@H]([C@@H](C)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19-16-35(17-28-33-26-9-7-20(30(37)38)14-27(26)36(28)12-13-39-2)11-10-23(19)25-4-3-5-29(34-25)40-18-21-6-8-22(31)15-24(21)32/h3-9,14-15,19,23H,10-13,16-18H2,1-2H3,(H,37,38)/t19-,23+/m0/s1 RDFWUVMSHIKLEP-WMZHIEFXSA-N 349678 US10208019, Example 1A-25::rac-2-{[(3R,4R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-methylpiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human 45.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349678&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208509 386051438 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691407 COCCn1c(CN2CC[C@H]([C@@H](C)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19-16-35(17-28-33-26-9-7-20(30(37)38)14-27(26)36(28)12-13-39-2)11-10-23(19)25-4-3-5-29(34-25)40-18-21-6-8-22(31)15-24(21)32/h3-9,14-15,19,23H,10-13,16-18H2,1-2H3,(H,37,38)/t19-,23+/m0/s1 RDFWUVMSHIKLEP-WMZHIEFXSA-N 349678 US10208019, Example 1A-25::rac-2-{[(3R,4R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-methylpiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human 1000 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349678&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208509 386051438 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691408 COCCn1c(CN2CC[C@H]([C@H](C)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19-16-35(17-28-33-26-9-7-20(30(37)38)14-27(26)36(28)12-13-39-2)11-10-23(19)25-4-3-5-29(34-25)40-18-21-6-8-22(31)15-24(21)32/h3-9,14-15,19,23H,10-13,16-18H2,1-2H3,(H,37,38)/t19-,23-/m1/s1 RDFWUVMSHIKLEP-AUSIDOKSSA-N 349679 US10208019, Example 1A-26::rac-2-{[(3S,4R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-methylpiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human 70.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349679&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208510 386051439 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691409 COCCn1c(CN2CC[C@H]([C@H](C)C2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19-16-35(17-28-33-26-9-7-20(30(37)38)14-27(26)36(28)12-13-39-2)11-10-23(19)25-4-3-5-29(34-25)40-18-21-6-8-22(31)15-24(21)32/h3-9,14-15,19,23H,10-13,16-18H2,1-2H3,(H,37,38)/t19-,23-/m1/s1 RDFWUVMSHIKLEP-AUSIDOKSSA-N 349679 US10208019, Example 1A-26::rac-2-{[(3S,4R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-3-methylpiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human 1800 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349679&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208510 386051439 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691410 CO[C@@H]1CCC[C@H]1n1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H34ClFN4O4/c1-41-29-6-3-5-27(29)38-28-16-21(32(39)40)9-11-26(28)35-30(38)18-37-14-12-20(13-15-37)25-4-2-7-31(36-25)42-19-22-8-10-23(33)17-24(22)34/h2,4,7-11,16-17,20,27,29H,3,5-6,12-15,18-19H2,1H3,(H,39,40)/t27-,29-/m1/s1 UMJIVSTZECPXBY-XRKRLSELSA-N 349680 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1R,2R)-2-methoxycyclopentyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-27 Glucagon-like peptide 1 receptor Human 190 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349680&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208511 386051440 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691411 CO[C@@H]1CCC[C@H]1n1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H34ClFN4O4/c1-41-29-6-3-5-27(29)38-28-16-21(32(39)40)9-11-26(28)35-30(38)18-37-14-12-20(13-15-37)25-4-2-7-31(36-25)42-19-22-8-10-23(33)17-24(22)34/h2,4,7-11,16-17,20,27,29H,3,5-6,12-15,18-19H2,1H3,(H,39,40)/t27-,29-/m1/s1 UMJIVSTZECPXBY-XRKRLSELSA-N 349680 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1R,2R)-2-methoxycyclopentyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-27 Glucagon-like peptide 1 receptor Human 1400 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349680&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208511 386051440 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691412 CO[C@@H]1C[C@H](Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)C1 InChI=1S/C32H34ClFN4O4/c1-41-25-13-20(14-25)17-38-29-15-22(32(39)40)6-8-28(29)35-30(38)18-37-11-9-21(10-12-37)27-3-2-4-31(36-27)42-19-23-5-7-24(33)16-26(23)34/h2-8,15-16,20-21,25H,9-14,17-19H2,1H3,(H,39,40)/t20-,25+ IRBBUDITUFXYMD-IHRKKFBRSA-N 349681 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(cis-3-methoxycyclobutyl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-28 Glucagon-like peptide 1 receptor Human 300 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349681&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208512 386051441 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691413 CO[C@@H]1C[C@H](Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)C1 InChI=1S/C32H34ClFN4O4/c1-41-25-13-20(14-25)17-38-29-15-22(32(39)40)6-8-28(29)35-30(38)18-37-11-9-21(10-12-37)27-3-2-4-31(36-27)42-19-23-5-7-24(33)16-26(23)34/h2-8,15-16,20-21,25H,9-14,17-19H2,1H3,(H,39,40)/t20-,25+ IRBBUDITUFXYMD-IHRKKFBRSA-N 349681 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(cis-3-methoxycyclobutyl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-28 Glucagon-like peptide 1 receptor Human 7700 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349681&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208512 386051441 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691414 CO[C@H]1CCC[C@H]1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C33H36ClFN4O4/c1-42-30-6-2-4-23(30)18-39-29-16-22(33(40)41)9-11-28(29)36-31(39)19-38-14-12-21(13-15-38)27-5-3-7-32(37-27)43-20-24-8-10-25(34)17-26(24)35/h3,5,7-11,16-17,21,23,30H,2,4,6,12-15,18-20H2,1H3,(H,40,41)/t23-,30-/m0/s1 KTYQEVFJKXYGKR-JHOBJCJYSA-N 349682 US10208019, Example 1A-29::rac-2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(1S,2S)-2-methoxycyclopentyl]methyl}-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human 260 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349682&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208513 386051442 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691415 CO[C@H]1CCC[C@H]1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C33H36ClFN4O4/c1-42-30-6-2-4-23(30)18-39-29-16-22(33(40)41)9-11-28(29)36-31(39)19-38-14-12-21(13-15-38)27-5-3-7-32(37-27)43-20-24-8-10-25(34)17-26(24)35/h3,5,7-11,16-17,21,23,30H,2,4,6,12-15,18-20H2,1H3,(H,40,41)/t23-,30-/m0/s1 KTYQEVFJKXYGKR-JHOBJCJYSA-N 349682 US10208019, Example 1A-29::rac-2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(1S,2S)-2-methoxycyclopentyl]methyl}-1H-benzimidazole-6-carboxylic acid Glucagon-like peptide 1 receptor Human 5600 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349682&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208513 386051442 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691416 COC[C@@H]1C[C@H]1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H34ClFN4O4/c1-41-18-24-13-23(24)16-38-29-14-21(32(39)40)6-8-28(29)35-30(38)17-37-11-9-20(10-12-37)27-3-2-4-31(36-27)42-19-22-5-7-25(33)15-26(22)34/h2-8,14-15,20,23-24H,9-13,16-19H2,1H3,(H,39,40)/t23-,24-/m0/s1 CYHLNBDXTJVIQP-ZEQRLZLVSA-N 349683 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(1R,2R)-2-(methoxymethyl)cyclopropyl]methyl}-1H-benzimidazole-6-carboxylic::US10208019, Example 1A-30 Glucagon-like peptide 1 receptor Human 150 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349683&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208514 386051443 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691417 COC[C@@H]1C[C@H]1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H34ClFN4O4/c1-41-18-24-13-23(24)16-38-29-14-21(32(39)40)6-8-28(29)35-30(38)17-37-11-9-20(10-12-37)27-3-2-4-31(36-27)42-19-22-5-7-25(33)15-26(22)34/h2-8,14-15,20,23-24H,9-13,16-19H2,1H3,(H,39,40)/t23-,24-/m0/s1 CYHLNBDXTJVIQP-ZEQRLZLVSA-N 349683 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(1R,2R)-2-(methoxymethyl)cyclopropyl]methyl}-1H-benzimidazole-6-carboxylic::US10208019, Example 1A-30 Glucagon-like peptide 1 receptor Human 4100 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349683&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208514 386051443 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691418 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(nc12)C(O)=O InChI=1S/C26H25ClFN5O3/c1-32-23(29-21-7-8-22(26(34)35)31-25(21)32)14-33-11-9-16(10-12-33)20-3-2-4-24(30-20)36-15-17-5-6-18(27)13-19(17)28/h2-8,13,16H,9-12,14-15H2,1H3,(H,34,35) ZFDHZDONBOMVLZ-UHFFFAOYSA-N 349684 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-3-methyl-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-01 Glucagon-like peptide 1 receptor Human 90.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349684&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611229 386051444 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691419 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(nc12)C(O)=O InChI=1S/C26H25ClFN5O3/c1-32-23(29-21-7-8-22(26(34)35)31-25(21)32)14-33-11-9-16(10-12-33)20-3-2-4-24(30-20)36-15-17-5-6-18(27)13-19(17)28/h2-8,13,16H,9-12,14-15H2,1H3,(H,34,35) ZFDHZDONBOMVLZ-UHFFFAOYSA-N 349684 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-3-methyl-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-01 Glucagon-like peptide 1 receptor Human 1800 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349684&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611229 386051444 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691420 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ncc(cc12)C(O)=O InChI=1S/C28H29ClFN5O4/c1-38-12-11-35-24-13-20(28(36)37)15-31-27(24)33-25(35)16-34-9-7-18(8-10-34)23-3-2-4-26(32-23)39-17-19-5-6-21(29)14-22(19)30/h2-6,13-15,18H,7-12,16-17H2,1H3,(H,36,37) CNFBZODHCRLGMO-UHFFFAOYSA-N 349685 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(2-methoxyethyl)-1H-imidazo[4,5-b]pyridine-6-carboxylic acid::US10208019, Example 2A-02 Glucagon-like peptide 1 receptor Human 7.90 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349685&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611139 386051445 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691421 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ncc(cc12)C(O)=O InChI=1S/C28H29ClFN5O4/c1-38-12-11-35-24-13-20(28(36)37)15-31-27(24)33-25(35)16-34-9-7-18(8-10-34)23-3-2-4-26(32-23)39-17-19-5-6-21(29)14-22(19)30/h2-6,13-15,18H,7-12,16-17H2,1H3,(H,36,37) CNFBZODHCRLGMO-UHFFFAOYSA-N 349685 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(2-methoxyethyl)-1H-imidazo[4,5-b]pyridine-6-carboxylic acid::US10208019, Example 2A-02 Glucagon-like peptide 1 receptor Human 110 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349685&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611139 386051445 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691422 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2cnc(cc12)C(O)=O InChI=1S/C26H25ClFN5O3/c1-32-23-12-21(26(34)35)29-13-22(23)30-24(32)14-33-9-7-16(8-10-33)20-3-2-4-25(31-20)36-15-17-5-6-18(27)11-19(17)28/h2-6,11-13,16H,7-10,14-15H2,1H3,(H,34,35) RCQYGXCXXXURDS-UHFFFAOYSA-N 349686 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-methyl-1H-imidazo[4,5-c]pyridine-6-carboxylic acid::US10208019, Example 2A-03 Glucagon-like peptide 1 receptor Human 150 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349686&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611147 386051446 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691423 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2cnc(cc12)C(O)=O InChI=1S/C26H25ClFN5O3/c1-32-23-12-21(26(34)35)29-13-22(23)30-24(32)14-33-9-7-16(8-10-33)20-3-2-4-25(31-20)36-15-17-5-6-18(27)11-19(17)28/h2-6,11-13,16H,7-10,14-15H2,1H3,(H,34,35) RCQYGXCXXXURDS-UHFFFAOYSA-N 349686 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-methyl-1H-imidazo[4,5-c]pyridine-6-carboxylic acid::US10208019, Example 2A-03 Glucagon-like peptide 1 receptor Human 1200 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349686&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611147 386051446 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691424 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ncc(cc12)C(O)=O InChI=1S/C26H25ClFN5O3/c1-32-22-11-18(26(34)35)13-29-25(22)31-23(32)14-33-9-7-16(8-10-33)21-3-2-4-24(30-21)36-15-17-5-6-19(27)12-20(17)28/h2-6,11-13,16H,7-10,14-15H2,1H3,(H,34,35) CLPPFFXIVOGIGL-UHFFFAOYSA-N 349687 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-imidazo[4,5-b]pyridine-6-carboxylic acid::US10208019, Example 2A-04 Glucagon-like peptide 1 receptor Human 36.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349687&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208515 386051447 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691425 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ncc(cc12)C(O)=O InChI=1S/C26H25ClFN5O3/c1-32-22-11-18(26(34)35)13-29-25(22)31-23(32)14-33-9-7-16(8-10-33)21-3-2-4-24(30-21)36-15-17-5-6-19(27)12-20(17)28/h2-6,11-13,16H,7-10,14-15H2,1H3,(H,34,35) CLPPFFXIVOGIGL-UHFFFAOYSA-N 349687 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-imidazo[4,5-b]pyridine-6-carboxylic acid::US10208019, Example 2A-04 Glucagon-like peptide 1 receptor Human 150 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349687&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208515 386051447 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691426 OC(=O)c1cc2n(C[C@@H]3CCO3)c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc2cn1 InChI=1S/C29H29ClFN5O4/c30-20-5-4-19(22(31)12-20)17-40-28-3-1-2-23(34-28)18-6-9-35(10-7-18)16-27-33-25-14-32-24(29(37)38)13-26(25)36(27)15-21-8-11-39-21/h1-5,12-14,18,21H,6-11,15-17H2,(H,37,38)/t21-/m0/s1 RQBVFOSCHIKSDZ-NRFANRHFSA-N 349688 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-imidazo[4,5-c]pyridine-6-carboxylic acid::US10208019, Example 2A-05 Glucagon-like peptide 1 receptor Human 6.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349688&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208516 386051448 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691427 OC(=O)c1cc2n(C[C@@H]3CCO3)c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc2cn1 InChI=1S/C29H29ClFN5O4/c30-20-5-4-19(22(31)12-20)17-40-28-3-1-2-23(34-28)18-6-9-35(10-7-18)16-27-33-25-14-32-24(29(37)38)13-26(25)36(27)15-21-8-11-39-21/h1-5,12-14,18,21H,6-11,15-17H2,(H,37,38)/t21-/m0/s1 RQBVFOSCHIKSDZ-NRFANRHFSA-N 349688 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-imidazo[4,5-c]pyridine-6-carboxylic acid::US10208019, Example 2A-05 Glucagon-like peptide 1 receptor Human 150 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349688&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208516 386051448 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691428 OC(=O)c1cc2n(Cc3ncco3)c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc2cn1 InChI=1S/C29H26ClFN6O4/c30-20-5-4-19(21(31)12-20)17-41-27-3-1-2-22(35-27)18-6-9-36(10-7-18)15-26-34-24-14-33-23(29(38)39)13-25(24)37(26)16-28-32-8-11-40-28/h1-5,8,11-14,18H,6-7,9-10,15-17H2,(H,38,39) WESXKAMQGXBWLH-UHFFFAOYSA-N 349689 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-imidazo[4,5-c]pyridine-6-carboxylic acid::US10208019, Example 2A-06 Glucagon-like peptide 1 receptor Human 9.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349689&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208517 386051449 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691429 OC(=O)c1cc2n(Cc3ncco3)c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc2cn1 InChI=1S/C29H26ClFN6O4/c30-20-5-4-19(21(31)12-20)17-41-27-3-1-2-22(35-27)18-6-9-36(10-7-18)15-26-34-24-14-33-23(29(38)39)13-25(24)37(26)16-28-32-8-11-40-28/h1-5,8,11-14,18H,6-7,9-10,15-17H2,(H,38,39) WESXKAMQGXBWLH-UHFFFAOYSA-N 349689 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-imidazo[4,5-c]pyridine-6-carboxylic acid::US10208019, Example 2A-06 Glucagon-like peptide 1 receptor Human 170 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349689&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208517 386051449 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691430 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2cnc(cc12)C(O)=O InChI=1S/C28H29ClFN5O4/c1-38-12-11-35-25-14-23(28(36)37)31-15-24(25)32-26(35)16-34-9-7-18(8-10-34)22-3-2-4-27(33-22)39-17-19-5-6-20(29)13-21(19)30/h2-6,13-15,18H,7-12,16-17H2,1H3,(H,36,37) GTALRPOVFNODDP-UHFFFAOYSA-N 349690 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxyethyl)-1H-imidazo[4,5-c]pyridine-6-carboxylic acid::US10208019, Example 2A-07 Glucagon-like peptide 1 receptor Human 140 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349690&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208518 386051450 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691431 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2cnc(cc12)C(O)=O InChI=1S/C28H29ClFN5O4/c1-38-12-11-35-25-14-23(28(36)37)31-15-24(25)32-26(35)16-34-9-7-18(8-10-34)22-3-2-4-27(33-22)39-17-19-5-6-20(29)13-21(19)30/h2-6,13-15,18H,7-12,16-17H2,1H3,(H,36,37) GTALRPOVFNODDP-UHFFFAOYSA-N 349690 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxyethyl)-1H-imidazo[4,5-c]pyridine-6-carboxylic acid::US10208019, Example 2A-07 Glucagon-like peptide 1 receptor Human 1600 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349690&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208518 386051450 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691432 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(C(O)=O)c(F)c12 InChI=1S/C29H29ClF2N4O4/c1-39-14-13-36-25(33-24-8-7-21(29(37)38)27(32)28(24)36)16-35-11-9-18(10-12-35)23-3-2-4-26(34-23)40-17-19-5-6-20(30)15-22(19)31/h2-8,15,18H,9-14,16-17H2,1H3,(H,37,38) WWOKCHZWAGJLHQ-UHFFFAOYSA-N 349691 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-7-fluoro-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 2A-08 Glucagon-like peptide 1 receptor Human 5.80 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349691&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611127 386051451 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691433 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(C(O)=O)c(F)c12 InChI=1S/C29H29ClF2N4O4/c1-39-14-13-36-25(33-24-8-7-21(29(37)38)27(32)28(24)36)16-35-11-9-18(10-12-35)23-3-2-4-26(34-23)40-17-19-5-6-20(30)15-22(19)31/h2-8,15,18H,9-14,16-17H2,1H3,(H,37,38) WWOKCHZWAGJLHQ-UHFFFAOYSA-N 349691 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-7-fluoro-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 2A-08 Glucagon-like peptide 1 receptor Human 94.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349691&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611127 386051451 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691434 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2cc(F)c(cc12)C(O)=O InChI=1S/C27H25ClF2N4O3/c1-33-24-12-19(27(35)36)21(30)13-23(24)31-25(33)14-34-9-7-16(8-10-34)22-3-2-4-26(32-22)37-15-17-5-6-18(28)11-20(17)29/h2-6,11-13,16H,7-10,14-15H2,1H3,(H,35,36) UIIMQZQSOSVUDP-UHFFFAOYSA-N 349692 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-5-fluoro-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 2A-09 Glucagon-like peptide 1 receptor Human 120 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349692&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208519 386051452 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691435 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2cc(F)c(cc12)C(O)=O InChI=1S/C27H25ClF2N4O3/c1-33-24-12-19(27(35)36)21(30)13-23(24)31-25(33)14-34-9-7-16(8-10-34)22-3-2-4-26(32-22)37-15-17-5-6-18(28)11-20(17)29/h2-6,11-13,16H,7-10,14-15H2,1H3,(H,35,36) UIIMQZQSOSVUDP-UHFFFAOYSA-N 349692 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-5-fluoro-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 2A-09 Glucagon-like peptide 1 receptor Human 2200 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349692&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208519 386051452 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691436 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ncc(nc12)C(O)=O InChI=1S/C27H28ClFN6O4/c1-38-12-11-35-23(33-25-26(35)32-22(14-30-25)27(36)37)15-34-9-7-17(8-10-34)21-3-2-4-24(31-21)39-16-18-5-6-19(28)13-20(18)29/h2-6,13-14,17H,7-12,15-16H2,1H3,(H,36,37) IVAAQYMIXMETCG-UHFFFAOYSA-N 349693 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxyethyl)-1H-imidazo[4,5-b]pyrazine-6-carboxylic acid::US10208019, Example 2A-10 Glucagon-like peptide 1 receptor Human 43.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349693&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208520 386051453 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691437 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ncc(nc12)C(O)=O InChI=1S/C27H28ClFN6O4/c1-38-12-11-35-23(33-25-26(35)32-22(14-30-25)27(36)37)15-34-9-7-17(8-10-34)21-3-2-4-24(31-21)39-16-18-5-6-19(28)13-20(18)29/h2-6,13-14,17H,7-12,15-16H2,1H3,(H,36,37) IVAAQYMIXMETCG-UHFFFAOYSA-N 349693 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxyethyl)-1H-imidazo[4,5-b]pyrazine-6-carboxylic acid::US10208019, Example 2A-10 Glucagon-like peptide 1 receptor Human 680 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349693&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208520 386051453 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691438 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ncc(C(O)=O)c(C)c12 InChI=1S/C29H31ClFN5O4/c1-18-22(29(37)38)15-32-28-27(18)36(12-13-39-2)25(34-28)16-35-10-8-19(9-11-35)24-4-3-5-26(33-24)40-17-20-6-7-21(30)14-23(20)31/h3-7,14-15,19H,8-13,16-17H2,1-2H3,(H,37,38) OZTAFVATPSCQSF-UHFFFAOYSA-N 349694 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxyethyl)-7-methyl-1H-imidazo[4,5-b]pyridine-6-carboxylic acid::US10208019, Example 2A-11 Glucagon-like peptide 1 receptor Human 210 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349694&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208521 386051454 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691439 Cc1nc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C)c2cc1C(O)=O InChI=1S/C27H27ClFN5O3/c1-16-20(27(35)36)13-23-26(30-16)32-24(33(23)2)14-34-10-8-17(9-11-34)22-4-3-5-25(31-22)37-15-18-6-7-19(28)12-21(18)29/h3-7,12-13,17H,8-11,14-15H2,1-2H3,(H,35,36) KKKIDDPSAYSHAZ-UHFFFAOYSA-N 349695 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1,5-dimethyl-1H-imidazo[4,5-b]pyridine-6-carboxylic acid::US10208019, Example 2A-12 Glucagon-like peptide 1 receptor Human 340 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349695&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208522 386051455 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691440 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2cc(Cl)c(cc12)C(O)=O InChI=1S/C27H25Cl2FN4O3/c1-33-24-12-19(27(35)36)20(29)13-23(24)31-25(33)14-34-9-7-16(8-10-34)22-3-2-4-26(32-22)37-15-17-5-6-18(28)11-21(17)30/h2-6,11-13,16H,7-10,14-15H2,1H3,(H,35,36) DHMZZUMJZBFLSN-UHFFFAOYSA-N 349696 5-chloro-2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 2A-13 Glucagon-like peptide 1 receptor Human 770 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349696&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208523 386051456 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691441 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2cc(Cl)c(cc12)C(O)=O InChI=1S/C27H25Cl2FN4O3/c1-33-24-12-19(27(35)36)20(29)13-23(24)31-25(33)14-34-9-7-16(8-10-34)22-3-2-4-26(32-22)37-15-17-5-6-18(28)11-21(17)30/h2-6,11-13,16H,7-10,14-15H2,1H3,(H,35,36) DHMZZUMJZBFLSN-UHFFFAOYSA-N 349696 5-chloro-2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 2A-13 Glucagon-like peptide 1 receptor Human >15000 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349696&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208523 386051456 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691442 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3)C#N)n2)nc2cc(F)c(cc12)C(O)=O InChI=1S/C30H30FN5O4/c1-39-14-13-36-27-15-23(30(37)38)24(31)16-26(27)33-28(36)18-35-11-9-22(10-12-35)25-3-2-4-29(34-25)40-19-21-7-5-20(17-32)6-8-21/h2-8,15-16,22H,9-14,18-19H2,1H3,(H,37,38) VUBPAWTVSCYULX-UHFFFAOYSA-N 349697 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-5-fluoro-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 2A-14 Glucagon-like peptide 1 receptor Human 110 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349697&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208524 386051457 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691443 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3)C#N)n2)nc2cc(F)c(cc12)C(O)=O InChI=1S/C30H30FN5O4/c1-39-14-13-36-27-15-23(30(37)38)24(31)16-26(27)33-28(36)18-35-11-9-22(10-12-35)25-3-2-4-29(34-25)40-19-21-7-5-20(17-32)6-8-21/h2-8,15-16,22H,9-14,18-19H2,1H3,(H,37,38) VUBPAWTVSCYULX-UHFFFAOYSA-N 349697 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-5-fluoro-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 2A-14 Glucagon-like peptide 1 receptor Human 3000 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349697&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208524 386051457 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691444 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3)C#N)n2)nc2ccc(C(O)=O)c(F)c12 InChI=1S/C30H30FN5O4/c1-39-16-15-36-26(33-25-10-9-23(30(37)38)28(31)29(25)36)18-35-13-11-22(12-14-35)24-3-2-4-27(34-24)40-19-21-7-5-20(17-32)6-8-21/h2-10,22H,11-16,18-19H2,1H3,(H,37,38) NKNKXCQSWOHJQE-UHFFFAOYSA-N 349698 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-7-fluoro-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 2A-15 Glucagon-like peptide 1 receptor Human 22.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349698&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611041 386051458 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691445 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3)C#N)n2)nc2ccc(C(O)=O)c(F)c12 InChI=1S/C30H30FN5O4/c1-39-16-15-36-26(33-25-10-9-23(30(37)38)28(31)29(25)36)18-35-13-11-22(12-14-35)24-3-2-4-27(34-24)40-19-21-7-5-20(17-32)6-8-21/h2-10,22H,11-16,18-19H2,1H3,(H,37,38) NKNKXCQSWOHJQE-UHFFFAOYSA-N 349698 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-7-fluoro-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 2A-15 Glucagon-like peptide 1 receptor Human 280 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349698&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611041 386051458 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691446 OC(=O)c1cnc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CC(F)(F)F)c2c1 InChI=1S/C27H24ClF4N5O3/c28-19-5-4-17(20(29)11-19)14-40-24-3-1-2-21(34-24)16-6-8-36(9-7-16)13-23-35-25-22(37(23)15-27(30,31)32)10-18(12-33-25)26(38)39/h1-5,10-12,16H,6-9,13-15H2,(H,38,39) QKUNULQVFWGNFO-UHFFFAOYSA-N 349699 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2,2,2-trifluoroethyl)-1H-imidazo[4,5-b]pyridine-6-carboxylic acid::US10208019, Example 2A-16 Glucagon-like peptide 1 receptor Human 370 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349699&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208525 386051459 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691447 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(nc12)C(O)=O InChI=1S/C28H29ClFN5O4/c1-38-14-13-35-25(31-23-7-8-24(28(36)37)33-27(23)35)16-34-11-9-18(10-12-34)22-3-2-4-26(32-22)39-17-19-5-6-20(29)15-21(19)30/h2-8,15,18H,9-14,16-17H2,1H3,(H,36,37) FMMWNOMKDZJRON-UHFFFAOYSA-N 349700 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-(2-methoxyethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-17 Glucagon-like peptide 1 receptor Human 24.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349700&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208526 386051460 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691448 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(nc12)C(O)=O InChI=1S/C28H29ClFN5O4/c1-38-14-13-35-25(31-23-7-8-24(28(36)37)33-27(23)35)16-34-11-9-18(10-12-34)22-3-2-4-26(32-22)39-17-19-5-6-20(29)15-21(19)30/h2-8,15,18H,9-14,16-17H2,1H3,(H,36,37) FMMWNOMKDZJRON-UHFFFAOYSA-N 349700 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-(2-methoxyethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-17 Glucagon-like peptide 1 receptor Human 1200 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349700&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208526 386051460 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691449 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ncco3)c2n1 InChI=1S/C29H26ClFN6O4/c30-20-5-4-19(21(31)14-20)17-41-26-3-1-2-22(34-26)18-8-11-36(12-9-18)15-25-33-23-6-7-24(29(38)39)35-28(23)37(25)16-27-32-10-13-40-27/h1-7,10,13-14,18H,8-9,11-12,15-17H2,(H,38,39) WLEWXMLOPOQSFY-UHFFFAOYSA-N 349701 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-(1,3-oxazol-2-ylmethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-18 Glucagon-like peptide 1 receptor Human 6.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349701&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611105 386051461 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691450 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ncco3)c2n1 InChI=1S/C29H26ClFN6O4/c30-20-5-4-19(21(31)14-20)17-41-26-3-1-2-22(34-26)18-8-11-36(12-9-18)15-25-33-23-6-7-24(29(38)39)35-28(23)37(25)16-27-32-10-13-40-27/h1-7,10,13-14,18H,8-9,11-12,15-17H2,(H,38,39) WLEWXMLOPOQSFY-UHFFFAOYSA-N 349701 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-(1,3-oxazol-2-ylmethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-18 Glucagon-like peptide 1 receptor Human 78.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349701&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611105 386051461 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691451 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3ncco3)c2n1 InChI=1S/C30H26FN7O4/c31-22-14-19(15-32)4-5-21(22)18-42-27-3-1-2-23(35-27)20-8-11-37(12-9-20)16-26-34-24-6-7-25(30(39)40)36-29(24)38(26)17-28-33-10-13-41-28/h1-7,10,13-14,20H,8-9,11-12,16-18H2,(H,39,40) WXVMPIKVKADUBX-UHFFFAOYSA-N 349702 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-(1,3-oxazol-2-ylmethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-19 Glucagon-like peptide 1 receptor Human 7.90 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349702&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611047 386051462 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691452 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3ncco3)c2n1 InChI=1S/C30H26FN7O4/c31-22-14-19(15-32)4-5-21(22)18-42-27-3-1-2-23(35-27)20-8-11-37(12-9-20)16-26-34-24-6-7-25(30(39)40)36-29(24)38(26)17-28-33-10-13-41-28/h1-7,10,13-14,20H,8-9,11-12,16-18H2,(H,39,40) WXVMPIKVKADUBX-UHFFFAOYSA-N 349702 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-(1,3-oxazol-2-ylmethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-19 Glucagon-like peptide 1 receptor Human 150 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349702&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611047 386051462 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691453 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(F)cc4F)n3)n(C[C@@H]3CCO3)c2n1 InChI=1S/C29H29F2N5O4/c30-20-5-4-19(22(31)14-20)17-40-27-3-1-2-23(33-27)18-8-11-35(12-9-18)16-26-32-24-6-7-25(29(37)38)34-28(24)36(26)15-21-10-13-39-21/h1-7,14,18,21H,8-13,15-17H2,(H,37,38)/t21-/m0/s1 CMOLDHCZCNUBKV-NRFANRHFSA-N 349703 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-20 Glucagon-like peptide 1 receptor Human 0.960 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349703&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611017 386051463 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691454 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(F)cc4F)n3)n(C[C@@H]3CCO3)c2n1 InChI=1S/C29H29F2N5O4/c30-20-5-4-19(22(31)14-20)17-40-27-3-1-2-23(33-27)18-8-11-35(12-9-18)16-26-32-24-6-7-25(29(37)38)34-28(24)36(26)15-21-10-13-39-21/h1-7,14,18,21H,8-13,15-17H2,(H,37,38)/t21-/m0/s1 CMOLDHCZCNUBKV-NRFANRHFSA-N 349703 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-20 Glucagon-like peptide 1 receptor Human 14.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349703&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611017 386051463 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691455 C[C@H]1CN(CCN1Cc1nc2ccc(nc2n1Cc1ncco1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C30H27FN8O4/c1-19-15-38(25-3-2-4-27(36-25)43-18-21-6-5-20(14-32)13-22(21)31)11-10-37(19)16-26-34-23-7-8-24(30(40)41)35-29(23)39(26)17-28-33-9-12-42-28/h2-9,12-13,19H,10-11,15-18H2,1H3,(H,40,41)/t19-/m0/s1 JPAUHWKLVGRYBD-IBGZPJMESA-N 349704 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-3-(1,3-oxazol-2-ylmethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-21 Glucagon-like peptide 1 receptor Human 8.50 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349704&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208527 386051464 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691456 C[C@H]1CN(CCN1Cc1nc2ccc(nc2n1Cc1ncco1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C30H27FN8O4/c1-19-15-38(25-3-2-4-27(36-25)43-18-21-6-5-20(14-32)13-22(21)31)11-10-37(19)16-26-34-23-7-8-24(30(40)41)35-29(23)39(26)17-28-33-9-12-42-28/h2-9,12-13,19H,10-11,15-18H2,1H3,(H,40,41)/t19-/m0/s1 JPAUHWKLVGRYBD-IBGZPJMESA-N 349704 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-3-(1,3-oxazol-2-ylmethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-21 Glucagon-like peptide 1 receptor Human 220 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349704&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208527 386051464 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691457 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@H]3CCO3)c2n1 InChI=1S/C29H29ClFN5O4/c30-20-5-4-19(22(31)14-20)17-40-27-3-1-2-23(33-27)18-8-11-35(12-9-18)16-26-32-24-6-7-25(29(37)38)34-28(24)36(26)15-21-10-13-39-21/h1-7,14,18,21H,8-13,15-17H2,(H,37,38)/t21-/m1/s1 FJNGXIOTJRWYGE-OAQYLSRUSA-N 349705 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(2R)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-22 Glucagon-like peptide 1 receptor Human 14.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349705&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208528 386051465 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691458 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@H]3CCO3)c2n1 InChI=1S/C29H29ClFN5O4/c30-20-5-4-19(22(31)14-20)17-40-27-3-1-2-23(33-27)18-8-11-35(12-9-18)16-26-32-24-6-7-25(29(37)38)34-28(24)36(26)15-21-10-13-39-21/h1-7,14,18,21H,8-13,15-17H2,(H,37,38)/t21-/m1/s1 FJNGXIOTJRWYGE-OAQYLSRUSA-N 349705 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(2R)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-22 Glucagon-like peptide 1 receptor Human 190 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349705&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208528 386051465 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691459 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@@H]3CCO3)c2n1 InChI=1S/C29H29ClFN5O4/c30-20-5-4-19(22(31)14-20)17-40-27-3-1-2-23(33-27)18-8-11-35(12-9-18)16-26-32-24-6-7-25(29(37)38)34-28(24)36(26)15-21-10-13-39-21/h1-7,14,18,21H,8-13,15-17H2,(H,37,38)/t21-/m0/s1 FJNGXIOTJRWYGE-NRFANRHFSA-N 349706 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-23 Glucagon-like peptide 1 receptor Human 0.500 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349706&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611062 386051466 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691460 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@@H]3CCO3)c2n1 InChI=1S/C29H29ClFN5O4/c30-20-5-4-19(22(31)14-20)17-40-27-3-1-2-23(33-27)18-8-11-35(12-9-18)16-26-32-24-6-7-25(29(37)38)34-28(24)36(26)15-21-10-13-39-21/h1-7,14,18,21H,8-13,15-17H2,(H,37,38)/t21-/m0/s1 FJNGXIOTJRWYGE-NRFANRHFSA-N 349706 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 2A-23 Glucagon-like peptide 1 receptor Human 22.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349706&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611062 386051466 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691461 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C30H30ClFN4O4/c31-22-6-4-21(24(32)15-22)18-40-29-3-1-2-25(34-29)19-8-11-35(12-9-19)17-28-33-26-7-5-20(30(37)38)14-27(26)36(28)16-23-10-13-39-23/h1-7,14-15,19,23H,8-13,16-18H2,(H,37,38)/t23-/m0/s1 ARXSFJSWUDNZOO-QHCPKHFHSA-N 349707 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 3A-01 Glucagon-like peptide 1 receptor Human 0.940 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349707&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611107 386051467 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691462 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C30H30ClFN4O4/c31-22-6-4-21(24(32)15-22)18-40-29-3-1-2-25(34-29)19-8-11-35(12-9-19)17-28-33-26-7-5-20(30(37)38)14-27(26)36(28)16-23-10-13-39-23/h1-7,14-15,19,23H,8-13,16-18H2,(H,37,38)/t23-/m0/s1 ARXSFJSWUDNZOO-QHCPKHFHSA-N 349707 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 3A-01 Glucagon-like peptide 1 receptor Human 12.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349707&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611107 386051467 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691463 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1 HYBAKUMPISVZQP-DEOSSOPVSA-N 349662 2-{[4-(6-{[(4-cyano-2-fluorophenyl)(methyl-d2)]oxy}pyridin-2-yl)piperidin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-09::US10208019, Example 4A-01 Glucagon-like peptide 1 receptor Human 1.10 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349662&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search UK4 6X1A,7LCI,7LCJ,7LCK 134611040 386051422 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691464 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1 HYBAKUMPISVZQP-DEOSSOPVSA-N 349662 2-{[4-(6-{[(4-cyano-2-fluorophenyl)(methyl-d2)]oxy}pyridin-2-yl)piperidin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 1A-09::US10208019, Example 4A-01 Glucagon-like peptide 1 receptor Human 13.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349662&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search UK4 6X1A,7LCI,7LCJ,7LCK 134611040 386051422 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691465 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C30H29FN6O4/c31-24-14-20(16-32)4-5-22(24)19-41-29-3-1-2-27(34-29)36-11-9-35(10-12-36)18-28-33-25-7-6-21(30(38)39)15-26(25)37(28)17-23-8-13-40-23/h1-7,14-15,23H,8-13,17-19H2,(H,38,39)/t23-/m0/s1 MHGRIBXIKDJHKB-QHCPKHFHSA-N 349709 2-[(4-{6-[(4-Cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 5A-01 Glucagon-like peptide 1 receptor Human 0.340 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349709&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611046 386051468 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691466 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C30H29FN6O4/c31-24-14-20(16-32)4-5-22(24)19-41-29-3-1-2-27(34-29)36-11-9-35(10-12-36)18-28-33-25-7-6-21(30(38)39)15-26(25)37(28)17-23-8-13-40-23/h1-7,14-15,23H,8-13,17-19H2,(H,38,39)/t23-/m0/s1 MHGRIBXIKDJHKB-QHCPKHFHSA-N 349709 2-[(4-{6-[(4-Cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 5A-01 Glucagon-like peptide 1 receptor Human 7.40 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349709&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611046 386051468 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691467 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2n1 InChI=1S/C30H29FN6O4/c31-23-14-19(15-32)4-5-21(23)18-41-28-3-1-2-24(34-28)20-8-11-36(12-9-20)17-27-33-25-6-7-26(30(38)39)35-29(25)37(27)16-22-10-13-40-22/h1-7,14,20,22H,8-13,16-18H2,(H,38,39)/t22-/m0/s1 ACNCYTDELKNLOL-QFIPXVFZSA-N 349710 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 6A-01 Glucagon-like peptide 1 receptor Human 0.760 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349710&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611093 386051469 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691468 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2n1 InChI=1S/C30H29FN6O4/c31-23-14-19(15-32)4-5-21(23)18-41-28-3-1-2-24(34-28)20-8-11-36(12-9-20)17-27-33-25-6-7-26(30(38)39)35-29(25)37(27)16-22-10-13-40-22/h1-7,14,20,22H,8-13,16-18H2,(H,38,39)/t22-/m0/s1 ACNCYTDELKNLOL-QFIPXVFZSA-N 349710 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 6A-01 Glucagon-like peptide 1 receptor Human 8.80 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349710&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611093 386051469 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691469 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3ncco3)c2c1 InChI=1S/C31H27FN6O4/c32-24-14-20(16-33)4-5-23(24)19-42-29-3-1-2-25(36-29)21-8-11-37(12-9-21)17-28-35-26-7-6-22(31(39)40)15-27(26)38(28)18-30-34-10-13-41-30/h1-7,10,13-15,21H,8-9,11-12,17-19H2,(H,39,40) OQTXBPNADRWVRC-UHFFFAOYSA-N 349711 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 7A-01 Glucagon-like peptide 1 receptor Human 3.20 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349711&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611111 386051470 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691470 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3ncco3)c2c1 InChI=1S/C31H27FN6O4/c32-24-14-20(16-33)4-5-23(24)19-42-29-3-1-2-25(36-29)21-8-11-37(12-9-21)17-28-35-26-7-6-22(31(39)40)15-27(26)38(28)18-30-34-10-13-41-30/h1-7,10,13-15,21H,8-9,11-12,17-19H2,(H,39,40) OQTXBPNADRWVRC-UHFFFAOYSA-N 349711 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 7A-01 Glucagon-like peptide 1 receptor Human 55.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349711&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611111 386051470 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691471 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(C)cc3)n2)nc2ccc(cc12)C([O-])=O InChI=1S/C30H34N4O4/c1-21-6-8-22(9-7-21)20-38-29-5-3-4-25(32-29)23-12-14-33(15-13-23)19-28-31-26-11-10-24(30(35)36)18-27(26)34(28)16-17-37-2/h3-11,18,23H,12-17,19-20H2,1-2H3,(H,35,36)/p-1 MLFBJQDSMCXSHS-UHFFFAOYSA-M 349712 Ammonium 2-((4-(6-((4-Methylbenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-6-carboxylate::US10208019, Example 8A-01 Glucagon-like peptide 1 receptor Human 100.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349712&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208529 386051471 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691472 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(C)cc3)n2)nc2ccc(cc12)C([O-])=O InChI=1S/C30H34N4O4/c1-21-6-8-22(9-7-21)20-38-29-5-3-4-25(32-29)23-12-14-33(15-13-23)19-28-31-26-11-10-24(30(35)36)18-27(26)34(28)16-17-37-2/h3-11,18,23H,12-17,19-20H2,1-2H3,(H,35,36)/p-1 MLFBJQDSMCXSHS-UHFFFAOYSA-M 349712 Ammonium 2-((4-(6-((4-Methylbenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-6-carboxylate::US10208019, Example 8A-01 Glucagon-like peptide 1 receptor Human 1100 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349712&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208529 386051471 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691473 COCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(C#N)c(C)c3)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H33N5O4/c1-21-16-22(6-7-25(21)18-32)20-40-30-5-3-4-26(34-30)23-10-12-35(13-11-23)19-29-33-27-9-8-24(31(37)38)17-28(27)36(29)14-15-39-2/h3-9,16-17,23H,10-15,19-20H2,1-2H3,(H,37,38) XJNNQNZPXDSJLO-UHFFFAOYSA-N 349713 2-((4-(6-((4-cyano-3-methylbenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 8A-02 Glucagon-like peptide 1 receptor Human 150 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349713&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208530 386051472 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691474 COCCn1c(CN2CCC(CC2)c2cccc(OCc3cc(F)c(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H29ClF2N4O4/c1-39-12-11-36-26-14-19(29(37)38)5-6-25(26)33-27(36)16-35-9-7-18(8-10-35)24-3-2-4-28(34-24)40-17-20-13-23(32)21(30)15-22(20)31/h2-6,13-15,18H,7-12,16-17H2,1H3,(H,37,38) HYQJZQDMUNJQKM-UHFFFAOYSA-N 349714 2-((4-(6-((4-chloro-2,5-difluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 8A-03 Glucagon-like peptide 1 receptor Human 18.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349714&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208531 386051473 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691475 COCCn1c(CN2CCC(CC2)c2cccc(OCc3cc(F)c(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H29ClF2N4O4/c1-39-12-11-36-26-14-19(29(37)38)5-6-25(26)33-27(36)16-35-9-7-18(8-10-35)24-3-2-4-28(34-24)40-17-20-13-23(32)21(30)15-22(20)31/h2-6,13-15,18H,7-12,16-17H2,1H3,(H,37,38) HYQJZQDMUNJQKM-UHFFFAOYSA-N 349714 2-((4-(6-((4-chloro-2,5-difluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 8A-03 Glucagon-like peptide 1 receptor Human 350 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349714&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208531 386051473 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691476 COCCn1c(CN2CCC(CC2)c2cccc(OCc3c(F)cc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H29ClF2N4O4/c1-39-12-11-36-26-13-19(29(37)38)5-6-25(26)33-27(36)16-35-9-7-18(8-10-35)24-3-2-4-28(34-24)40-17-21-22(31)14-20(30)15-23(21)32/h2-6,13-15,18H,7-12,16-17H2,1H3,(H,37,38) CZOKYDRLYWVXGK-UHFFFAOYSA-N 349715 2-((4-(6-((4-chloro-2,6-difluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 8A-04 Glucagon-like peptide 1 receptor Human 120 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349715&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208532 386051474 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691477 COCCn1c(CN2CCC(CC2)c2cccc(OCc3c(F)cc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H29ClF2N4O4/c1-39-12-11-36-26-13-19(29(37)38)5-6-25(26)33-27(36)16-35-9-7-18(8-10-35)24-3-2-4-28(34-24)40-17-21-22(31)14-20(30)15-23(21)32/h2-6,13-15,18H,7-12,16-17H2,1H3,(H,37,38) CZOKYDRLYWVXGK-UHFFFAOYSA-N 349715 2-((4-(6-((4-chloro-2,6-difluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 8A-04 Glucagon-like peptide 1 receptor Human 1700 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349715&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208532 386051474 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691478 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccccc3)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H28N4O3/c1-30-24-16-21(27(32)33)10-11-23(24)28-25(30)17-31-14-12-20(13-15-31)22-8-5-9-26(29-22)34-18-19-6-3-2-4-7-19/h2-11,16,20H,12-15,17-18H2,1H3,(H,32,33) ICFURHQAHRYUKG-UHFFFAOYSA-N 349716 2-((4-(6-(Benzyloxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 9A-01 Glucagon-like peptide 1 receptor Human 1200 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349716&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611126 386051475 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691479 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C(F)(F)F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C28H26F4N4O3/c1-35-24-13-18(27(37)38)6-8-23(24)33-25(35)15-36-11-9-17(10-12-36)22-3-2-4-26(34-22)39-16-19-5-7-20(14-21(19)29)28(30,31)32/h2-8,13-14,17H,9-12,15-16H2,1H3,(H,37,38) ATOJGDNDFRZGIY-UHFFFAOYSA-N 349717 2-{[4-(6-{[2-fluoro-4-(trifluoromethyl)benzyl]oxy}pyridin-2-yl)piperidin-1-yl]methyl}-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-02 Glucagon-like peptide 1 receptor Human 79.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349717&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208533 386051476 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691480 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C(F)(F)F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C28H26F4N4O3/c1-35-24-13-18(27(37)38)6-8-23(24)33-25(35)15-36-11-9-17(10-12-36)22-3-2-4-26(34-22)39-16-19-5-7-20(14-21(19)29)28(30,31)32/h2-8,13-14,17H,9-12,15-16H2,1H3,(H,37,38) ATOJGDNDFRZGIY-UHFFFAOYSA-N 349717 2-{[4-(6-{[2-fluoro-4-(trifluoromethyl)benzyl]oxy}pyridin-2-yl)piperidin-1-yl]methyl}-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-02 Glucagon-like peptide 1 receptor Human 4000 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349717&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208533 386051476 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691481 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(F)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H26F2N4O3/c1-32-24-13-18(27(34)35)6-8-23(24)30-25(32)15-33-11-9-17(10-12-33)22-3-2-4-26(31-22)36-16-19-5-7-20(28)14-21(19)29/h2-8,13-14,17H,9-12,15-16H2,1H3,(H,34,35) KWSQPUDNCIAXPU-UHFFFAOYSA-N 349718 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-03 Glucagon-like peptide 1 receptor Human 200 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349718&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208534 386051477 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691482 Cn1c(CN2CCC(CC2)c2cccc(OCc3c(F)cccc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H26F2N4O3/c1-32-24-14-18(27(34)35)8-9-23(24)30-25(32)15-33-12-10-17(11-13-33)22-6-3-7-26(31-22)36-16-19-20(28)4-2-5-21(19)29/h2-9,14,17H,10-13,15-16H2,1H3,(H,34,35) JQVABXMSJJPFMP-UHFFFAOYSA-N 349719 2-[(4-{6-[(2,6-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-04 Glucagon-like peptide 1 receptor Human 2900 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349719&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208535 386051478 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691483 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H27ClN4O3/c1-31-24-15-20(27(33)34)7-10-23(24)29-25(31)16-32-13-11-19(12-14-32)22-3-2-4-26(30-22)35-17-18-5-8-21(28)9-6-18/h2-10,15,19H,11-14,16-17H2,1H3,(H,33,34) RVUQCRSBZLCWQA-UHFFFAOYSA-N 349720 2-[(4-{6-[(4-chlorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-05::US10208019, Example 9A-07 Glucagon-like peptide 1 receptor Human 2700 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349720&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208536 386051479 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691484 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccccc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H27FN4O3/c1-31-24-15-19(27(33)34)9-10-23(24)29-25(31)16-32-13-11-18(12-14-32)22-7-4-8-26(30-22)35-17-20-5-2-3-6-21(20)28/h2-10,15,18H,11-14,16-17H2,1H3,(H,33,34) IRRZNMGGHGRLHS-UHFFFAOYSA-N 349721 2-[(4-{6-[(2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-06 Glucagon-like peptide 1 receptor Human 870 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349721 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349721&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208537 386051480 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691485 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H27ClN4O3/c1-31-24-15-20(27(33)34)7-10-23(24)29-25(31)16-32-13-11-19(12-14-32)22-3-2-4-26(30-22)35-17-18-5-8-21(28)9-6-18/h2-10,15,19H,11-14,16-17H2,1H3,(H,33,34) RVUQCRSBZLCWQA-UHFFFAOYSA-N 349720 2-[(4-{6-[(4-chlorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-05::US10208019, Example 9A-07 Glucagon-like peptide 1 receptor Human 170 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349720&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208536 386051479 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691486 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H27ClN4O3/c1-31-24-15-20(27(33)34)7-10-23(24)29-25(31)16-32-13-11-19(12-14-32)22-3-2-4-26(30-22)35-17-18-5-8-21(28)9-6-18/h2-10,15,19H,11-14,16-17H2,1H3,(H,33,34) RVUQCRSBZLCWQA-UHFFFAOYSA-N 349720 2-[(4-{6-[(4-chlorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-05::US10208019, Example 9A-07 Glucagon-like peptide 1 receptor Human 2100 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349720&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208536 386051479 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691487 Cn1c(CN2CCC(CC2)c2cccc(OCc3cccc(F)c3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H26F2N4O3/c1-32-23-14-18(27(34)35)8-9-22(23)30-24(32)15-33-12-10-17(11-13-33)21-6-3-7-25(31-21)36-16-19-4-2-5-20(28)26(19)29/h2-9,14,17H,10-13,15-16H2,1H3,(H,34,35) CZSIFAHOSPVOIA-UHFFFAOYSA-N 349723 2-[(4-{6-[(2,3-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-08 Glucagon-like peptide 1 receptor Human 2400 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349723&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208538 386051481 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691488 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(OC(F)(F)F)cc3)n2)nc2ccc(cc12)C(O)=O InChI=1S/C28H27F3N4O4/c1-34-24-15-20(27(36)37)7-10-23(24)32-25(34)16-35-13-11-19(12-14-35)22-3-2-4-26(33-22)38-17-18-5-8-21(9-6-18)39-28(29,30)31/h2-10,15,19H,11-14,16-17H2,1H3,(H,36,37) ONXGLTQORNOAEC-UHFFFAOYSA-N 349724 1-methyl-2-{[4-(6-{[4-(trifluoromethoxy)benzyl]oxy}pyridin-2-yl)piperidin-1-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-09 Glucagon-like peptide 1 receptor Human 880 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349724&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208539 386051482 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691489 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccccc3OC(F)(F)F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C28H27F3N4O4/c1-34-23-15-19(27(36)37)9-10-22(23)32-25(34)16-35-13-11-18(12-14-35)21-6-4-8-26(33-21)38-17-20-5-2-3-7-24(20)39-28(29,30)31/h2-10,15,18H,11-14,16-17H2,1H3,(H,36,37) XATUUKCTPNNCJN-UHFFFAOYSA-N 349725 1-methyl-2-{[4-(6-{[2-(trifluoromethoxy)benzyl]oxy}pyridin-2-yl)piperidin-1-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-10 Glucagon-like peptide 1 receptor Human 4500 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349725&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208540 386051483 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691490 Cc1ccccc1COc1cccc(n1)C1CCN(Cc2nc3ccc(cc3n2C)C(O)=O)CC1 InChI=1S/C28H30N4O3/c1-19-6-3-4-7-22(19)18-35-27-9-5-8-23(30-27)20-12-14-32(15-13-20)17-26-29-24-11-10-21(28(33)34)16-25(24)31(26)2/h3-11,16,20H,12-15,17-18H2,1-2H3,(H,33,34) PLRNXJDXQRCJRE-UHFFFAOYSA-N 349726 1-methyl-2-[(4-{6-[(2-methylbenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-11 Glucagon-like peptide 1 receptor Human 1600 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349726&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208541 386051484 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691491 Cn1c(CN2CCC(CC2)c2cccc(OCc3cccc(c3)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C28H27N5O3/c1-32-25-15-22(28(34)35)8-9-24(25)30-26(32)17-33-12-10-21(11-13-33)23-6-3-7-27(31-23)36-18-20-5-2-4-19(14-20)16-29/h2-9,14-15,21H,10-13,17-18H2,1H3,(H,34,35) YNVREYIOYRFFKY-UHFFFAOYSA-N 349727 2-[(4-{6-[(3-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-12 Glucagon-like peptide 1 receptor Human >17000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349727&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208542 386051485 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691492 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3)C(F)(F)F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C28H27F3N4O3/c1-34-24-15-20(27(36)37)7-10-23(24)32-25(34)16-35-13-11-19(12-14-35)22-3-2-4-26(33-22)38-17-18-5-8-21(9-6-18)28(29,30)31/h2-10,15,19H,11-14,16-17H2,1H3,(H,36,37) QVXROQVKRRYRSX-UHFFFAOYSA-N 349728 1-methyl-2-{[4-(6-{[4-(trifluoromethyl)benzyl]oxy}pyridin-2-yl)piperidin-1-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-13 Glucagon-like peptide 1 receptor Human 170 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349728&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208543 386051486 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691493 Cn1c(CN2CCC(CC2)c2cccc(OCc3cc(F)ccc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C27H26F2N4O3/c1-32-24-14-18(27(34)35)5-8-23(24)30-25(32)15-33-11-9-17(10-12-33)22-3-2-4-26(31-22)36-16-19-13-20(28)6-7-21(19)29/h2-8,13-14,17H,9-12,15-16H2,1H3,(H,34,35) FQIFPJAMQFQGRE-UHFFFAOYSA-N 349729 2-[(4-{6-[(2,5-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-14 Glucagon-like peptide 1 receptor Human 1800 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349729&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208544 386051487 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691494 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C28H27N5O3/c1-32-25-15-22(28(34)35)9-10-24(25)30-26(32)17-33-13-11-21(12-14-33)23-3-2-4-27(31-23)36-18-20-7-5-19(16-29)6-8-20/h2-10,15,21H,11-14,17-18H2,1H3,(H,34,35) AQBXHSPTORCTCI-UHFFFAOYSA-N 349730 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-15 Glucagon-like peptide 1 receptor Human 180 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349730&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208545 386051488 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691495 Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C28H27N5O3/c1-32-25-15-22(28(34)35)9-10-24(25)30-26(32)17-33-13-11-21(12-14-33)23-3-2-4-27(31-23)36-18-20-7-5-19(16-29)6-8-20/h2-10,15,21H,11-14,17-18H2,1H3,(H,34,35) AQBXHSPTORCTCI-UHFFFAOYSA-N 349730 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-methyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 9A-15 Glucagon-like peptide 1 receptor Human 3500 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349730&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208545 386051488 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691496 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cnco3)c2c1 InChI=1S/C30H27ClFN5O4/c31-22-6-4-21(24(32)13-22)17-40-29-3-1-2-25(35-29)19-8-10-36(11-9-19)16-28-34-26-7-5-20(30(38)39)12-27(26)37(28)15-23-14-33-18-41-23/h1-7,12-14,18-19H,8-11,15-17H2,(H,38,39) VBPFAHLTCDPLIP-UHFFFAOYSA-N 349731 2-[(4-{6-[(4-Chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-01 Glucagon-like peptide 1 receptor Human 3.20 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349731&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611028 386051489 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691497 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cnco3)c2c1 InChI=1S/C30H27ClFN5O4/c31-22-6-4-21(24(32)13-22)17-40-29-3-1-2-25(35-29)19-8-10-36(11-9-19)16-28-34-26-7-5-20(30(38)39)12-27(26)37(28)15-23-14-33-18-41-23/h1-7,12-14,18-19H,8-11,15-17H2,(H,38,39) VBPFAHLTCDPLIP-UHFFFAOYSA-N 349731 2-[(4-{6-[(4-Chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-01 Glucagon-like peptide 1 receptor Human 43.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349731&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611028 386051489 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691498 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H32ClFN6O3/c1-2-39-20-35-16-25(39)17-40-29-14-22(32(41)42)7-9-28(29)36-30(40)18-38-12-10-21(11-13-38)27-4-3-5-31(37-27)43-19-23-6-8-24(33)15-26(23)34/h3-9,14-16,20-21H,2,10-13,17-19H2,1H3,(H,41,42) LZFWKROSKZLYHR-UHFFFAOYSA-N 349732 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-02 Glucagon-like peptide 1 receptor Human 0.340 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349732&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611149 386051490 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691499 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H32ClFN6O3/c1-2-39-20-35-16-25(39)17-40-29-14-22(32(41)42)7-9-28(29)36-30(40)18-38-12-10-21(11-13-38)27-4-3-5-31(37-27)43-19-23-6-8-24(33)15-26(23)34/h3-9,14-16,20-21H,2,10-13,17-19H2,1H3,(H,41,42) LZFWKROSKZLYHR-UHFFFAOYSA-N 349732 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-02 Glucagon-like peptide 1 receptor Human 2.20 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349732&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611149 386051490 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691500 CC1(C)CC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)O1 InChI=1S/C32H34ClFN4O4/c1-32(2)16-24(42-32)17-38-28-14-21(31(39)40)7-9-27(28)35-29(38)18-37-12-10-20(11-13-37)26-4-3-5-30(36-26)41-19-22-6-8-23(33)15-25(22)34/h3-9,14-15,20,24H,10-13,16-19H2,1-2H3,(H,39,40) JCAOWKUHXMMLLL-UHFFFAOYSA-N 349733 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4,4-dimethyloxetan-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-03::US10208019, Example 10A-04 Glucagon-like peptide 1 receptor Human 1700 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349733&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208546 386051491 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691501 CC1(C)CC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)O1 InChI=1S/C32H34ClFN4O4/c1-32(2)16-24(42-32)17-38-28-14-21(31(39)40)7-9-27(28)35-29(38)18-37-12-10-20(11-13-37)26-4-3-5-30(36-26)41-19-22-6-8-23(33)15-25(22)34/h3-9,14-15,20,24H,10-13,16-19H2,1-2H3,(H,39,40) JCAOWKUHXMMLLL-UHFFFAOYSA-N 349733 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4,4-dimethyloxetan-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-03::US10208019, Example 10A-04 Glucagon-like peptide 1 receptor Human 49.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349733&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208546 386051491 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691502 CC1(C)CC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)O1 InChI=1S/C32H34ClFN4O4/c1-32(2)16-24(42-32)17-38-28-14-21(31(39)40)7-9-27(28)35-29(38)18-37-12-10-20(11-13-37)26-4-3-5-30(36-26)41-19-22-6-8-23(33)15-25(22)34/h3-9,14-15,20,24H,10-13,16-19H2,1-2H3,(H,39,40) JCAOWKUHXMMLLL-UHFFFAOYSA-N 349733 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4,4-dimethyloxetan-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-03::US10208019, Example 10A-04 Glucagon-like peptide 1 receptor Human 2100 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349733&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208546 386051491 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691503 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(F)cc4F)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C30H30F2N4O4/c31-22-6-4-21(24(32)15-22)18-40-29-3-1-2-25(34-29)19-8-11-35(12-9-19)17-28-33-26-7-5-20(30(37)38)14-27(26)36(28)16-23-10-13-39-23/h1-7,14-15,19,23H,8-13,16-18H2,(H,37,38)/t23-/m0/s1 MGOLYDAGSTYTCT-QHCPKHFHSA-N 349735 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-05 Glucagon-like peptide 1 receptor Human 2.40 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349735&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611146 386051492 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691504 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(F)cc4F)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C30H30F2N4O4/c31-22-6-4-21(24(32)15-22)18-40-29-3-1-2-25(34-29)19-8-11-35(12-9-19)17-28-33-26-7-5-20(30(37)38)14-27(26)36(28)16-23-10-13-39-23/h1-7,14-15,19,23H,8-13,16-18H2,(H,37,38)/t23-/m0/s1 MGOLYDAGSTYTCT-QHCPKHFHSA-N 349735 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-05 Glucagon-like peptide 1 receptor Human 38.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349735&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611146 386051492 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691505 CC(C)n1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H33ClFN7O3/c1-20(2)41-19-35-38-30(41)17-40-28-14-22(32(42)43)7-9-27(28)36-29(40)16-39-12-10-21(11-13-39)26-4-3-5-31(37-26)44-18-23-6-8-24(33)15-25(23)34/h3-9,14-15,19-21H,10-13,16-18H2,1-2H3,(H,42,43) MQZIEBUYNKEPRV-UHFFFAOYSA-N 349736 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-06 Glucagon-like peptide 1 receptor Human 68.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349736&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208547 386051493 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691506 CC(C)n1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H33ClFN7O3/c1-20(2)41-19-35-38-30(41)17-40-28-14-22(32(42)43)7-9-27(28)36-29(40)16-39-12-10-21(11-13-39)26-4-3-5-31(37-26)44-18-23-6-8-24(33)15-25(23)34/h3-9,14-15,19-21H,10-13,16-18H2,1-2H3,(H,42,43) MQZIEBUYNKEPRV-UHFFFAOYSA-N 349736 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-06 Glucagon-like peptide 1 receptor Human 1700 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349736&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208547 386051493 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691507 CCn1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H31ClFN7O3/c1-2-39-19-34-37-29(39)17-40-27-14-21(31(41)42)7-9-26(27)35-28(40)16-38-12-10-20(11-13-38)25-4-3-5-30(36-25)43-18-22-6-8-23(32)15-24(22)33/h3-9,14-15,19-20H,2,10-13,16-18H2,1H3,(H,41,42) KKFPEFVOHABYDX-UHFFFAOYSA-N 349737 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4-ethyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-07 Glucagon-like peptide 1 receptor Human 2.80 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349737&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208548 386051494 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691508 CCn1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H31ClFN7O3/c1-2-39-19-34-37-29(39)17-40-27-14-21(31(41)42)7-9-26(27)35-28(40)16-38-12-10-20(11-13-38)25-4-3-5-30(36-25)43-18-22-6-8-23(32)15-24(22)33/h3-9,14-15,19-20H,2,10-13,16-18H2,1H3,(H,41,42) KKFPEFVOHABYDX-UHFFFAOYSA-N 349737 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4-ethyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-07 Glucagon-like peptide 1 receptor Human 68.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349737&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208548 386051494 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691509 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C29H29ClFN5O4/c30-21-6-4-20(23(31)15-21)18-40-28-3-1-2-26(33-28)35-11-9-34(10-12-35)17-27-32-24-7-5-19(29(37)38)14-25(24)36(27)16-22-8-13-39-22/h1-7,14-15,22H,8-13,16-18H2,(H,37,38)/t22-/m0/s1 HEOZZICHEQVNNT-QFIPXVFZSA-N 349738 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-08 Glucagon-like peptide 1 receptor Human 0.550 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349738&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611076 386051495 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691510 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C29H29ClFN5O4/c30-21-6-4-20(23(31)15-21)18-40-28-3-1-2-26(33-28)35-11-9-34(10-12-35)17-27-32-24-7-5-19(29(37)38)14-25(24)36(27)16-22-8-13-39-22/h1-7,14-15,22H,8-13,16-18H2,(H,37,38)/t22-/m0/s1 HEOZZICHEQVNNT-QFIPXVFZSA-N 349738 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-08 Glucagon-like peptide 1 receptor Human 9.20 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349738&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611076 386051495 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691511 C[C@H]1CN(CCN1Cc1nc2ccc(nc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C30H30FN7O4/c1-19-15-37(26-3-2-4-28(35-26)42-18-21-6-5-20(14-32)13-23(21)31)11-10-36(19)17-27-33-24-7-8-25(30(39)40)34-29(24)38(27)16-22-9-12-41-22/h2-8,13,19,22H,9-12,15-18H2,1H3,(H,39,40)/t19-,22-/m0/s1 OZKITKMVFYBIAG-UGKGYDQZSA-N 349739 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-09 Glucagon-like peptide 1 receptor Human 0.990 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349739&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611023 386051496 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691512 C[C@H]1CN(CCN1Cc1nc2ccc(nc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C30H30FN7O4/c1-19-15-37(26-3-2-4-28(35-26)42-18-21-6-5-20(14-32)13-23(21)31)11-10-36(19)17-27-33-24-7-8-25(30(39)40)34-29(24)38(27)16-22-9-12-41-22/h2-8,13,19,22H,9-12,15-18H2,1H3,(H,39,40)/t19-,22-/m0/s1 OZKITKMVFYBIAG-UGKGYDQZSA-N 349739 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-09 Glucagon-like peptide 1 receptor Human 10.00 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349739&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611023 386051496 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691513 C[C@H]1CN(CCN1Cc1nc2ccc(nc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C29H30ClFN6O4/c1-18-14-36(25-3-2-4-27(34-25)41-17-19-5-6-20(30)13-22(19)31)11-10-35(18)16-26-32-23-7-8-24(29(38)39)33-28(23)37(26)15-21-9-12-40-21/h2-8,13,18,21H,9-12,14-17H2,1H3,(H,38,39)/t18-,21-/m0/s1 RKYFCKIFKKELMF-RXVVDRJESA-N 349740 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-10 Glucagon-like peptide 1 receptor Human 0.300 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349740&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611132 386051497 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691514 C[C@H]1CN(CCN1Cc1nc2ccc(nc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C29H30ClFN6O4/c1-18-14-36(25-3-2-4-27(34-25)41-17-19-5-6-20(30)13-22(19)31)11-10-35(18)16-26-32-23-7-8-24(29(38)39)33-28(23)37(26)15-21-9-12-40-21/h2-8,13,18,21H,9-12,14-17H2,1H3,(H,38,39)/t18-,21-/m0/s1 RKYFCKIFKKELMF-RXVVDRJESA-N 349740 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-10 Glucagon-like peptide 1 receptor Human 4.10 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349740&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611132 386051497 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691515 CN(C)CCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H33ClFN5O3/c1-35(2)14-15-37-27-16-21(30(38)39)7-9-26(27)33-28(37)18-36-12-10-20(11-13-36)25-4-3-5-29(34-25)40-19-22-6-8-23(31)17-24(22)32/h3-9,16-17,20H,10-15,18-19H2,1-2H3,(H,38,39) PBLNDIVXDSFGFZ-UHFFFAOYSA-N 349741 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(dimethylamino)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-11 Glucagon-like peptide 1 receptor Human 75.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349741&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208549 386051498 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691516 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCN3CCCC3=O)c2c1 InChI=1S/C32H33ClFN5O4/c33-24-8-6-23(25(34)18-24)20-43-30-4-1-3-26(36-30)21-10-13-37(14-11-21)19-29-35-27-9-7-22(32(41)42)17-28(27)39(29)16-15-38-12-2-5-31(38)40/h1,3-4,6-9,17-18,21H,2,5,10-16,19-20H2,(H,41,42) NCDGJXOJZALYPW-UHFFFAOYSA-N 349742 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(2-oxopyrrolidin-1-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-12 Glucagon-like peptide 1 receptor Human 110 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349742&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208550 386051499 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691517 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCN3CCCC3=O)c2c1 InChI=1S/C32H33ClFN5O4/c33-24-8-6-23(25(34)18-24)20-43-30-4-1-3-26(36-30)21-10-13-37(14-11-21)19-29-35-27-9-7-22(32(41)42)17-28(27)39(29)16-15-38-12-2-5-31(38)40/h1,3-4,6-9,17-18,21H,2,5,10-16,19-20H2,(H,41,42) NCDGJXOJZALYPW-UHFFFAOYSA-N 349742 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(2-oxopyrrolidin-1-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-12 Glucagon-like peptide 1 receptor Human 4400 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349742&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208550 386051499 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691518 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cocn1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H28ClFN6O4/c1-19-13-37(27-3-2-4-29(35-27)42-16-21-5-7-22(31)12-24(21)32)10-9-36(19)15-28-34-25-8-6-20(30(39)40)11-26(25)38(28)14-23-17-41-18-33-23/h2-8,11-12,17-19H,9-10,13-16H2,1H3,(H,39,40)/t19-/m0/s1 XVNUBAZDBSFGQA-IBGZPJMESA-N 349743 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-13 Glucagon-like peptide 1 receptor Human 4.10 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349743&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208551 386051500 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691519 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cocn1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H28ClFN6O4/c1-19-13-37(27-3-2-4-29(35-27)42-16-21-5-7-22(31)12-24(21)32)10-9-36(19)15-28-34-25-8-6-20(30(39)40)11-26(25)38(28)14-23-17-41-18-33-23/h2-8,11-12,17-19H,9-10,13-16H2,1H3,(H,39,40)/t19-/m0/s1 XVNUBAZDBSFGQA-IBGZPJMESA-N 349743 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-13 Glucagon-like peptide 1 receptor Human 170 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349743&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208551 386051500 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691520 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cocn1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C31H28FN7O4/c1-20-14-38(28-3-2-4-30(36-28)43-17-23-6-5-21(13-33)11-25(23)32)10-9-37(20)16-29-35-26-8-7-22(31(40)41)12-27(26)39(29)15-24-18-42-19-34-24/h2-8,11-12,18-20H,9-10,14-17H2,1H3,(H,40,41)/t20-/m0/s1 AFCVUIXVCXCDPS-FQEVSTJZSA-N 349744 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-14 Glucagon-like peptide 1 receptor Human 8.10 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349744&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208552 386051501 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691521 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cocn1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C31H28FN7O4/c1-20-14-38(28-3-2-4-30(36-28)43-17-23-6-5-21(13-33)11-25(23)32)10-9-37(20)16-29-35-26-8-7-22(31(40)41)12-27(26)39(29)15-24-18-42-19-34-24/h2-8,11-12,18-20H,9-10,14-17H2,1H3,(H,40,41)/t20-/m0/s1 AFCVUIXVCXCDPS-FQEVSTJZSA-N 349744 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-14 Glucagon-like peptide 1 receptor Human 220 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349744&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208552 386051501 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691522 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1ncco1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C31H28FN7O4/c1-20-16-38(27-3-2-4-29(36-27)43-19-23-6-5-21(15-33)13-24(23)32)11-10-37(20)17-28-35-25-8-7-22(31(40)41)14-26(25)39(28)18-30-34-9-12-42-30/h2-9,12-14,20H,10-11,16-19H2,1H3,(H,40,41)/t20-/m0/s1 YZCFDTHBGFWNIS-FQEVSTJZSA-N 349745 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-15 Glucagon-like peptide 1 receptor Human 1.30 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349745&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611022 386051502 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691523 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1ncco1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C31H28FN7O4/c1-20-16-38(27-3-2-4-29(36-27)43-19-23-6-5-21(15-33)13-24(23)32)11-10-37(20)17-28-35-25-8-7-22(31(40)41)14-26(25)39(28)18-30-34-9-12-42-30/h2-9,12-14,20H,10-11,16-19H2,1H3,(H,40,41)/t20-/m0/s1 YZCFDTHBGFWNIS-FQEVSTJZSA-N 349745 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-15 Glucagon-like peptide 1 receptor Human 27.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349745&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611022 386051502 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691524 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cnco1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H28ClFN6O4/c1-19-14-37(27-3-2-4-29(35-27)41-17-21-5-7-22(31)12-24(21)32)10-9-36(19)16-28-34-25-8-6-20(30(39)40)11-26(25)38(28)15-23-13-33-18-42-23/h2-8,11-13,18-19H,9-10,14-17H2,1H3,(H,39,40)/t19-/m0/s1 GUBXUCWEROKBFD-IBGZPJMESA-N 349746 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-16 Glucagon-like peptide 1 receptor Human 1.70 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349746&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611100 386051503 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691525 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cnco1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H28ClFN6O4/c1-19-14-37(27-3-2-4-29(35-27)41-17-21-5-7-22(31)12-24(21)32)10-9-36(19)16-28-34-25-8-6-20(30(39)40)11-26(25)38(28)15-23-13-33-18-42-23/h2-8,11-13,18-19H,9-10,14-17H2,1H3,(H,39,40)/t19-/m0/s1 GUBXUCWEROKBFD-IBGZPJMESA-N 349746 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-16 Glucagon-like peptide 1 receptor Human 45.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349746&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611100 386051503 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691526 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cnco1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C31H28FN7O4/c1-20-15-38(28-3-2-4-30(36-28)42-18-23-6-5-21(13-33)11-25(23)32)10-9-37(20)17-29-35-26-8-7-22(31(40)41)12-27(26)39(29)16-24-14-34-19-43-24/h2-8,11-12,14,19-20H,9-10,15-18H2,1H3,(H,40,41)/t20-/m0/s1 HJHXYMNSLTWVAZ-FQEVSTJZSA-N 349747 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-17 Glucagon-like peptide 1 receptor Human 1.80 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349747&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208553 386051504 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691527 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cnco1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C31H28FN7O4/c1-20-15-38(28-3-2-4-30(36-28)42-18-23-6-5-21(13-33)11-25(23)32)10-9-37(20)17-29-35-26-8-7-22(31(40)41)12-27(26)39(29)16-24-14-34-19-43-24/h2-8,11-12,14,19-20H,9-10,15-18H2,1H3,(H,40,41)/t20-/m0/s1 HJHXYMNSLTWVAZ-FQEVSTJZSA-N 349747 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-17 Glucagon-like peptide 1 receptor Human 59.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349747&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208553 386051504 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691528 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1ncco1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H28ClFN6O4/c1-19-15-37(26-3-2-4-28(35-26)42-18-21-5-7-22(31)14-23(21)32)11-10-36(19)16-27-34-24-8-6-20(30(39)40)13-25(24)38(27)17-29-33-9-12-41-29/h2-9,12-14,19H,10-11,15-18H2,1H3,(H,39,40)/t19-/m0/s1 XKYHUPKIMCLAID-IBGZPJMESA-N 349748 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-18 Glucagon-like peptide 1 receptor Human 1.60 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349748&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611141 386051505 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691529 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1ncco1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H28ClFN6O4/c1-19-15-37(26-3-2-4-28(35-26)42-18-21-5-7-22(31)14-23(21)32)11-10-36(19)16-27-34-24-8-6-20(30(39)40)13-25(24)38(27)17-29-33-9-12-41-29/h2-9,12-14,19H,10-11,15-18H2,1H3,(H,39,40)/t19-/m0/s1 XKYHUPKIMCLAID-IBGZPJMESA-N 349748 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-18 Glucagon-like peptide 1 receptor Human 33.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349748&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611141 386051505 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691530 CN1CC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)C1 InChI=1S/C31H33ClFN5O3/c1-36-15-20(16-36)17-38-28-13-22(31(39)40)6-8-27(28)34-29(38)18-37-11-9-21(10-12-37)26-3-2-4-30(35-26)41-19-23-5-7-24(32)14-25(23)33/h2-8,13-14,20-21H,9-12,15-19H2,1H3,(H,39,40) XSNYGEVGAYXCKW-UHFFFAOYSA-N 349749 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methylazetidin-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-19 Glucagon-like peptide 1 receptor Human >19000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349749&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208554 386051506 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691531 Cc1nnc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1C InChI=1S/C31H31ClFN7O3/c1-19-36-37-29(38(19)2)17-40-27-14-21(31(41)42)7-9-26(27)34-28(40)16-39-12-10-20(11-13-39)25-4-3-5-30(35-25)43-18-22-6-8-23(32)15-24(22)33/h3-9,14-15,20H,10-13,16-18H2,1-2H3,(H,41,42) RUIZMSHNGSKZPO-UHFFFAOYSA-N 349750 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4,5-dimethyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-20 Glucagon-like peptide 1 receptor Human >15000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349750&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208555 386051507 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691532 Cc1nnc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1C InChI=1S/C31H31ClFN7O3/c1-19-36-37-29(38(19)2)17-40-27-14-21(31(41)42)7-9-26(27)34-28(40)16-39-12-10-20(11-13-39)25-4-3-5-30(35-25)43-18-22-6-8-23(32)15-24(22)33/h3-9,14-15,20H,10-13,16-18H2,1-2H3,(H,41,42) RUIZMSHNGSKZPO-UHFFFAOYSA-N 349750 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4,5-dimethyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-20 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349750&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208555 386051507 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691533 CCn1cnnc1Cn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H32ClFN8O3/c1-3-38-19-34-37-29(38)17-41-26-13-21(31(42)43)8-10-25(26)35-28(41)16-39-11-12-40(15-20(39)2)27-5-4-6-30(36-27)44-18-22-7-9-23(32)14-24(22)33/h4-10,13-14,19-20H,3,11-12,15-18H2,1-2H3,(H,42,43)/t20-/m0/s1 PVSBJUMNPUPYKN-FQEVSTJZSA-N 349751 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(4-ethyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-21 Glucagon-like peptide 1 receptor Human 18.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349751&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208556 386051508 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691534 CCn1cnnc1Cn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H32ClFN8O3/c1-3-38-19-34-37-29(38)17-41-26-13-21(31(42)43)8-10-25(26)35-28(41)16-39-11-12-40(15-20(39)2)27-5-4-6-30(36-27)44-18-22-7-9-23(32)14-24(22)33/h4-10,13-14,19-20H,3,11-12,15-18H2,1-2H3,(H,42,43)/t20-/m0/s1 PVSBJUMNPUPYKN-FQEVSTJZSA-N 349751 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(4-ethyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-21 Glucagon-like peptide 1 receptor Human 400 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349751&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208556 386051508 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691535 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cnnn1C)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H30ClFN8O3/c1-19-15-39(27-4-3-5-29(35-27)43-18-21-6-8-22(31)13-24(21)32)11-10-38(19)17-28-34-25-9-7-20(30(41)42)12-26(25)40(28)16-23-14-33-36-37(23)2/h3-9,12-14,19H,10-11,15-18H2,1-2H3,(H,41,42)/t19-/m0/s1 HSXUQQRVUNVBDQ-IBGZPJMESA-N 349752 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(1-methyl-1H-1,2,3-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-22 Glucagon-like peptide 1 receptor Human 5.70 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349752&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208557 386051509 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691536 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cnnn1C)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H30ClFN8O3/c1-19-15-39(27-4-3-5-29(35-27)43-18-21-6-8-22(31)13-24(21)32)11-10-38(19)17-28-34-25-9-7-20(30(41)42)12-26(25)40(28)16-23-14-33-36-37(23)2/h3-9,12-14,19H,10-11,15-18H2,1-2H3,(H,41,42)/t19-/m0/s1 HSXUQQRVUNVBDQ-IBGZPJMESA-N 349752 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(1-methyl-1H-1,2,3-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-22 Glucagon-like peptide 1 receptor Human 100.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349752&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208557 386051509 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691537 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cnnn1C)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C31H30FN9O3/c1-20-16-40(28-4-3-5-30(36-28)44-19-23-7-6-21(14-33)12-25(23)32)11-10-39(20)18-29-35-26-9-8-22(31(42)43)13-27(26)41(29)17-24-15-34-37-38(24)2/h3-9,12-13,15,20H,10-11,16-19H2,1-2H3,(H,42,43)/t20-/m0/s1 FGPJCAXLCVJZJR-FQEVSTJZSA-N 349753 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(1-methyl-1H-1,2,3-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-23 Glucagon-like peptide 1 receptor Human 38.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349753&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208558 386051510 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691538 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cnnn1C)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C31H30FN9O3/c1-20-16-40(28-4-3-5-30(36-28)44-19-23-7-6-21(14-33)12-25(23)32)11-10-39(20)18-29-35-26-9-8-22(31(42)43)13-27(26)41(29)17-24-15-34-37-38(24)2/h3-9,12-13,15,20H,10-11,16-19H2,1-2H3,(H,42,43)/t20-/m0/s1 FGPJCAXLCVJZJR-FQEVSTJZSA-N 349753 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(1-methyl-1H-1,2,3-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-23 Glucagon-like peptide 1 receptor Human 760 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349753&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208558 386051510 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691539 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3cnco3)c2n1 InChI=1S/C30H26FN7O4/c31-23-12-19(13-32)4-5-21(23)17-41-28-3-1-2-24(35-28)20-8-10-37(11-9-20)16-27-34-25-6-7-26(30(39)40)36-29(25)38(27)15-22-14-33-18-42-22/h1-7,12,14,18,20H,8-11,15-17H2,(H,39,40) XYNURCMZBARSGK-UHFFFAOYSA-N 349754 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-(1,3-oxazol-5-ylmethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-24 Glucagon-like peptide 1 receptor Human 5.70 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349754&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208559 386051511 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691540 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3cnco3)c2n1 InChI=1S/C30H26FN7O4/c31-23-12-19(13-32)4-5-21(23)17-41-28-3-1-2-24(35-28)20-8-10-37(11-9-20)16-27-34-25-6-7-26(30(39)40)36-29(25)38(27)15-22-14-33-18-42-22/h1-7,12,14,18,20H,8-11,15-17H2,(H,39,40) XYNURCMZBARSGK-UHFFFAOYSA-N 349754 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-(1,3-oxazol-5-ylmethyl)-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-24 Glucagon-like peptide 1 receptor Human 130 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349754&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208559 386051511 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691541 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cncn1C)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C32H31FN8O3/c1-21-16-40(29-4-3-5-31(37-29)44-19-24-7-6-22(14-34)12-26(24)33)11-10-39(21)18-30-36-27-9-8-23(32(42)43)13-28(27)41(30)17-25-15-35-20-38(25)2/h3-9,12-13,15,20-21H,10-11,16-19H2,1-2H3,(H,42,43)/t21-/m0/s1 CNODQZZKYGRRAS-NRFANRHFSA-N 349755 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-25 Glucagon-like peptide 1 receptor Human 1.70 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349755&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208560 386051512 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691542 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cncn1C)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C32H31FN8O3/c1-21-16-40(29-4-3-5-31(37-29)44-19-24-7-6-22(14-34)12-26(24)33)11-10-39(21)18-30-36-27-9-8-23(32(42)43)13-28(27)41(30)17-25-15-35-20-38(25)2/h3-9,12-13,15,20-21H,10-11,16-19H2,1-2H3,(H,42,43)/t21-/m0/s1 CNODQZZKYGRRAS-NRFANRHFSA-N 349755 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-25 Glucagon-like peptide 1 receptor Human 41.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349755&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208560 386051512 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691543 COC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CCC1 InChI=1S/C32H34ClFN4O4/c1-41-32(12-3-13-32)20-38-28-16-22(31(39)40)7-9-27(28)35-29(38)18-37-14-10-21(11-15-37)26-4-2-5-30(36-26)42-19-23-6-8-24(33)17-25(23)34/h2,4-9,16-17,21H,3,10-15,18-20H2,1H3,(H,39,40) ZNJWWBZJDHDSLA-UHFFFAOYSA-N 349756 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methoxycyclobutyl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-26 Glucagon-like peptide 1 receptor Human 7.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349756&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611054 386051513 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691544 COC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CCC1 InChI=1S/C32H34ClFN4O4/c1-41-32(12-3-13-32)20-38-28-16-22(31(39)40)7-9-27(28)35-29(38)18-37-14-10-21(11-15-37)26-4-2-5-30(36-26)42-19-23-6-8-24(33)17-25(23)34/h2,4-9,16-17,21H,3,10-15,18-20H2,1H3,(H,39,40) ZNJWWBZJDHDSLA-UHFFFAOYSA-N 349756 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methoxycyclobutyl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-26 Glucagon-like peptide 1 receptor Human 190 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349756&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611054 386051513 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691545 CC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)COC1 InChI=1S/C31H32ClFN4O4/c1-31(18-40-19-31)17-37-27-13-21(30(38)39)6-8-26(27)34-28(37)15-36-11-9-20(10-12-36)25-3-2-4-29(35-25)41-16-22-5-7-23(32)14-24(22)33/h2-8,13-14,20H,9-12,15-19H2,1H3,(H,38,39) ORTFSZUWUBZAKJ-UHFFFAOYSA-N 349757 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3-methyloxetan-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-27 Glucagon-like peptide 1 receptor Human 13.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349757&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208561 386051514 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691546 CC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)COC1 InChI=1S/C31H32ClFN4O4/c1-31(18-40-19-31)17-37-27-13-21(30(38)39)6-8-26(27)34-28(37)15-36-11-9-20(10-12-36)25-3-2-4-29(35-25)41-16-22-5-7-23(32)14-24(22)33/h2-8,13-14,20H,9-12,15-19H2,1H3,(H,38,39) ORTFSZUWUBZAKJ-UHFFFAOYSA-N 349757 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3-methyloxetan-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-27 Glucagon-like peptide 1 receptor Human 250 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349757&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208561 386051514 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691547 CC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)COC1 InChI=1S/C31H32ClFN4O4/c1-31(18-40-19-31)17-37-27-13-21(30(38)39)6-8-26(27)34-28(37)15-36-11-9-20(10-12-36)25-3-2-4-29(35-25)41-16-22-5-7-23(32)14-24(22)33/h2-8,13-14,20H,9-12,15-19H2,1H3,(H,38,39) ORTFSZUWUBZAKJ-UHFFFAOYSA-N 349757 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3-methyloxetan-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-27 Glucagon-like peptide 1 receptor Human 50.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349757&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208561 386051514 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691548 CC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)COC1 InChI=1S/C31H32ClFN4O4/c1-31(18-40-19-31)17-37-27-13-21(30(38)39)6-8-26(27)34-28(37)15-36-11-9-20(10-12-36)25-3-2-4-29(35-25)41-16-22-5-7-23(32)14-24(22)33/h2-8,13-14,20H,9-12,15-19H2,1H3,(H,38,39) ORTFSZUWUBZAKJ-UHFFFAOYSA-N 349757 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3-methyloxetan-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-27 Glucagon-like peptide 1 receptor Human 870 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349757&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208561 386051514 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691549 Cc1nnc(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)o1 InChI=1S/C31H30ClFN6O4/c1-19-36-37-30(43-19)11-14-39-27-15-21(31(40)41)6-8-26(27)34-28(39)17-38-12-9-20(10-13-38)25-3-2-4-29(35-25)42-18-22-5-7-23(32)16-24(22)33/h2-8,15-16,20H,9-14,17-18H2,1H3,(H,40,41) OICUMTZNNHVYHF-UHFFFAOYSA-N 349758 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(5-methyl-1,3,4-oxadiazol-2-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-28 Glucagon-like peptide 1 receptor Human 190 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349758&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208562 386051515 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691550 Cc1nnc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)o1 InChI=1S/C30H28ClFN6O4/c1-18-35-36-29(42-18)16-38-26-13-20(30(39)40)6-8-25(26)33-27(38)15-37-11-9-19(10-12-37)24-3-2-4-28(34-24)41-17-21-5-7-22(31)14-23(21)32/h2-8,13-14,19H,9-12,15-17H2,1H3,(H,39,40) FJEUBBLFIZXECZ-UHFFFAOYSA-N 349759 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-29 Glucagon-like peptide 1 receptor Human 390 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349759&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208563 386051516 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691551 Cn1cnc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)c1 InChI=1S/C31H30ClFN6O3/c1-37-15-24(34-19-37)16-39-28-13-21(31(40)41)6-8-27(28)35-29(39)17-38-11-9-20(10-12-38)26-3-2-4-30(36-26)42-18-22-5-7-23(32)14-25(22)33/h2-8,13-15,19-20H,9-12,16-18H2,1H3,(H,40,41) JLBLGDLNIWTZCS-UHFFFAOYSA-N 349760 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-4-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-30 Glucagon-like peptide 1 receptor Human 550 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349760&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208564 386051517 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691552 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(F)cc4F)n3)n(Cc3ncco3)c2c1 InChI=1S/C30H27F2N5O4/c31-22-6-4-21(23(32)15-22)18-41-28-3-1-2-24(35-28)19-8-11-36(12-9-19)16-27-34-25-7-5-20(30(38)39)14-26(25)37(27)17-29-33-10-13-40-29/h1-7,10,13-15,19H,8-9,11-12,16-18H2,(H,38,39) AKULQFSHEFUQBF-UHFFFAOYSA-N 349761 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-31 Glucagon-like peptide 1 receptor Human 3.40 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349761&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611082 386051518 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691553 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(F)cc4F)n3)n(Cc3ncco3)c2c1 InChI=1S/C30H27F2N5O4/c31-22-6-4-21(23(32)15-22)18-41-28-3-1-2-24(35-28)19-8-11-36(12-9-19)16-27-34-25-7-5-20(30(38)39)14-26(25)37(27)17-29-33-10-13-40-29/h1-7,10,13-15,19H,8-9,11-12,16-18H2,(H,38,39) AKULQFSHEFUQBF-UHFFFAOYSA-N 349761 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-31 Glucagon-like peptide 1 receptor Human 59.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349761&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611082 386051518 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691554 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(F)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H32F2N6O3/c1-2-39-20-35-16-25(39)17-40-29-14-22(32(41)42)7-9-28(29)36-30(40)18-38-12-10-21(11-13-38)27-4-3-5-31(37-27)43-19-23-6-8-24(33)15-26(23)34/h3-9,14-16,20-21H,2,10-13,17-19H2,1H3,(H,41,42) IFXPEJAGKQFBER-UHFFFAOYSA-N 349762 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-32 Glucagon-like peptide 1 receptor Human 0.470 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349762&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 82L 7S15 134611223 386051519 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691555 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(F)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H32F2N6O3/c1-2-39-20-35-16-25(39)17-40-29-14-22(32(41)42)7-9-28(29)36-30(40)18-38-12-10-21(11-13-38)27-4-3-5-31(37-27)43-19-23-6-8-24(33)15-26(23)34/h3-9,14-16,20-21H,2,10-13,17-19H2,1H3,(H,41,42) IFXPEJAGKQFBER-UHFFFAOYSA-N 349762 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-32 Glucagon-like peptide 1 receptor Human 5.00 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349762&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 82L 7S15 134611223 386051519 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691556 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ncco3)c2c1 InChI=1S/C29H26ClFN6O4/c30-21-6-4-20(22(31)15-21)18-41-27-3-1-2-25(34-27)36-11-9-35(10-12-36)16-26-33-23-7-5-19(29(38)39)14-24(23)37(26)17-28-32-8-13-40-28/h1-8,13-15H,9-12,16-18H2,(H,38,39) FIUTUKCXJKLYNY-UHFFFAOYSA-N 349763 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-33 Glucagon-like peptide 1 receptor Human 1.50 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349763&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611080 386051520 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691557 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ncco3)c2c1 InChI=1S/C29H26ClFN6O4/c30-21-6-4-20(22(31)15-21)18-41-27-3-1-2-25(34-27)36-11-9-35(10-12-36)16-26-33-23-7-5-19(29(38)39)14-24(23)37(26)17-28-32-8-13-40-28/h1-8,13-15H,9-12,16-18H2,(H,38,39) FIUTUKCXJKLYNY-UHFFFAOYSA-N 349763 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-33 Glucagon-like peptide 1 receptor Human 24.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349763&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611080 386051520 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691558 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3ncco3)c2c1 InChI=1S/C30H26FN7O4/c31-23-14-20(16-32)4-5-22(23)19-42-28-3-1-2-26(35-28)37-11-9-36(10-12-37)17-27-34-24-7-6-21(30(39)40)15-25(24)38(27)18-29-33-8-13-41-29/h1-8,13-15H,9-12,17-19H2,(H,39,40) ZAULIVVEBASLNV-UHFFFAOYSA-N 349764 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-34 Glucagon-like peptide 1 receptor Human 1.50 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349764&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611029 386051521 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691559 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3ncco3)c2c1 InChI=1S/C30H26FN7O4/c31-23-14-20(16-32)4-5-22(23)19-42-28-3-1-2-26(35-28)37-11-9-36(10-12-37)17-27-34-24-7-6-21(30(39)40)15-25(24)38(27)18-29-33-8-13-41-29/h1-8,13-15H,9-12,17-19H2,(H,39,40) ZAULIVVEBASLNV-UHFFFAOYSA-N 349764 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-34 Glucagon-like peptide 1 receptor Human 29.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349764&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611029 386051521 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691560 CCn1cncc1Cn1c(CN2CCN(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H31FN8O3/c1-2-39-21-35-17-25(39)18-41-28-15-23(32(42)43)8-9-27(28)36-30(41)19-38-10-12-40(13-11-38)29-4-3-5-31(37-29)44-20-24-7-6-22(16-34)14-26(24)33/h3-9,14-15,17,21H,2,10-13,18-20H2,1H3,(H,42,43) XNNLCCDKBAIKHT-UHFFFAOYSA-N 349765 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-35 Glucagon-like peptide 1 receptor Human 0.300 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349765&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611026 386051522 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691561 CCn1cncc1Cn1c(CN2CCN(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H31FN8O3/c1-2-39-21-35-17-25(39)18-41-28-15-23(32(42)43)8-9-27(28)36-30(41)19-38-10-12-40(13-11-38)29-4-3-5-31(37-29)44-20-24-7-6-22(16-34)14-26(24)33/h3-9,14-15,17,21H,2,10-13,18-20H2,1H3,(H,42,43) XNNLCCDKBAIKHT-UHFFFAOYSA-N 349765 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-35 Glucagon-like peptide 1 receptor Human 3.80 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349765&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611026 386051522 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691562 Cn1cncc1Cn1c(CN2CCN(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN7O3/c1-36-19-33-15-23(36)16-39-26-13-20(30(40)41)6-8-25(26)34-28(39)17-37-9-11-38(12-10-37)27-3-2-4-29(35-27)42-18-21-5-7-22(31)14-24(21)32/h2-8,13-15,19H,9-12,16-18H2,1H3,(H,40,41) KUFGQAHAJORGEJ-UHFFFAOYSA-N 349766 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-36 Glucagon-like peptide 1 receptor Human 0.330 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349766&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611070 386051523 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691563 Cn1cncc1Cn1c(CN2CCN(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN7O3/c1-36-19-33-15-23(36)16-39-26-13-20(30(40)41)6-8-25(26)34-28(39)17-37-9-11-38(12-10-37)27-3-2-4-29(35-27)42-18-21-5-7-22(31)14-24(21)32/h2-8,13-15,19H,9-12,16-18H2,1H3,(H,40,41) KUFGQAHAJORGEJ-UHFFFAOYSA-N 349766 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-36 Glucagon-like peptide 1 receptor Human 13.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349766&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611070 386051523 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691564 Cn1cncc1Cn1c(CN2CCN(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H29FN8O3/c1-37-20-34-16-24(37)17-40-27-14-22(31(41)42)7-8-26(27)35-29(40)18-38-9-11-39(12-10-38)28-3-2-4-30(36-28)43-19-23-6-5-21(15-33)13-25(23)32/h2-8,13-14,16,20H,9-12,17-19H2,1H3,(H,41,42) UKUDXTCSFFALTE-UHFFFAOYSA-N 349767 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-37 Glucagon-like peptide 1 receptor Human 3.40 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349767&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611027 386051524 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691565 Cn1cncc1Cn1c(CN2CCN(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H29FN8O3/c1-37-20-34-16-24(37)17-40-27-14-22(31(41)42)7-8-26(27)35-29(40)18-38-9-11-39(12-10-38)28-3-2-4-30(36-28)43-19-23-6-5-21(15-33)13-25(23)32/h2-8,13-14,16,20H,9-12,17-19H2,1H3,(H,41,42) UKUDXTCSFFALTE-UHFFFAOYSA-N 349767 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-37 Glucagon-like peptide 1 receptor Human 23.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349767&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611027 386051524 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691566 Cn1ccnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H30ClFN6O3/c1-37-14-11-34-28(37)18-39-27-15-21(31(40)41)6-8-26(27)35-29(39)17-38-12-9-20(10-13-38)25-3-2-4-30(36-25)42-19-22-5-7-23(32)16-24(22)33/h2-8,11,14-16,20H,9-10,12-13,17-19H2,1H3,(H,40,41) RRXMBJVJHJJPLH-UHFFFAOYSA-N 349768 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-38 Glucagon-like peptide 1 receptor Human 130 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349768&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208565 386051525 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691567 CCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C28H28ClFN4O3/c1-2-34-25-14-19(28(35)36)7-9-24(25)31-26(34)16-33-12-10-18(11-13-33)23-4-3-5-27(32-23)37-17-20-6-8-21(29)15-22(20)30/h3-9,14-15,18H,2,10-13,16-17H2,1H3,(H,35,36) LXXGFWSWETZUHL-UHFFFAOYSA-N 349769 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-ethyl-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-39 Glucagon-like peptide 1 receptor Human 170 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349769&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208566 386051526 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691568 CC(C)n1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H30ClFN4O3/c1-18(2)35-26-14-20(29(36)37)7-9-25(26)32-27(35)16-34-12-10-19(11-13-34)24-4-3-5-28(33-24)38-17-21-6-8-22(30)15-23(21)31/h3-9,14-15,18-19H,10-13,16-17H2,1-2H3,(H,36,37) DMHGOXXGEJODEA-UHFFFAOYSA-N 349770 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(propan-2-yl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-40 Glucagon-like peptide 1 receptor Human 1200 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349770&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208567 386051527 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691569 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cocn3)c2c1 InChI=1S/C30H27ClFN5O4/c31-22-6-4-21(24(32)13-22)16-41-29-3-1-2-25(35-29)19-8-10-36(11-9-19)15-28-34-26-7-5-20(30(38)39)12-27(26)37(28)14-23-17-40-18-33-23/h1-7,12-13,17-19H,8-11,14-16H2,(H,38,39) ZPTQGMVSXQKVJA-UHFFFAOYSA-N 349771 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-41 Glucagon-like peptide 1 receptor Human 12.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349771&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611119 386051528 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691570 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cocn3)c2c1 InChI=1S/C30H27ClFN5O4/c31-22-6-4-21(24(32)13-22)16-41-29-3-1-2-25(35-29)19-8-10-36(11-9-19)15-28-34-26-7-5-20(30(38)39)12-27(26)37(28)14-23-17-40-18-33-23/h1-7,12-13,17-19H,8-11,14-16H2,(H,38,39) ZPTQGMVSXQKVJA-UHFFFAOYSA-N 349771 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-41 Glucagon-like peptide 1 receptor Human 140 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349771&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611119 386051528 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691571 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ncco3)c2c1 InChI=1S/C30H27ClFN5O4/c31-22-6-4-21(23(32)15-22)18-41-28-3-1-2-24(35-28)19-8-11-36(12-9-19)16-27-34-25-7-5-20(30(38)39)14-26(25)37(27)17-29-33-10-13-40-29/h1-7,10,13-15,19H,8-9,11-12,16-18H2,(H,38,39) BMPHLUBITKQXBW-UHFFFAOYSA-N 349772 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-42 Glucagon-like peptide 1 receptor Human 2.70 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349772&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611118 386051529 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691572 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ncco3)c2c1 InChI=1S/C30H27ClFN5O4/c31-22-6-4-21(23(32)15-22)18-41-28-3-1-2-24(35-28)19-8-11-36(12-9-19)16-27-34-25-7-5-20(30(38)39)14-26(25)37(27)17-29-33-10-13-40-29/h1-7,10,13-15,19H,8-9,11-12,16-18H2,(H,38,39) BMPHLUBITKQXBW-UHFFFAOYSA-N 349772 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-42 Glucagon-like peptide 1 receptor Human 29.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349772&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611118 386051529 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691573 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3cnco3)c2c1 InChI=1S/C31H27FN6O4/c32-25-12-20(14-33)4-5-23(25)18-41-30-3-1-2-26(36-30)21-8-10-37(11-9-21)17-29-35-27-7-6-22(31(39)40)13-28(27)38(29)16-24-15-34-19-42-24/h1-7,12-13,15,19,21H,8-11,16-18H2,(H,39,40) MXWZLVOFIPRJMR-UHFFFAOYSA-N 349773 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-43 Glucagon-like peptide 1 receptor Human 4.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349773&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611177 386051530 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691574 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3cnco3)c2c1 InChI=1S/C31H27FN6O4/c32-25-12-20(14-33)4-5-23(25)18-41-30-3-1-2-26(36-30)21-8-10-37(11-9-21)17-29-35-27-7-6-22(31(39)40)13-28(27)38(29)16-24-15-34-19-42-24/h1-7,12-13,15,19,21H,8-11,16-18H2,(H,39,40) MXWZLVOFIPRJMR-UHFFFAOYSA-N 349773 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-43 Glucagon-like peptide 1 receptor Human 48.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349773&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611177 386051530 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691575 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(F)cc4F)n3)n(Cc3cnco3)c2c1 InChI=1S/C30H27F2N5O4/c31-22-6-4-21(24(32)13-22)17-40-29-3-1-2-25(35-29)19-8-10-36(11-9-19)16-28-34-26-7-5-20(30(38)39)12-27(26)37(28)15-23-14-33-18-41-23/h1-7,12-14,18-19H,8-11,15-17H2,(H,38,39) GZUZQZQINOFHND-UHFFFAOYSA-N 349774 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-44 Glucagon-like peptide 1 receptor Human 6.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349774&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611024 386051531 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691576 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(F)cc4F)n3)n(Cc3cnco3)c2c1 InChI=1S/C30H27F2N5O4/c31-22-6-4-21(24(32)13-22)17-40-29-3-1-2-25(35-29)19-8-10-36(11-9-19)16-28-34-26-7-5-20(30(38)39)12-27(26)37(28)15-23-14-33-18-41-23/h1-7,12-14,18-19H,8-11,15-17H2,(H,38,39) GZUZQZQINOFHND-UHFFFAOYSA-N 349774 2-[(4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-44 Glucagon-like peptide 1 receptor Human 99.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349774&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611024 386051531 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691577 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cnco3)c2c1 InChI=1S/C29H26ClFN6O4/c30-21-6-4-20(23(31)13-21)17-40-28-3-1-2-26(34-28)36-10-8-35(9-11-36)16-27-33-24-7-5-19(29(38)39)12-25(24)37(27)15-22-14-32-18-41-22/h1-7,12-14,18H,8-11,15-17H2,(H,38,39) LYPNLENSLKGIJB-UHFFFAOYSA-N 349775 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-45 Glucagon-like peptide 1 receptor Human 1.000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349775&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611098 386051532 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691578 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cnco3)c2c1 InChI=1S/C29H26ClFN6O4/c30-21-6-4-20(23(31)13-21)17-40-28-3-1-2-26(34-28)36-10-8-35(9-11-36)16-27-33-24-7-5-19(29(38)39)12-25(24)37(27)15-22-14-32-18-41-22/h1-7,12-14,18H,8-11,15-17H2,(H,38,39) LYPNLENSLKGIJB-UHFFFAOYSA-N 349775 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-45 Glucagon-like peptide 1 receptor Human 19.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349775&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611098 386051532 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691579 CC(C)(C)n1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C33H35ClFN7O3/c1-33(2,3)42-20-36-39-30(42)18-41-28-15-22(32(43)44)8-10-27(28)37-29(41)17-40-13-11-21(12-14-40)26-5-4-6-31(38-26)45-19-23-7-9-24(34)16-25(23)35/h4-10,15-16,20-21H,11-14,17-19H2,1-3H3,(H,43,44) MZWVGGHWGSLFTK-UHFFFAOYSA-N 349776 1-[(4-tert-butyl-4H-1,2,4-triazol-3-yl)methyl]-2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-46 Glucagon-like peptide 1 receptor Human 1700 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349776&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208568 386051533 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691580 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C31H31FN6O4/c1-20-16-37(28-3-2-4-30(35-28)42-19-23-6-5-21(15-33)13-25(23)32)11-10-36(20)18-29-34-26-8-7-22(31(39)40)14-27(26)38(29)17-24-9-12-41-24/h2-8,13-14,20,24H,9-12,16-19H2,1H3,(H,39,40)/t20-,24-/m0/s1 CFAVRXZUGJHUQM-RDPSFJRHSA-N 349777 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-47 Glucagon-like peptide 1 receptor Human 0.300 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349777&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611059 386051534 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691581 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C31H31FN6O4/c1-20-16-37(28-3-2-4-30(35-28)42-19-23-6-5-21(15-33)13-25(23)32)11-10-36(20)18-29-34-26-8-7-22(31(39)40)14-27(26)38(29)17-24-9-12-41-24/h2-8,13-14,20,24H,9-12,16-19H2,1H3,(H,39,40)/t20-,24-/m0/s1 CFAVRXZUGJHUQM-RDPSFJRHSA-N 349777 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-47 Glucagon-like peptide 1 receptor Human 4.40 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349777&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611059 386051534 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691582 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@H]3CCO3)c2c1 InChI=1S/C29H29ClFN5O4/c30-21-6-4-20(23(31)15-21)18-40-28-3-1-2-26(33-28)35-11-9-34(10-12-35)17-27-32-24-7-5-19(29(37)38)14-25(24)36(27)16-22-8-13-39-22/h1-7,14-15,22H,8-13,16-18H2,(H,37,38)/t22-/m1/s1 HEOZZICHEQVNNT-JOCHJYFZSA-N 349778 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(2R)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-48 Glucagon-like peptide 1 receptor Human 8.60 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349778&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208569 386051535 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691583 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@H]3CCO3)c2c1 InChI=1S/C29H29ClFN5O4/c30-21-6-4-20(23(31)15-21)18-40-28-3-1-2-26(33-28)35-11-9-34(10-12-35)17-27-32-24-7-5-19(29(37)38)14-25(24)36(27)16-22-8-13-39-22/h1-7,14-15,22H,8-13,16-18H2,(H,37,38)/t22-/m1/s1 HEOZZICHEQVNNT-JOCHJYFZSA-N 349778 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(2R)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-48 Glucagon-like peptide 1 receptor Human 140 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349778&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208569 386051535 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691584 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(cc2)C#N)n1 InChI=1S/C31H32N6O4/c1-21-17-36(28-3-2-4-30(34-28)41-20-23-7-5-22(16-32)6-8-23)13-12-35(21)19-29-33-26-10-9-24(31(38)39)15-27(26)37(29)18-25-11-14-40-25/h2-10,15,21,25H,11-14,17-20H2,1H3,(H,38,39)/t21-,25-/m0/s1 FZNRZOTZQPJANW-OFVILXPXSA-N 349779 2-{[(2S)-4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-49 Glucagon-like peptide 1 receptor Human 0.560 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349779&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611178 386051536 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691585 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(cc2)C#N)n1 InChI=1S/C31H32N6O4/c1-21-17-36(28-3-2-4-30(34-28)41-20-23-7-5-22(16-32)6-8-23)13-12-35(21)19-29-33-26-10-9-24(31(38)39)15-27(26)37(29)18-25-11-14-40-25/h2-10,15,21,25H,11-14,17-20H2,1H3,(H,38,39)/t21-,25-/m0/s1 FZNRZOTZQPJANW-OFVILXPXSA-N 349779 2-{[(2S)-4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-49 Glucagon-like peptide 1 receptor Human 9.60 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349779&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611178 386051536 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691586 OCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C28H28ClFN4O4/c29-21-6-4-20(22(30)15-21)17-38-27-3-1-2-23(32-27)18-8-10-33(11-9-18)16-26-31-24-7-5-19(28(36)37)14-25(24)34(26)12-13-35/h1-7,14-15,18,35H,8-13,16-17H2,(H,36,37) SOGFEOQOINQMQT-UHFFFAOYSA-N 349780 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-hydroxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-50 Glucagon-like peptide 1 receptor Human 290 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349780&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208570 386051537 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691587 CCc1nc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)no1 InChI=1S/C31H30ClFN6O4/c1-2-29-36-27(37-43-29)16-39-26-14-20(31(40)41)7-9-25(26)34-28(39)17-38-12-10-19(11-13-38)24-4-3-5-30(35-24)42-18-21-6-8-22(32)15-23(21)33/h3-9,14-15,19H,2,10-13,16-18H2,1H3,(H,40,41) QHFLUGPAOCKTRG-UHFFFAOYSA-N 349781 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-51 Glucagon-like peptide 1 receptor Human 390 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349781&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208571 386051538 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691588 CCc1noc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1 InChI=1S/C31H30ClFN6O4/c1-2-27-36-30(43-37-27)17-39-26-14-20(31(40)41)7-9-25(26)34-28(39)16-38-12-10-19(11-13-38)24-4-3-5-29(35-24)42-18-21-6-8-22(32)15-23(21)33/h3-9,14-15,19H,2,10-13,16-18H2,1H3,(H,40,41) BASVTHKZOORJQJ-UHFFFAOYSA-N 349782 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-52 Glucagon-like peptide 1 receptor Human 1300 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349782&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208572 386051539 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691589 CC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CCO1 InChI=1S/C31H32ClFN4O4/c1-31(11-14-41-31)19-37-27-15-21(30(38)39)6-8-26(27)34-28(37)17-36-12-9-20(10-13-36)25-3-2-4-29(35-25)40-18-22-5-7-23(32)16-24(22)33/h2-8,15-16,20H,9-14,17-19H2,1H3,(H,38,39) SBVHNOWNKQSSPJ-UHFFFAOYSA-N 349783 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2-methyloxetan-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-53 Glucagon-like peptide 1 receptor Human 3.20 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349783&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208573 386051540 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691590 CC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CCO1 InChI=1S/C31H32ClFN4O4/c1-31(11-14-41-31)19-37-27-15-21(30(38)39)6-8-26(27)34-28(37)17-36-12-9-20(10-13-36)25-3-2-4-29(35-25)40-18-22-5-7-23(32)16-24(22)33/h2-8,15-16,20H,9-14,17-19H2,1H3,(H,38,39) SBVHNOWNKQSSPJ-UHFFFAOYSA-N 349783 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2-methyloxetan-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-53 Glucagon-like peptide 1 receptor Human 39.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349783&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208573 386051540 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691591 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C31H29F2N5O4/c32-24-4-6-26(36-30(24)42-18-22-2-1-19(15-34)13-25(22)33)20-7-10-37(11-8-20)17-29-35-27-5-3-21(31(39)40)14-28(27)38(29)16-23-9-12-41-23/h1-6,13-14,20,23H,7-12,16-18H2,(H,39,40)/t23-/m0/s1 BGGOPJONUKJHSL-QHCPKHFHSA-N 349784 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-54 Glucagon-like peptide 1 receptor Human 0.710 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349784&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611211 386051541 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691592 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C31H29F2N5O4/c32-24-4-6-26(36-30(24)42-18-22-2-1-19(15-34)13-25(22)33)20-7-10-37(11-8-20)17-29-35-27-5-3-21(31(39)40)14-28(27)38(29)16-23-9-12-41-23/h1-6,13-14,20,23H,7-12,16-18H2,(H,39,40)/t23-/m0/s1 BGGOPJONUKJHSL-QHCPKHFHSA-N 349784 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-54 Glucagon-like peptide 1 receptor Human 11.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349784&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611211 386051541 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691593 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C31H30FN5O4/c32-25-6-8-26(35-30(25)41-19-21-3-1-20(16-33)2-4-21)22-9-12-36(13-10-22)18-29-34-27-7-5-23(31(38)39)15-28(27)37(29)17-24-11-14-40-24/h1-8,15,22,24H,9-14,17-19H2,(H,38,39)/t24-/m0/s1 QHRUSAYNQULGEA-DEOSSOPVSA-N 349785 2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-55 Glucagon-like peptide 1 receptor Human 1.20 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349785&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611052 386051542 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691594 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C31H30FN5O4/c32-25-6-8-26(35-30(25)41-19-21-3-1-20(16-33)2-4-21)22-9-12-36(13-10-22)18-29-34-27-7-5-23(31(38)39)15-28(27)37(29)17-24-11-14-40-24/h1-8,15,22,24H,9-14,17-19H2,(H,38,39)/t24-/m0/s1 QHRUSAYNQULGEA-DEOSSOPVSA-N 349785 2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-55 Glucagon-like peptide 1 receptor Human 24.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349785&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611052 386051542 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691595 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@@H]1CCO1)C(O)=O)c1ccc(F)c(OCc2ccc(F)cc2F)n1 InChI=1S/C30H30F3N5O4/c1-18-14-37(27-7-5-23(32)29(35-27)42-17-20-2-4-21(31)13-24(20)33)10-9-36(18)16-28-34-25-6-3-19(30(39)40)12-26(25)38(28)15-22-8-11-41-22/h2-7,12-13,18,22H,8-11,14-17H2,1H3,(H,39,40)/t18-,22-/m0/s1 ZQQMPHJMAHUMQA-AVRDEDQJSA-N 349786 2-{[(2S)-4-{6-[(2,4-difluorobenzyl)oxy]-5-fluoropyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-56 Glucagon-like peptide 1 receptor Human 0.500 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349786&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611056 386051543 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691596 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@@H]1CCO1)C(O)=O)c1ccc(F)c(OCc2ccc(F)cc2F)n1 InChI=1S/C30H30F3N5O4/c1-18-14-37(27-7-5-23(32)29(35-27)42-17-20-2-4-21(31)13-24(20)33)10-9-36(18)16-28-34-25-6-3-19(30(39)40)12-26(25)38(28)15-22-8-11-41-22/h2-7,12-13,18,22H,8-11,14-17H2,1H3,(H,39,40)/t18-,22-/m0/s1 ZQQMPHJMAHUMQA-AVRDEDQJSA-N 349786 2-{[(2S)-4-{6-[(2,4-difluorobenzyl)oxy]-5-fluoropyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-56 Glucagon-like peptide 1 receptor Human 16.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349786&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611056 386051543 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691597 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@H]1CCO1)C(O)=O)c1ccc(F)c(OCc2ccc(F)cc2F)n1 InChI=1S/C30H30F3N5O4/c1-18-14-37(27-7-5-23(32)29(35-27)42-17-20-2-4-21(31)13-24(20)33)10-9-36(18)16-28-34-25-6-3-19(30(39)40)12-26(25)38(28)15-22-8-11-41-22/h2-7,12-13,18,22H,8-11,14-17H2,1H3,(H,39,40)/t18-,22+/m0/s1 ZQQMPHJMAHUMQA-PGRDOPGGSA-N 349787 2-{[(2S)-4-{6-[(2,4-difluorobenzyl)oxy]-5-fluoropyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2R)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-57 Glucagon-like peptide 1 receptor Human 9.40 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349787&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208574 386051544 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691598 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@H]1CCO1)C(O)=O)c1ccc(F)c(OCc2ccc(F)cc2F)n1 InChI=1S/C30H30F3N5O4/c1-18-14-37(27-7-5-23(32)29(35-27)42-17-20-2-4-21(31)13-24(20)33)10-9-36(18)16-28-34-25-6-3-19(30(39)40)12-26(25)38(28)15-22-8-11-41-22/h2-7,12-13,18,22H,8-11,14-17H2,1H3,(H,39,40)/t18-,22+/m0/s1 ZQQMPHJMAHUMQA-PGRDOPGGSA-N 349787 2-{[(2S)-4-{6-[(2,4-difluorobenzyl)oxy]-5-fluoropyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2R)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-57 Glucagon-like peptide 1 receptor Human 160 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349787&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208574 386051544 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691599 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(F)cc2F)n1 InChI=1S/C30H31F2N5O4/c1-19-15-36(27-3-2-4-29(34-27)41-18-21-5-7-22(31)14-24(21)32)11-10-35(19)17-28-33-25-8-6-20(30(38)39)13-26(25)37(28)16-23-9-12-40-23/h2-8,13-14,19,23H,9-12,15-18H2,1H3,(H,38,39)/t19-,23-/m0/s1 FKZZWVWCDFMCKX-CVDCTZTESA-N 349788 2-{[(2S)-4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-58 Glucagon-like peptide 1 receptor Human 0.520 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349788&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611036 386051545 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691600 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@@H]1CCO1)C(O)=O)c1cccc(OCc2ccc(F)cc2F)n1 InChI=1S/C30H31F2N5O4/c1-19-15-36(27-3-2-4-29(34-27)41-18-21-5-7-22(31)14-24(21)32)11-10-35(19)17-28-33-25-8-6-20(30(38)39)13-26(25)37(28)16-23-9-12-40-23/h2-8,13-14,19,23H,9-12,15-18H2,1H3,(H,38,39)/t19-,23-/m0/s1 FKZZWVWCDFMCKX-CVDCTZTESA-N 349788 2-{[(2S)-4-{6-[(2,4-difluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-58 Glucagon-like peptide 1 receptor Human 8.50 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349788&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611036 386051545 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691601 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@H]1CCOC1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C32H33FN6O4/c1-21-16-38(29-3-2-4-31(36-29)43-20-25-6-5-22(15-34)13-26(25)33)11-10-37(21)18-30-35-27-8-7-24(32(40)41)14-28(27)39(30)17-23-9-12-42-19-23/h2-8,13-14,21,23H,9-12,16-20H2,1H3,(H,40,41)/t21-,23+/m0/s1 UTGCMTZPWNPDAN-JTHBVZDNSA-N 349789 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(3R)-tetrahydrofuran-3-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-59 Glucagon-like peptide 1 receptor Human 4.70 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349789&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208575 386051546 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691602 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1C[C@H]1CCOC1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C32H33FN6O4/c1-21-16-38(29-3-2-4-31(36-29)43-20-25-6-5-22(15-34)13-26(25)33)11-10-37(21)18-30-35-27-8-7-24(32(40)41)14-28(27)39(30)17-23-9-12-42-19-23/h2-8,13-14,21,23H,9-12,16-20H2,1H3,(H,40,41)/t21-,23+/m0/s1 UTGCMTZPWNPDAN-JTHBVZDNSA-N 349789 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(3R)-tetrahydrofuran-3-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-59 Glucagon-like peptide 1 receptor Human 84.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349789&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208575 386051546 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691603 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n([C@@H]3CCOC3)c2c1 InChI=1S/C30H30ClFN4O4/c31-22-6-4-21(24(32)15-22)17-40-29-3-1-2-25(34-29)19-8-11-35(12-9-19)16-28-33-26-7-5-20(30(37)38)14-27(26)36(28)23-10-13-39-18-23/h1-7,14-15,19,23H,8-13,16-18H2,(H,37,38)/t23-/m1/s1 UYJXJIBVBWHBQJ-HSZRJFAPSA-N 349790 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3R)-tetrahydrofuran-3-yl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-60 Glucagon-like peptide 1 receptor Human 31.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349790&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208576 386051547 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691604 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n([C@@H]3CCOC3)c2c1 InChI=1S/C30H30ClFN4O4/c31-22-6-4-21(24(32)15-22)17-40-29-3-1-2-25(34-29)19-8-11-35(12-9-19)16-28-33-26-7-5-20(30(37)38)14-27(26)36(28)23-10-13-39-18-23/h1-7,14-15,19,23H,8-13,16-18H2,(H,37,38)/t23-/m1/s1 UYJXJIBVBWHBQJ-HSZRJFAPSA-N 349790 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3R)-tetrahydrofuran-3-yl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-60 Glucagon-like peptide 1 receptor Human 460 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349790&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208576 386051547 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691605 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3cnco3)c2c1 InChI=1S/C30H26FN7O4/c31-24-12-20(14-32)4-5-22(24)18-41-29-3-1-2-27(35-29)37-10-8-36(9-11-37)17-28-34-25-7-6-21(30(39)40)13-26(25)38(28)16-23-15-33-19-42-23/h1-7,12-13,15,19H,8-11,16-18H2,(H,39,40) DGUQZFHWJDDMLD-UHFFFAOYSA-N 349791 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-61 Glucagon-like peptide 1 receptor Human 1.50 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349791&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611101 386051548 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691606 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3cnco3)c2c1 InChI=1S/C30H26FN7O4/c31-24-12-20(14-32)4-5-22(24)18-41-29-3-1-2-27(35-29)37-10-8-36(9-11-37)17-28-34-25-7-6-21(30(39)40)13-26(25)38(28)16-23-15-33-19-42-23/h1-7,12-13,15,19H,8-11,16-18H2,(H,39,40) DGUQZFHWJDDMLD-UHFFFAOYSA-N 349791 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-(1,3-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-61 Glucagon-like peptide 1 receptor Human 35.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349791&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611101 386051548 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691607 CCn1nncc1Cn1c(CN2CCN(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H30FN9O3/c1-2-41-24(17-34-37-41)18-40-27-15-22(31(42)43)8-9-26(27)35-29(40)19-38-10-12-39(13-11-38)28-4-3-5-30(36-28)44-20-23-7-6-21(16-33)14-25(23)32/h3-9,14-15,17H,2,10-13,18-20H2,1H3,(H,42,43) MEILDZONVGDFNF-UHFFFAOYSA-N 349792 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(1-ethyl-1H-1,2,3-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-62 Glucagon-like peptide 1 receptor Human 2.90 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349792&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611069 386051549 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691608 CCn1nncc1Cn1c(CN2CCN(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H30FN9O3/c1-2-41-24(17-34-37-41)18-40-27-15-22(31(42)43)8-9-26(27)35-29(40)19-38-10-12-39(13-11-38)28-4-3-5-30(36-28)44-20-23-7-6-21(16-33)14-25(23)32/h3-9,14-15,17H,2,10-13,18-20H2,1H3,(H,42,43) MEILDZONVGDFNF-UHFFFAOYSA-N 349792 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-1-[(1-ethyl-1H-1,2,3-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-62 Glucagon-like peptide 1 receptor Human 28.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349792&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611069 386051549 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691609 CCn1cncc1Cn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C33H33FN8O3/c1-3-39-21-36-16-26(39)18-42-29-14-24(33(43)44)9-10-28(29)37-31(42)19-40-11-12-41(17-22(40)2)30-5-4-6-32(38-30)45-20-25-8-7-23(15-35)13-27(25)34/h4-10,13-14,16,21-22H,3,11-12,17-20H2,1-2H3,(H,43,44)/t22-/m0/s1 GAOPVLGZOUBZDB-QFIPXVFZSA-N 349793 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-63 Glucagon-like peptide 1 receptor Human 0.580 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349793&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208577 386051550 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691610 CCn1cncc1Cn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C33H33FN8O3/c1-3-39-21-36-16-26(39)18-42-29-14-24(33(43)44)9-10-28(29)37-31(42)19-40-11-12-41(17-22(40)2)30-5-4-6-32(38-30)45-20-25-8-7-23(15-35)13-27(25)34/h4-10,13-14,16,21-22H,3,11-12,17-20H2,1-2H3,(H,43,44)/t22-/m0/s1 GAOPVLGZOUBZDB-QFIPXVFZSA-N 349793 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-63 Glucagon-like peptide 1 receptor Human 11.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349793&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208577 386051550 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691611 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ccno3)c2c1 InChI=1S/C30H27ClFN5O4/c31-22-6-4-21(24(32)15-22)18-40-29-3-1-2-25(35-29)19-9-12-36(13-10-19)17-28-34-26-7-5-20(30(38)39)14-27(26)37(28)16-23-8-11-33-41-23/h1-8,11,14-15,19H,9-10,12-13,16-18H2,(H,38,39) JHTWEGZYAKIQIS-UHFFFAOYSA-N 349794 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,2-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-64 Glucagon-like peptide 1 receptor Human 2.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349794&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611032 386051551 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691612 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ccno3)c2c1 InChI=1S/C30H27ClFN5O4/c31-22-6-4-21(24(32)15-22)18-40-29-3-1-2-25(35-29)19-9-12-36(13-10-19)17-28-34-26-7-5-20(30(38)39)14-27(26)37(28)16-23-8-11-33-41-23/h1-8,11,14-15,19H,9-10,12-13,16-18H2,(H,38,39) JHTWEGZYAKIQIS-UHFFFAOYSA-N 349794 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,2-oxazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-64 Glucagon-like peptide 1 receptor Human 32.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349794&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611032 386051551 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691613 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3ccon3)c2c1 InChI=1S/C31H27FN6O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-37(12-9-21)18-29-34-27-7-6-22(31(39)40)15-28(27)38(29)17-24-10-13-42-36-24/h1-7,10,13-15,21H,8-9,11-12,17-19H2,(H,39,40) WETGNQFNWZICPZ-UHFFFAOYSA-N 349795 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,2-oxazol-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-65 Glucagon-like peptide 1 receptor Human 1.60 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349795&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611058 386051552 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691614 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(Cc3ccon3)c2c1 InChI=1S/C31H27FN6O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-37(12-9-21)18-29-34-27-7-6-22(31(39)40)15-28(27)38(29)17-24-10-13-42-36-24/h1-7,10,13-15,21H,8-9,11-12,17-19H2,(H,39,40) WETGNQFNWZICPZ-UHFFFAOYSA-N 349795 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,2-oxazol-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-65 Glucagon-like peptide 1 receptor Human 35.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349795&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611058 386051552 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691615 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C33H32FN7O3/c1-2-40-21-36-17-26(40)18-41-30-15-24(33(42)43)8-9-29(30)37-31(41)19-39-12-10-23(11-13-39)28-4-3-5-32(38-28)44-20-25-7-6-22(16-35)14-27(25)34/h3-9,14-15,17,21,23H,2,10-13,18-20H2,1H3,(H,42,43) WQNQFKWZTAZBGZ-UHFFFAOYSA-N 349796 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-66 Glucagon-like peptide 1 receptor Human 0.390 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349796&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611055 386051553 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691616 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C33H32FN7O3/c1-2-40-21-36-17-26(40)18-41-30-15-24(33(42)43)8-9-29(30)37-31(41)19-39-12-10-23(11-13-39)28-4-3-5-32(38-28)44-20-25-7-6-22(16-35)14-27(25)34/h3-9,14-15,17,21,23H,2,10-13,18-20H2,1H3,(H,42,43) WQNQFKWZTAZBGZ-UHFFFAOYSA-N 349796 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-66 Glucagon-like peptide 1 receptor Human 3.40 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349796&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611055 386051553 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691617 CCn1cncc1Cn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H33ClFN7O3/c1-3-38-20-35-15-25(38)17-41-28-13-22(32(42)43)8-10-27(28)36-30(41)18-39-11-12-40(16-21(39)2)29-5-4-6-31(37-29)44-19-23-7-9-24(33)14-26(23)34/h4-10,13-15,20-21H,3,11-12,16-19H2,1-2H3,(H,42,43)/t21-/m0/s1 JTLADJZARDLFCQ-NRFANRHFSA-N 349797 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-67 Glucagon-like peptide 1 receptor Human 0.590 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349797&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611164 386051554 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691618 CCn1cncc1Cn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H33ClFN7O3/c1-3-38-20-35-15-25(38)17-41-28-13-22(32(42)43)8-10-27(28)36-30(41)18-39-11-12-40(16-21(39)2)29-5-4-6-31(37-29)44-19-23-7-9-24(33)14-26(23)34/h4-10,13-15,20-21H,3,11-12,16-19H2,1-2H3,(H,42,43)/t21-/m0/s1 JTLADJZARDLFCQ-NRFANRHFSA-N 349797 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-[(1-ethyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-67 Glucagon-like peptide 1 receptor Human 6.80 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349797&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611164 386051554 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691619 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cnoc3)c2c1 InChI=1S/C30H27ClFN5O4/c31-23-6-4-22(24(32)13-23)18-40-29-3-1-2-25(35-29)20-8-10-36(11-9-20)16-28-34-26-7-5-21(30(38)39)12-27(26)37(28)15-19-14-33-41-17-19/h1-7,12-14,17,20H,8-11,15-16,18H2,(H,38,39) RTOMCASIGVARMX-UHFFFAOYSA-N 349798 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,2-oxazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-68 Glucagon-like peptide 1 receptor Human 140 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349798&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208578 386051555 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691620 CCn1nncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H31FN8O3/c1-2-41-25(17-35-38-41)18-40-29-15-23(32(42)43)8-9-28(29)36-30(40)19-39-12-10-22(11-13-39)27-4-3-5-31(37-27)44-20-24-7-6-21(16-34)14-26(24)33/h3-9,14-15,17,22H,2,10-13,18-20H2,1H3,(H,42,43) SUDUVYVOAWVFQI-UHFFFAOYSA-N 349799 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-1,2,3-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-69 Glucagon-like peptide 1 receptor Human 2.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349799&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611094 386051556 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691621 CCn1nncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H31FN8O3/c1-2-41-25(17-35-38-41)18-40-29-15-23(32(42)43)8-9-28(29)36-30(40)19-39-12-10-22(11-13-39)27-4-3-5-31(37-27)44-20-24-7-6-21(16-34)14-26(24)33/h3-9,14-15,17,22H,2,10-13,18-20H2,1H3,(H,42,43) SUDUVYVOAWVFQI-UHFFFAOYSA-N 349799 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-1,2,3-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-69 Glucagon-like peptide 1 receptor Human 20.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349799&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611094 386051556 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691622 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ncon3)c2c1 InChI=1S/C29H26ClFN6O4/c30-21-6-4-20(22(31)13-21)16-40-28-3-1-2-23(34-28)18-8-10-36(11-9-18)15-27-33-24-7-5-19(29(38)39)12-25(24)37(27)14-26-32-17-41-35-26/h1-7,12-13,17-18H,8-11,14-16H2,(H,38,39) SMCJJZZJGNHVDY-UHFFFAOYSA-N 349800 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,2,4-oxadiazol-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-70 Glucagon-like peptide 1 receptor Human 5.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349800&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208579 386051557 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691623 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ncon3)c2c1 InChI=1S/C29H26ClFN6O4/c30-21-6-4-20(22(31)13-21)16-40-28-3-1-2-23(34-28)18-8-10-36(11-9-18)15-27-33-24-7-5-19(29(38)39)12-25(24)37(27)14-26-32-17-41-35-26/h1-7,12-13,17-18H,8-11,14-16H2,(H,38,39) SMCJJZZJGNHVDY-UHFFFAOYSA-N 349800 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,2,4-oxadiazol-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-70 Glucagon-like peptide 1 receptor Human 72.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349800&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208579 386051557 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691624 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n([C@H]3CCOC3)c2c1 InChI=1S/C30H30ClFN4O4/c31-22-6-4-21(24(32)15-22)17-40-29-3-1-2-25(34-29)19-8-11-35(12-9-19)16-28-33-26-7-5-20(30(37)38)14-27(26)36(28)23-10-13-39-18-23/h1-7,14-15,19,23H,8-13,16-18H2,(H,37,38)/t23-/m0/s1 UYJXJIBVBWHBQJ-QHCPKHFHSA-N 349801 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3S)-tetrahydrofuran-3-yl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-71 Glucagon-like peptide 1 receptor Human 190 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349801&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208580 386051558 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691625 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n([C@H]3CCOC3)c2c1 InChI=1S/C30H30ClFN4O4/c31-22-6-4-21(24(32)15-22)17-40-29-3-1-2-25(34-29)19-8-11-35(12-9-19)16-28-33-26-7-5-20(30(37)38)14-27(26)36(28)23-10-13-39-18-23/h1-7,14-15,19,23H,8-13,16-18H2,(H,37,38)/t23-/m0/s1 UYJXJIBVBWHBQJ-QHCPKHFHSA-N 349801 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3S)-tetrahydrofuran-3-yl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-71 Glucagon-like peptide 1 receptor Human 5800 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349801&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208580 386051558 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691626 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@H]3CCOC3)c2c1 InChI=1S/C31H32ClFN4O4/c32-24-6-4-23(25(33)15-24)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)17-29-34-27-7-5-22(31(38)39)14-28(27)37(29)16-20-10-13-40-18-20/h1-7,14-15,20-21H,8-13,16-19H2,(H,38,39)/t20-/m1/s1 CGRPMZZQTGYYOE-HXUWFJFHSA-N 349802 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3R)-tetrahydrofuran-3-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-72 Glucagon-like peptide 1 receptor Human 3.40 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349802&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611063 386051559 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691627 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@H]3CCOC3)c2c1 InChI=1S/C31H32ClFN4O4/c32-24-6-4-23(25(33)15-24)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)17-29-34-27-7-5-22(31(38)39)14-28(27)37(29)16-20-10-13-40-18-20/h1-7,14-15,20-21H,8-13,16-19H2,(H,38,39)/t20-/m1/s1 CGRPMZZQTGYYOE-HXUWFJFHSA-N 349802 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3R)-tetrahydrofuran-3-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-72 Glucagon-like peptide 1 receptor Human 53.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349802&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611063 386051559 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691628 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@@H]3CCCO3)c2c1 InChI=1S/C31H32ClFN4O4/c32-23-8-6-22(25(33)16-23)19-41-30-5-1-4-26(35-30)20-10-12-36(13-11-20)18-29-34-27-9-7-21(31(38)39)15-28(27)37(29)17-24-3-2-14-40-24/h1,4-9,15-16,20,24H,2-3,10-14,17-19H2,(H,38,39)/t24-/m0/s1 BYYUOSXFZIZLGT-DEOSSOPVSA-N 349803 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-tetrahydrofuran-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-73 Glucagon-like peptide 1 receptor Human 8.60 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349803&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611078 386051560 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691629 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@@H]3CCCO3)c2c1 InChI=1S/C31H32ClFN4O4/c32-23-8-6-22(25(33)16-23)19-41-30-5-1-4-26(35-30)20-10-12-36(13-11-20)18-29-34-27-9-7-21(31(38)39)15-28(27)37(29)17-24-3-2-14-40-24/h1,4-9,15-16,20,24H,2-3,10-14,17-19H2,(H,38,39)/t24-/m0/s1 BYYUOSXFZIZLGT-DEOSSOPVSA-N 349803 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-tetrahydrofuran-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-73 Glucagon-like peptide 1 receptor Human 88.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349803&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611078 386051560 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691630 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@@H]3CCO3)c2n1 InChI=1S/C28H28ClFN6O4/c29-19-5-4-18(21(30)14-19)17-40-26-3-1-2-24(33-26)35-11-9-34(10-12-35)16-25-31-22-6-7-23(28(37)38)32-27(22)36(25)15-20-8-13-39-20/h1-7,14,20H,8-13,15-17H2,(H,37,38)/t20-/m0/s1 OGNAGORTOWDZPV-FQEVSTJZSA-N 349804 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-74 Glucagon-like peptide 1 receptor Human 0.900 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349804&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611035 386051561 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691631 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@@H]3CCO3)c2n1 InChI=1S/C28H28ClFN6O4/c29-19-5-4-18(21(30)14-19)17-40-26-3-1-2-24(33-26)35-11-9-34(10-12-35)16-25-31-22-6-7-23(28(37)38)32-27(22)36(25)15-20-8-13-39-20/h1-7,14,20H,8-13,15-17H2,(H,37,38)/t20-/m0/s1 OGNAGORTOWDZPV-FQEVSTJZSA-N 349804 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-74 Glucagon-like peptide 1 receptor Human 9.70 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349804&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611035 386051561 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691632 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(nc12)C(O)=O InChI=1S/C32H31FN8O3/c1-2-40-20-35-16-24(40)17-41-29(36-27-8-9-28(32(42)43)38-31(27)41)18-39-12-10-22(11-13-39)26-4-3-5-30(37-26)44-19-23-7-6-21(15-34)14-25(23)33/h3-9,14,16,20,22H,2,10-13,17-19H2,1H3,(H,42,43) FIHGQLUWCVWMJD-UHFFFAOYSA-N 349805 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(1-ethyl-1H-imidazol-5-yl)methyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-75 Glucagon-like peptide 1 receptor Human 0.950 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349805&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208581 386051562 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691633 CCn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(nc12)C(O)=O InChI=1S/C32H31FN8O3/c1-2-40-20-35-16-24(40)17-41-29(36-27-8-9-28(32(42)43)38-31(27)41)18-39-12-10-22(11-13-39)26-4-3-5-30(37-26)44-19-23-7-6-21(15-34)14-25(23)33/h3-9,14,16,20,22H,2,10-13,17-19H2,1H3,(H,42,43) FIHGQLUWCVWMJD-UHFFFAOYSA-N 349805 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(1-ethyl-1H-imidazol-5-yl)methyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-75 Glucagon-like peptide 1 receptor Human 13.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349805&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208581 386051562 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691634 Cn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(nc12)C(O)=O InChI=1S/C31H29FN8O3/c1-38-19-34-15-23(38)16-40-28(35-26-7-8-27(31(41)42)37-30(26)40)17-39-11-9-21(10-12-39)25-3-2-4-29(36-25)43-18-22-6-5-20(14-33)13-24(22)32/h2-8,13,15,19,21H,9-12,16-18H2,1H3,(H,41,42) JODISBZDGRVQLH-UHFFFAOYSA-N 349806 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(1-methyl-1H-imidazol-5-yl)methyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-76 Glucagon-like peptide 1 receptor Human 2.90 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349806&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208582 386051563 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691635 Cn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(cc3F)C#N)n2)nc2ccc(nc12)C(O)=O InChI=1S/C31H29FN8O3/c1-38-19-34-15-23(38)16-40-28(35-26-7-8-27(31(41)42)37-30(26)40)17-39-11-9-21(10-12-39)25-3-2-4-29(36-25)43-18-22-6-5-20(14-33)13-24(22)32/h2-8,13,15,19,21H,9-12,16-18H2,1H3,(H,41,42) JODISBZDGRVQLH-UHFFFAOYSA-N 349806 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-3-[(1-methyl-1H-imidazol-5-yl)methyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-76 Glucagon-like peptide 1 receptor Human 51.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349806&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208582 386051563 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691636 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2n1 InChI=1S/C29H28FN7O4/c30-22-14-19(15-31)4-5-20(22)18-41-27-3-1-2-25(34-27)36-11-9-35(10-12-36)17-26-32-23-6-7-24(29(38)39)33-28(23)37(26)16-21-8-13-40-21/h1-7,14,21H,8-13,16-18H2,(H,38,39)/t21-/m0/s1 ONXBVBLWZIBJCL-NRFANRHFSA-N 349807 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-77 Glucagon-like peptide 1 receptor Human 0.960 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349807&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611103 386051564 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691637 OC(=O)c1ccc2nc(CN3CCN(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(C[C@@H]3CCO3)c2n1 InChI=1S/C29H28FN7O4/c30-22-14-19(15-31)4-5-20(22)18-41-27-3-1-2-25(34-27)36-11-9-35(10-12-36)17-26-32-23-6-7-24(29(38)39)33-28(23)37(26)16-21-8-13-40-21/h1-7,14,21H,8-13,16-18H2,(H,38,39)/t21-/m0/s1 ONXBVBLWZIBJCL-NRFANRHFSA-N 349807 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperazin-1-yl)methyl]-3-[(2S)-oxetan-2-ylmethyl]-3H-imidazo[4,5-b]pyridine-5-carboxylic acid::US10208019, Example 10A-77 Glucagon-like peptide 1 receptor Human 10.00 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349807&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611103 386051564 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691638 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C31H31N5O4/c32-17-21-4-6-22(7-5-21)20-40-30-3-1-2-26(34-30)23-10-13-35(14-11-23)19-29-33-27-9-8-24(31(37)38)16-28(27)36(29)18-25-12-15-39-25/h1-9,16,23,25H,10-15,18-20H2,(H,37,38)/t25-/m0/s1 KWYDOKLBVSCOKI-VWLOTQADSA-N 349808 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-78 Glucagon-like peptide 1 receptor Human 1.60 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349808&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611031 386051565 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691639 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4)C#N)n3)n(C[C@@H]3CCO3)c2c1 InChI=1S/C31H31N5O4/c32-17-21-4-6-22(7-5-21)20-40-30-3-1-2-26(34-30)23-10-13-35(14-11-23)19-29-33-27-9-8-24(31(37)38)16-28(27)36(29)18-25-12-15-39-25/h1-9,16,23,25H,10-15,18-20H2,(H,37,38)/t25-/m0/s1 KWYDOKLBVSCOKI-VWLOTQADSA-N 349808 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-78 Glucagon-like peptide 1 receptor Human 28.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349808&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611031 386051565 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691640 CN1CCC1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H33ClFN5O3/c1-36-12-11-24(36)17-38-28-15-21(31(39)40)6-8-27(28)34-29(38)18-37-13-9-20(10-14-37)26-3-2-4-30(35-26)41-19-22-5-7-23(32)16-25(22)33/h2-8,15-16,20,24H,9-14,17-19H2,1H3,(H,39,40) FXCXHKBFPJZKNH-UHFFFAOYSA-N 349809 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methylazetidin-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-79 Glucagon-like peptide 1 receptor Human 33.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349809&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208583 386051566 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691641 CN1CCC1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H33ClFN5O3/c1-36-12-11-24(36)17-38-28-15-21(31(39)40)6-8-27(28)34-29(38)18-37-13-9-20(10-14-37)26-3-2-4-30(35-26)41-19-22-5-7-23(32)16-25(22)33/h2-8,15-16,20,24H,9-14,17-19H2,1H3,(H,39,40) FXCXHKBFPJZKNH-UHFFFAOYSA-N 349809 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methylazetidin-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-79 Glucagon-like peptide 1 receptor Human 670 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349809&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208583 386051566 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691642 Cn1cnc(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)c1 InChI=1S/C32H32ClFN6O3/c1-38-17-25(35-20-38)11-14-40-29-15-22(32(41)42)6-8-28(29)36-30(40)18-39-12-9-21(10-13-39)27-3-2-4-31(37-27)43-19-23-5-7-24(33)16-26(23)34/h2-8,15-17,20-21H,9-14,18-19H2,1H3,(H,41,42) WLOAUKMCQADUOR-UHFFFAOYSA-N 349810 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1-methyl-1H-imidazol-4-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-01 Glucagon-like peptide 1 receptor Human >10000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349810&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208584 386051567 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691643 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ccc(Cl)cn3)c2c1 InChI=1S/C32H28Cl2FN5O3/c33-23-6-4-22(26(35)15-23)19-43-31-3-1-2-27(38-31)20-10-12-39(13-11-20)18-30-37-28-9-5-21(32(41)42)14-29(28)40(30)17-25-8-7-24(34)16-36-25/h1-9,14-16,20H,10-13,17-19H2,(H,41,42) AMQXNLMECJMZKC-UHFFFAOYSA-N 349811 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(5-chloropyridin-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-02 Glucagon-like peptide 1 receptor Human >15000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349811&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208585 386051568 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691644 CCN1CCC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)C1 InChI=1S/C33H37ClFN5O3/c1-2-38-13-10-22(18-38)19-40-30-16-24(33(41)42)7-9-29(30)36-31(40)20-39-14-11-23(12-15-39)28-4-3-5-32(37-28)43-21-25-6-8-26(34)17-27(25)35/h3-9,16-17,22-23H,2,10-15,18-21H2,1H3,(H,41,42) NUMLBMCIIKXCRB-UHFFFAOYSA-N 349812 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethylpyrrolidin-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-03 Glucagon-like peptide 1 receptor Human >16000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349812&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208586 386051569 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691645 CN1CCCC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)C1 InChI=1S/C33H37ClFN5O3/c1-38-13-3-4-22(18-38)19-40-30-16-24(33(41)42)8-10-29(30)36-31(40)20-39-14-11-23(12-15-39)28-5-2-6-32(37-28)43-21-25-7-9-26(34)17-27(25)35/h2,5-10,16-17,22-23H,3-4,11-15,18-21H2,1H3,(H,41,42) WPGRFYGCDSOUAN-UHFFFAOYSA-N 349813 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methylpiperidin-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-04 Glucagon-like peptide 1 receptor Human >19000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349813&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208587 386051570 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691646 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCC3CCCCO3)c2c1 InChI=1S/C33H36ClFN4O4/c34-25-9-7-24(27(35)19-25)21-43-32-6-3-5-28(37-32)22-11-14-38(15-12-22)20-31-36-29-10-8-23(33(40)41)18-30(29)39(31)16-13-26-4-1-2-17-42-26/h3,5-10,18-19,22,26H,1-2,4,11-17,20-21H2,(H,40,41) OUYJKCDLBNBAEC-UHFFFAOYSA-N 349814 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(tetrahydro-2H-pyran-2-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-05 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349814&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208588 386051571 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691647 CC(C)c1cc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)on1 InChI=1S/C33H33ClFN5O4/c1-20(2)29-16-25(44-38-29)17-40-30-14-22(33(41)42)7-9-28(30)36-31(40)18-39-12-10-21(11-13-39)27-4-3-5-32(37-27)43-19-23-6-8-24(34)15-26(23)35/h3-9,14-16,20-21H,10-13,17-19H2,1-2H3,(H,41,42) UZVJSBBUFMMVRX-UHFFFAOYSA-N 349815 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[3-(propan-2-yl)-1,2-oxazol-5-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-06 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349815&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208589 386051572 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691648 CN1CCC(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CC1 InChI=1S/C34H39ClFN5O3/c1-39-14-9-23(10-15-39)11-18-41-31-19-25(34(42)43)6-8-30(31)37-32(41)21-40-16-12-24(13-17-40)29-3-2-4-33(38-29)44-22-26-5-7-27(35)20-28(26)36/h2-8,19-20,23-24H,9-18,21-22H2,1H3,(H,42,43) RJIIYNCEXBKZIZ-UHFFFAOYSA-N 349816 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1-methylpiperidin-4-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-07 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349816&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208590 386051573 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691649 CN1CCC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CC1 InChI=1S/C33H37ClFN5O3/c1-38-13-9-22(10-14-38)19-40-30-17-24(33(41)42)6-8-29(30)36-31(40)20-39-15-11-23(12-16-39)28-3-2-4-32(37-28)43-21-25-5-7-26(34)18-27(25)35/h2-8,17-18,22-23H,9-16,19-21H2,1H3,(H,41,42) FIGQFFVSSXMCTA-UHFFFAOYSA-N 349817 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methylpiperidin-4-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-08 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349817&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208591 386051574 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691650 CN1CCCC1CCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C33H37ClFN5O3/c1-38-14-3-4-26(38)13-17-40-30-18-23(33(41)42)8-10-29(30)36-31(40)20-39-15-11-22(12-16-39)28-5-2-6-32(37-28)43-21-24-7-9-25(34)19-27(24)35/h2,5-10,18-19,22,26H,3-4,11-17,20-21H2,1H3,(H,41,42) VNKOZLKNDHAWLE-UHFFFAOYSA-N 349818 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-09 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349818&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208592 386051575 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691651 CN1CCCCC1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C33H37ClFN5O3/c1-38-14-3-2-5-26(38)19-40-30-17-23(33(41)42)9-11-29(30)36-31(40)20-39-15-12-22(13-16-39)28-6-4-7-32(37-28)43-21-24-8-10-25(34)18-27(24)35/h4,6-11,17-18,22,26H,2-3,5,12-16,19-21H2,1H3,(H,41,42) RSGDTHRNGKHWTB-UHFFFAOYSA-N 349819 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methylpiperidin-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-10 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349819&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208593 386051576 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691652 CN1CCOC(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)C1 InChI=1S/C33H37ClFN5O4/c1-38-15-16-43-26(19-38)11-14-40-30-17-23(33(41)42)6-8-29(30)36-31(40)20-39-12-9-22(10-13-39)28-3-2-4-32(37-28)44-21-24-5-7-25(34)18-27(24)35/h2-8,17-18,22,26H,9-16,19-21H2,1H3,(H,41,42) RYCNUSCCAKYDHQ-UHFFFAOYSA-N 349820 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1[2-(4-methylmorpholin-2-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-11 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349820&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208594 386051577 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691653 COCCN1CCC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CC1 InChI=1S/C35H41ClFN5O4/c1-45-18-17-40-13-9-24(10-14-40)21-42-32-19-26(35(43)44)6-8-31(32)38-33(42)22-41-15-11-25(12-16-41)30-3-2-4-34(39-30)46-23-27-5-7-28(36)20-29(27)37/h2-8,19-20,24-25H,9-18,21-23H2,1H3,(H,43,44) JWNTZMOCHBONLV-UHFFFAOYSA-N 349821 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[1-(2-methoxyethyl)piperidin-4-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-12 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349821&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208595 386051578 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691654 COCCN1CCCC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)C1 InChI=1S/C35H41ClFN5O4/c1-45-17-16-40-13-3-4-24(20-40)21-42-32-18-26(35(43)44)8-10-31(32)38-33(42)22-41-14-11-25(12-15-41)30-5-2-6-34(39-30)46-23-27-7-9-28(36)19-29(27)37/h2,5-10,18-19,24-25H,3-4,11-17,20-23H2,1H3,(H,43,44) ZBYNCTXBLDJORZ-UHFFFAOYSA-N 349822 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[1-(2-methoxyethyl)piperidin-3-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-13 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349822&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208596 386051579 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691655 CC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CCOC1 InChI=1S/C32H34ClFN4O4/c1-32(11-14-41-20-32)19-38-28-15-22(31(39)40)6-8-27(28)35-29(38)17-37-12-9-21(10-13-37)26-3-2-4-30(36-26)42-18-23-5-7-24(33)16-25(23)34/h2-8,15-16,21H,9-14,17-20H2,1H3,(H,39,40) HAVPKFZTUQWPGJ-UHFFFAOYSA-N 349823 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3-methyltetrahydrofuran-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-14 Glucagon-like peptide 1 receptor Human 8.10 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349823&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208597 386051580 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691656 CC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CCOC1 InChI=1S/C32H34ClFN4O4/c1-32(11-14-41-20-32)19-38-28-15-22(31(39)40)6-8-27(28)35-29(38)17-37-12-9-21(10-13-37)26-3-2-4-30(36-26)42-18-23-5-7-24(33)16-25(23)34/h2-8,15-16,21H,9-14,17-20H2,1H3,(H,39,40) HAVPKFZTUQWPGJ-UHFFFAOYSA-N 349823 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3-methyltetrahydrofuran-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-14 Glucagon-like peptide 1 receptor Human 230 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349823&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208597 386051580 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691657 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cn[nH]c3)c2c1 InChI=1S/C30H28ClFN6O3/c31-23-6-4-22(24(32)13-23)18-41-29-3-1-2-25(36-29)20-8-10-37(11-9-20)17-28-35-26-7-5-21(30(39)40)12-27(26)38(28)16-19-14-33-34-15-19/h1-7,12-15,20H,8-11,16-18H2,(H,33,34)(H,39,40) URIZEIIICQRHRO-UHFFFAOYSA-N 349824 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1H-pyrazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-15 Glucagon-like peptide 1 receptor Human 9.40 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349824&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208598 386051581 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691658 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cn[nH]c3)c2c1 InChI=1S/C30H28ClFN6O3/c31-23-6-4-22(24(32)13-23)18-41-29-3-1-2-25(36-29)20-8-10-37(11-9-20)17-28-35-26-7-5-21(30(39)40)12-27(26)38(28)16-19-14-33-34-15-19/h1-7,12-15,20H,8-11,16-18H2,(H,33,34)(H,39,40) URIZEIIICQRHRO-UHFFFAOYSA-N 349824 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1H-pyrazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-15 Glucagon-like peptide 1 receptor Human 94.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349824&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208598 386051581 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691659 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CC3CCC3)c2c1 InChI=1S/C31H32ClFN4O3/c32-24-9-7-23(25(33)16-24)19-40-30-6-2-5-26(35-30)21-11-13-36(14-12-21)18-29-34-27-10-8-22(31(38)39)15-28(27)37(29)17-20-3-1-4-20/h2,5-10,15-16,20-21H,1,3-4,11-14,17-19H2,(H,38,39) JMMMZAIZZZDSDD-UHFFFAOYSA-N 349825 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(cyclobutylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-16 Glucagon-like peptide 1 receptor Human 11.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349825&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208599 386051582 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691660 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CC3CCC3)c2c1 InChI=1S/C31H32ClFN4O3/c32-24-9-7-23(25(33)16-24)19-40-30-6-2-5-26(35-30)21-11-13-36(14-12-21)18-29-34-27-10-8-22(31(38)39)15-28(27)37(29)17-20-3-1-4-20/h2,5-10,15-16,20-21H,1,3-4,11-14,17-19H2,(H,38,39) JMMMZAIZZZDSDD-UHFFFAOYSA-N 349825 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(cyclobutylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-16 Glucagon-like peptide 1 receptor Human 410 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349825&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208599 386051582 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691661 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCn3cncn3)c2c1 InChI=1S/C30H29ClFN7O3/c31-23-6-4-22(24(32)15-23)17-42-29-3-1-2-25(36-29)20-8-10-37(11-9-20)16-28-35-26-7-5-21(30(40)41)14-27(26)39(28)13-12-38-19-33-18-34-38/h1-7,14-15,18-20H,8-13,16-17H2,(H,40,41) MLQIGMVIHYGBNQ-UHFFFAOYSA-N 349826 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1H-1,2,4-triazol-1-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-17 Glucagon-like peptide 1 receptor Human 11.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349826&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208600 386051583 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691662 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCn3cncn3)c2c1 InChI=1S/C30H29ClFN7O3/c31-23-6-4-22(24(32)15-23)17-42-29-3-1-2-25(36-29)20-8-10-37(11-9-20)16-28-35-26-7-5-21(30(40)41)14-27(26)39(28)13-12-38-19-33-18-34-38/h1-7,14-15,18-20H,8-13,16-17H2,(H,40,41) MLQIGMVIHYGBNQ-UHFFFAOYSA-N 349826 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1H-1,2,4-triazol-1-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-17 Glucagon-like peptide 1 receptor Human 380 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349826&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208600 386051583 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691663 CCOC(C)Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H34ClFN4O4/c1-3-40-20(2)17-37-28-15-22(31(38)39)8-10-27(28)34-29(37)18-36-13-11-21(12-14-36)26-5-4-6-30(35-26)41-19-23-7-9-24(32)16-25(23)33/h4-10,15-16,20-21H,3,11-14,17-19H2,1-2H3,(H,38,39) BLQJPTDECJOAOX-UHFFFAOYSA-N 349827 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-ethoxypropyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-18 Glucagon-like peptide 1 receptor Human 14.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349827&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208601 386051584 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691664 CCOC(C)Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H34ClFN4O4/c1-3-40-20(2)17-37-28-15-22(31(38)39)8-10-27(28)34-29(37)18-36-13-11-21(12-14-36)26-5-4-6-30(35-26)41-19-23-7-9-24(32)16-25(23)33/h4-10,15-16,20-21H,3,11-14,17-19H2,1-2H3,(H,38,39) BLQJPTDECJOAOX-UHFFFAOYSA-N 349827 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-ethoxypropyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-18 Glucagon-like peptide 1 receptor Human 270 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349827&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208601 386051584 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691665 COCCn1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H33ClFN7O4/c1-44-14-13-40-20-35-38-30(40)18-41-28-15-22(32(42)43)6-8-27(28)36-29(41)17-39-11-9-21(10-12-39)26-3-2-4-31(37-26)45-19-23-5-7-24(33)16-25(23)34/h2-8,15-16,20-21H,9-14,17-19H2,1H3,(H,42,43) IPYTXHFHKSBGOB-UHFFFAOYSA-N 349828 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[4-(2-methoxyethyl)-4H-1,2,4-triazol-3-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-19 Glucagon-like peptide 1 receptor Human 15.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349828&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208602 386051585 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691666 COCCn1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H33ClFN7O4/c1-44-14-13-40-20-35-38-30(40)18-41-28-15-22(32(42)43)6-8-27(28)36-29(41)17-39-11-9-21(10-12-39)26-3-2-4-31(37-26)45-19-23-5-7-24(33)16-25(23)34/h2-8,15-16,20-21H,9-14,17-19H2,1H3,(H,42,43) IPYTXHFHKSBGOB-UHFFFAOYSA-N 349828 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[4-(2-methoxyethyl)-4H-1,2,4-triazol-3-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-19 Glucagon-like peptide 1 receptor Human 230 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349828&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208602 386051585 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691667 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CN3CCOC3=O)c2c1 InChI=1S/C30H29ClFN5O5/c31-22-6-4-21(23(32)15-22)17-42-28-3-1-2-24(34-28)19-8-10-35(11-9-19)16-27-33-25-7-5-20(29(38)39)14-26(25)37(27)18-36-12-13-41-30(36)40/h1-7,14-15,19H,8-13,16-18H2,(H,38,39) ABCNTLFWXSCOCC-UHFFFAOYSA-N 349829 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2-oxo-1,3-oxazolidin-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-20 Glucagon-like peptide 1 receptor Human 15.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349829&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208603 386051586 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691668 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CN3CCOC3=O)c2c1 InChI=1S/C30H29ClFN5O5/c31-22-6-4-21(23(32)15-22)17-42-28-3-1-2-24(34-28)19-8-10-35(11-9-19)16-27-33-25-7-5-20(29(38)39)14-26(25)37(27)18-36-12-13-41-30(36)40/h1-7,14-15,19H,8-13,16-18H2,(H,38,39) ABCNTLFWXSCOCC-UHFFFAOYSA-N 349829 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2-oxo-1,3-oxazolidin-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-20 Glucagon-like peptide 1 receptor Human 270 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349829&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208603 386051586 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691669 Cn1nccc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H30ClFN6O3/c1-37-24(9-12-34-37)17-39-28-15-21(31(40)41)6-8-27(28)35-29(39)18-38-13-10-20(11-14-38)26-3-2-4-30(36-26)42-19-22-5-7-23(32)16-25(22)33/h2-9,12,15-16,20H,10-11,13-14,17-19H2,1H3,(H,40,41) JEUBOGCULMMXEQ-UHFFFAOYSA-N 349830 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-pyrazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-21 Glucagon-like peptide 1 receptor Human 18.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349830&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208604 386051587 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691670 Cn1nccc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H30ClFN6O3/c1-37-24(9-12-34-37)17-39-28-15-21(31(40)41)6-8-27(28)35-29(39)18-38-13-10-20(11-14-38)26-3-2-4-30(36-26)42-19-22-5-7-23(32)16-25(22)33/h2-9,12,15-16,20H,10-11,13-14,17-19H2,1H3,(H,40,41) JEUBOGCULMMXEQ-UHFFFAOYSA-N 349830 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-pyrazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-21 Glucagon-like peptide 1 receptor Human 270 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349830&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208604 386051587 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691671 COC(C)(C)Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H34ClFN4O4/c1-31(2,40-3)19-37-27-15-21(30(38)39)8-10-26(27)34-28(37)17-36-13-11-20(12-14-36)25-5-4-6-29(35-25)41-18-22-7-9-23(32)16-24(22)33/h4-10,15-16,20H,11-14,17-19H2,1-3H3,(H,38,39) ZXWMRFVVGGHFLA-UHFFFAOYSA-N 349831 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxy-2-methylpropyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-22 Glucagon-like peptide 1 receptor Human 21.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349831&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208605 386051588 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691672 COC(C)(C)Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H34ClFN4O4/c1-31(2,40-3)19-37-27-15-21(30(38)39)8-10-26(27)34-28(37)17-36-13-11-20(12-14-36)25-5-4-6-29(35-25)41-18-22-7-9-23(32)16-24(22)33/h4-10,15-16,20H,11-14,17-19H2,1-3H3,(H,38,39) ZXWMRFVVGGHFLA-UHFFFAOYSA-N 349831 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2-methoxy-2-methylpropyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-22 Glucagon-like peptide 1 receptor Human 200 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349831&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208605 386051588 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691673 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3c[nH]nn3)c2c1 InChI=1S/C29H27ClFN7O3/c30-21-6-4-20(23(31)13-21)17-41-28-3-1-2-24(34-28)18-8-10-37(11-9-18)16-27-33-25-7-5-19(29(39)40)12-26(25)38(27)15-22-14-32-36-35-22/h1-7,12-14,18H,8-11,15-17H2,(H,39,40)(H,32,35,36) LSZQTQOJBWQTPT-UHFFFAOYSA-N 349832 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1H-1,2,3-triazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-23 Glucagon-like peptide 1 receptor Human 25.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349832&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208606 386051589 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691674 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3c[nH]nn3)c2c1 InChI=1S/C29H27ClFN7O3/c30-21-6-4-20(23(31)13-21)17-41-28-3-1-2-24(34-28)18-8-10-37(11-9-18)16-27-33-25-7-5-19(29(39)40)12-26(25)38(27)15-22-14-32-36-35-22/h1-7,12-14,18H,8-11,15-17H2,(H,39,40)(H,32,35,36) LSZQTQOJBWQTPT-UHFFFAOYSA-N 349832 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1H-1,2,3-triazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-23 Glucagon-like peptide 1 receptor Human 330 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349832&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208606 386051589 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691675 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cc[nH]n3)c2c1 InChI=1S/C30H28ClFN6O3/c31-22-6-4-21(24(32)15-22)18-41-29-3-1-2-25(35-29)19-9-12-37(13-10-19)17-28-34-26-7-5-20(30(39)40)14-27(26)38(28)16-23-8-11-33-36-23/h1-8,11,14-15,19H,9-10,12-13,16-18H2,(H,33,36)(H,39,40) MCTCSSCMBIUEFG-UHFFFAOYSA-N 349833 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1H-pyrazol-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-24 Glucagon-like peptide 1 receptor Human 28.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349833&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208607 386051590 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691676 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cc[nH]n3)c2c1 InChI=1S/C30H28ClFN6O3/c31-22-6-4-21(24(32)15-22)18-41-29-3-1-2-25(35-29)19-9-12-37(13-10-19)17-28-34-26-7-5-20(30(39)40)14-27(26)38(28)16-23-8-11-33-36-23/h1-8,11,14-15,19H,9-10,12-13,16-18H2,(H,33,36)(H,39,40) MCTCSSCMBIUEFG-UHFFFAOYSA-N 349833 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1H-pyrazol-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-24 Glucagon-like peptide 1 receptor Human 450 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349833&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208607 386051590 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691677 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3nnc[nH]3)c2c1 InChI=1S/C29H27ClFN7O3/c30-21-6-4-20(22(31)13-21)16-41-28-3-1-2-23(35-28)18-8-10-37(11-9-18)15-27-34-24-7-5-19(29(39)40)12-25(24)38(27)14-26-32-17-33-36-26/h1-7,12-13,17-18H,8-11,14-16H2,(H,39,40)(H,32,33,36) DEWPZZYAJPWTCX-UHFFFAOYSA-N 349834 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(4H-1,2,4-triazol-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-25 Glucagon-like peptide 1 receptor Human 30.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349834&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208608 386051591 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691678 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3nnc[nH]3)c2c1 InChI=1S/C29H27ClFN7O3/c30-21-6-4-20(22(31)13-21)16-41-28-3-1-2-23(35-28)18-8-10-37(11-9-18)15-27-34-24-7-5-19(29(39)40)12-25(24)38(27)14-26-32-17-33-36-26/h1-7,12-13,17-18H,8-11,14-16H2,(H,39,40)(H,32,33,36) DEWPZZYAJPWTCX-UHFFFAOYSA-N 349834 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(4H-1,2,4-triazol-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-25 Glucagon-like peptide 1 receptor Human 360 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349834&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208608 386051591 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691679 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C3CCOC3)c2c1 InChI=1S/C30H30ClFN4O4/c31-22-6-4-21(24(32)15-22)17-40-29-3-1-2-25(34-29)19-8-11-35(12-9-19)16-28-33-26-7-5-20(30(37)38)14-27(26)36(28)23-10-13-39-18-23/h1-7,14-15,19,23H,8-13,16-18H2,(H,37,38) UYJXJIBVBWHBQJ-UHFFFAOYSA-N 349835 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-3-yl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-26 Glucagon-like peptide 1 receptor Human 36.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349835&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208609 386051592 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691680 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C3CCOC3)c2c1 InChI=1S/C30H30ClFN4O4/c31-22-6-4-21(24(32)15-22)17-40-29-3-1-2-25(34-29)19-8-11-35(12-9-19)16-28-33-26-7-5-20(30(37)38)14-27(26)36(28)23-10-13-39-18-23/h1-7,14-15,19,23H,8-13,16-18H2,(H,37,38) UYJXJIBVBWHBQJ-UHFFFAOYSA-N 349835 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-3-yl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-26 Glucagon-like peptide 1 receptor Human 1100 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349835&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208609 386051592 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691681 CC(F)(F)Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H28ClF3N4O3/c1-29(32,33)17-37-25-13-19(28(38)39)6-8-24(25)34-26(37)15-36-11-9-18(10-12-36)23-3-2-4-27(35-23)40-16-20-5-7-21(30)14-22(20)31/h2-8,13-14,18H,9-12,15-17H2,1H3,(H,38,39) RDQMGFBJWPGCON-UHFFFAOYSA-N 349836 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2,2-difluoropropyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-27 Glucagon-like peptide 1 receptor Human 44.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349836&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208610 386051593 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691682 CC(F)(F)Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H28ClF3N4O3/c1-29(32,33)17-37-25-13-19(28(38)39)6-8-24(25)34-26(37)15-36-11-9-18(10-12-36)23-3-2-4-27(35-23)40-16-20-5-7-21(30)14-22(20)31/h2-8,13-14,18H,9-12,15-17H2,1H3,(H,38,39) RDQMGFBJWPGCON-UHFFFAOYSA-N 349836 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(2,2-difluoropropyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-27 Glucagon-like peptide 1 receptor Human 490 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349836&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208610 386051593 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691683 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCn3cccn3)c2c1 InChI=1S/C31H30ClFN6O3/c32-24-7-5-23(25(33)18-24)20-42-30-4-1-3-26(36-30)21-9-13-37(14-10-21)19-29-35-27-8-6-22(31(40)41)17-28(27)39(29)16-15-38-12-2-11-34-38/h1-8,11-12,17-18,21H,9-10,13-16,19-20H2,(H,40,41) CIHPGYUQNFZFNU-UHFFFAOYSA-N 349837 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1H-pyrazol-1-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-28 Glucagon-like peptide 1 receptor Human 54.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349837&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208611 386051594 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691684 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCn3cccn3)c2c1 InChI=1S/C31H30ClFN6O3/c32-24-7-5-23(25(33)18-24)20-42-30-4-1-3-26(36-30)21-9-13-37(14-10-21)19-29-35-27-8-6-22(31(40)41)17-28(27)39(29)16-15-38-12-2-11-34-38/h1-8,11-12,17-18,21H,9-10,13-16,19-20H2,(H,40,41) CIHPGYUQNFZFNU-UHFFFAOYSA-N 349837 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1H-pyrazol-1-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-28 Glucagon-like peptide 1 receptor Human 1200 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349837&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208611 386051594 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691685 Cc1noc(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1 InChI=1S/C31H30ClFN6O4/c1-19-34-30(43-37-19)11-14-39-27-15-21(31(40)41)6-8-26(27)35-28(39)17-38-12-9-20(10-13-38)25-3-2-4-29(36-25)42-18-22-5-7-23(32)16-24(22)33/h2-8,15-16,20H,9-14,17-18H2,1H3,(H,40,41) PKFHBQRWBSYREQ-UHFFFAOYSA-N 349838 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(3-methyl-1,2,4-oxadiazol-5-yl)ethyl]-1H-benzim idazole-6-carboxylic acid::US10208019, Example 11A-29 Glucagon-like peptide 1 receptor Human 55.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349838&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208612 386051595 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691686 Cc1noc(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1 InChI=1S/C31H30ClFN6O4/c1-19-34-30(43-37-19)11-14-39-27-15-21(31(40)41)6-8-26(27)35-28(39)17-38-12-9-20(10-13-38)25-3-2-4-29(36-25)42-18-22-5-7-23(32)16-24(22)33/h2-8,15-16,20H,9-14,17-18H2,1H3,(H,40,41) PKFHBQRWBSYREQ-UHFFFAOYSA-N 349838 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(3-methyl-1,2,4-oxadiazol-5-yl)ethyl]-1H-benzim idazole-6-carboxylic acid::US10208019, Example 11A-29 Glucagon-like peptide 1 receptor Human 1700 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349838&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208612 386051595 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691687 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCN3CCCOC3=O)c2c1 InChI=1S/C32H33ClFN5O5/c33-24-7-5-23(25(34)18-24)20-44-30-4-1-3-26(36-30)21-9-12-37(13-10-21)19-29-35-27-8-6-22(31(40)41)17-28(27)39(29)15-14-38-11-2-16-43-32(38)42/h1,3-8,17-18,21H,2,9-16,19-20H2,(H,40,41) XMGFQTOJLQYCHP-UHFFFAOYSA-N 349839 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(2-oxo-1,3-oxazinan-3-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-30 Glucagon-like peptide 1 receptor Human 56.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349839&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208613 386051596 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691688 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCN3CCCOC3=O)c2c1 InChI=1S/C32H33ClFN5O5/c33-24-7-5-23(25(34)18-24)20-44-30-4-1-3-26(36-30)21-9-12-37(13-10-21)19-29-35-27-8-6-22(31(40)41)17-28(27)39(29)15-14-38-11-2-16-43-32(38)42/h1,3-8,17-18,21H,2,9-16,19-20H2,(H,40,41) XMGFQTOJLQYCHP-UHFFFAOYSA-N 349839 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(2-oxo-1,3-oxazinan-3-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-30 Glucagon-like peptide 1 receptor Human 590 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349839&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208613 386051596 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691689 Cc1ccn(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1 InChI=1S/C32H32ClFN6O3/c1-21-9-14-39(37-21)15-16-40-29-17-23(32(41)42)6-8-28(29)35-30(40)19-38-12-10-22(11-13-38)27-3-2-4-31(36-27)43-20-24-5-7-25(33)18-26(24)34/h2-9,14,17-18,22H,10-13,15-16,19-20H2,1H3,(H,41,42) MKHLSCZFQYGGCU-UHFFFAOYSA-N 349840 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(3-methyl-1H-pyrazol-1-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-31 Glucagon-like peptide 1 receptor Human 72.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349840&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208614 386051597 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691690 Cc1ccn(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1 InChI=1S/C32H32ClFN6O3/c1-21-9-14-39(37-21)15-16-40-29-17-23(32(41)42)6-8-28(29)35-30(40)19-38-12-10-22(11-13-38)27-3-2-4-31(36-27)43-20-24-5-7-25(33)18-26(24)34/h2-9,14,17-18,22H,10-13,15-16,19-20H2,1H3,(H,41,42) MKHLSCZFQYGGCU-UHFFFAOYSA-N 349840 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(3-methyl-1H-pyrazol-1-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-31 Glucagon-like peptide 1 receptor Human 1500 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349840&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208614 386051597 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691691 Cn1cc(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)cn1 InChI=1S/C32H32ClFN6O3/c1-38-18-21(17-35-38)9-14-40-29-15-23(32(41)42)6-8-28(29)36-30(40)19-39-12-10-22(11-13-39)27-3-2-4-31(37-27)43-20-24-5-7-25(33)16-26(24)34/h2-8,15-18,22H,9-14,19-20H2,1H3,(H,41,42) ZNRSXBBWFRFSML-UHFFFAOYSA-N 349841 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1-methyl-1H-pyrazol-4-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-32 Glucagon-like peptide 1 receptor Human 87.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349841&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208615 386051598 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691692 Cn1cc(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)cn1 InChI=1S/C32H32ClFN6O3/c1-38-18-21(17-35-38)9-14-40-29-15-23(32(41)42)6-8-28(29)36-30(40)19-39-12-10-22(11-13-39)27-3-2-4-31(37-27)43-20-24-5-7-25(33)16-26(24)34/h2-8,15-18,22H,9-14,19-20H2,1H3,(H,41,42) ZNRSXBBWFRFSML-UHFFFAOYSA-N 349841 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1-methyl-1H-pyrazol-4-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-32 Glucagon-like peptide 1 receptor Human 3100 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349841&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208615 386051598 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691693 Cn1ncnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN7O3/c1-37-27(33-18-34-37)16-39-26-13-20(30(40)41)6-8-25(26)35-28(39)15-38-11-9-19(10-12-38)24-3-2-4-29(36-24)42-17-21-5-7-22(31)14-23(21)32/h2-8,13-14,18-19H,9-12,15-17H2,1H3,(H,40,41) JJIVKLWJMIGOHY-UHFFFAOYSA-N 349842 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-1,2,4-triazol-5yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-33 Glucagon-like peptide 1 receptor Human 96.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349842&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208616 386051599 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691694 Cn1ncnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN7O3/c1-37-27(33-18-34-37)16-39-26-13-20(30(40)41)6-8-25(26)35-28(39)15-38-11-9-19(10-12-38)24-3-2-4-29(36-24)42-17-21-5-7-22(31)14-23(21)32/h2-8,13-14,18-19H,9-12,15-17H2,1H3,(H,40,41) JJIVKLWJMIGOHY-UHFFFAOYSA-N 349842 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-1,2,4-triazol-5yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-33 Glucagon-like peptide 1 receptor Human 1400 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349842&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208616 386051599 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691695 CN1CCC[C@@H]1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H35ClFN5O3/c1-37-13-3-4-25(37)18-39-29-16-22(32(40)41)8-10-28(29)35-30(39)19-38-14-11-21(12-15-38)27-5-2-6-31(36-27)42-20-23-7-9-24(33)17-26(23)34/h2,5-10,16-17,21,25H,3-4,11-15,18-20H2,1H3,(H,40,41)/t25-/m1/s1 UBRSAJFWQJSPTH-RUZDIDTESA-N 349843 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-34 Glucagon-like peptide 1 receptor Human 110 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349843&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208617 386051600 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691696 CN1CCC[C@@H]1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H35ClFN5O3/c1-37-13-3-4-25(37)18-39-29-16-22(32(40)41)8-10-28(29)35-30(39)19-38-14-11-21(12-15-38)27-5-2-6-31(36-27)42-20-23-7-9-24(33)17-26(23)34/h2,5-10,16-17,21,25H,3-4,11-15,18-20H2,1H3,(H,40,41)/t25-/m1/s1 UBRSAJFWQJSPTH-RUZDIDTESA-N 349843 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(2R)-1-methylpyrrolidin-2-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-34 Glucagon-like peptide 1 receptor Human 3500 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349843&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208617 386051600 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691697 Cc1cc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)no1 InChI=1S/C31H29ClFN5O4/c1-19-13-24(36-42-19)16-38-28-14-21(31(39)40)6-8-27(28)34-29(38)17-37-11-9-20(10-12-37)26-3-2-4-30(35-26)41-18-22-5-7-23(32)15-25(22)33/h2-8,13-15,20H,9-12,16-18H2,1H3,(H,39,40) ZSURQMMETHQHKY-UHFFFAOYSA-N 349844 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-35 Glucagon-like peptide 1 receptor Human 110 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349844&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208618 386051601 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691698 Cc1cc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)no1 InChI=1S/C31H29ClFN5O4/c1-19-13-24(36-42-19)16-38-28-14-21(31(39)40)6-8-27(28)34-29(38)17-37-11-9-20(10-12-37)26-3-2-4-30(35-26)41-18-22-5-7-23(32)15-25(22)33/h2-8,13-15,20H,9-12,16-18H2,1H3,(H,39,40) ZSURQMMETHQHKY-UHFFFAOYSA-N 349844 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(5-methyl-1,2-oxazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-35 Glucagon-like peptide 1 receptor Human 2700 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349844&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208618 386051601 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691699 Cn1cc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)nn1 InChI=1S/C30H29ClFN7O3/c1-37-15-23(35-36-37)16-39-27-13-20(30(40)41)6-8-26(27)33-28(39)17-38-11-9-19(10-12-38)25-3-2-4-29(34-25)42-18-21-5-7-22(31)14-24(21)32/h2-8,13-15,19H,9-12,16-18H2,1H3,(H,40,41) FZRBXPBZZIRUAY-UHFFFAOYSA-N 349845 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-36 Glucagon-like peptide 1 receptor Human 110 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349845&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208619 386051602 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691700 Cn1cc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)nn1 InChI=1S/C30H29ClFN7O3/c1-37-15-23(35-36-37)16-39-27-13-20(30(40)41)6-8-26(27)33-28(39)17-38-11-9-19(10-12-38)25-3-2-4-29(34-25)42-18-21-5-7-22(31)14-24(21)32/h2-8,13-15,19H,9-12,16-18H2,1H3,(H,40,41) FZRBXPBZZIRUAY-UHFFFAOYSA-N 349845 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-36 Glucagon-like peptide 1 receptor Human 2200 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349845&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208619 386051602 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691701 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cnc[nH]3)c2c1 InChI=1S/C30H28ClFN6O3/c31-22-6-4-21(24(32)13-22)17-41-29-3-1-2-25(36-29)19-8-10-37(11-9-19)16-28-35-26-7-5-20(30(39)40)12-27(26)38(28)15-23-14-33-18-34-23/h1-7,12-14,18-19H,8-11,15-17H2,(H,33,34)(H,39,40) HFXUWEPQRLHPAI-UHFFFAOYSA-N 349846 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1H-imidazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-37 Glucagon-like peptide 1 receptor Human 120 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349846&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208620 386051603 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691702 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3cnc[nH]3)c2c1 InChI=1S/C30H28ClFN6O3/c31-22-6-4-21(24(32)13-22)17-41-29-3-1-2-25(36-29)19-8-10-37(11-9-19)16-28-35-26-7-5-20(30(39)40)12-27(26)38(28)15-23-14-33-18-34-23/h1-7,12-14,18-19H,8-11,15-17H2,(H,33,34)(H,39,40) HFXUWEPQRLHPAI-UHFFFAOYSA-N 349846 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1H-imidazol-5-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-37 Glucagon-like peptide 1 receptor Human 1300 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349846&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208620 386051603 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691703 COCCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-39-15-3-12-36-27-16-21(30(37)38)7-9-26(27)33-28(36)18-35-13-10-20(11-14-35)25-4-2-5-29(34-25)40-19-22-6-8-23(31)17-24(22)32/h2,4-9,16-17,20H,3,10-15,18-19H2,1H3,(H,37,38) LRGOBCLEMLAZMX-UHFFFAOYSA-N 349847 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(3-methoxypropyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-38 Glucagon-like peptide 1 receptor Human 120 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349847&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208621 386051604 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691704 COCCCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-39-15-3-12-36-27-16-21(30(37)38)7-9-26(27)33-28(36)18-35-13-10-20(11-14-35)25-4-2-5-29(34-25)40-19-22-6-8-23(31)17-24(22)32/h2,4-9,16-17,20H,3,10-15,18-19H2,1H3,(H,37,38) LRGOBCLEMLAZMX-UHFFFAOYSA-N 349847 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(3-methoxypropyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-38 Glucagon-like peptide 1 receptor Human 1500 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349847&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208621 386051604 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691705 CCn1ccnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C32H32ClFN6O3/c1-2-39-15-12-35-29(39)19-40-28-16-22(32(41)42)7-9-27(28)36-30(40)18-38-13-10-21(11-14-38)26-4-3-5-31(37-26)43-20-23-6-8-24(33)17-25(23)34/h3-9,12,15-17,21H,2,10-11,13-14,18-20H2,1H3,(H,41,42) GYJSBKLQKDSRBN-UHFFFAOYSA-N 349848 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-ethyl-1H-imidazol-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-39 Glucagon-like peptide 1 receptor Human 130 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349848&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208622 386051605 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691706 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CC3CCCOC3)c2c1 InChI=1S/C32H34ClFN4O4/c33-25-8-6-24(26(34)16-25)20-42-31-5-1-4-27(36-31)22-10-12-37(13-11-22)18-30-35-28-9-7-23(32(39)40)15-29(28)38(30)17-21-3-2-14-41-19-21/h1,4-9,15-16,21-22H,2-3,10-14,17-20H2,(H,39,40) SFPNLRBMMWSTHO-UHFFFAOYSA-N 349849 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydro-2H-pyran-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-40 Glucagon-like peptide 1 receptor Human 170 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349849&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208623 386051606 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691707 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCc3c[nH]cn3)c2c1 InChI=1S/C31H30ClFN6O3/c32-23-6-4-22(25(33)15-23)18-42-30-3-1-2-26(37-30)20-8-11-38(12-9-20)17-29-36-27-7-5-21(31(40)41)14-28(27)39(29)13-10-24-16-34-19-35-24/h1-7,14-16,19-20H,8-13,17-18H2,(H,34,35)(H,40,41) CSOQWHUKBVCZQO-UHFFFAOYSA-N 349850 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1H-imidazol-4-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-41 Glucagon-like peptide 1 receptor Human 190 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349850&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208624 386051607 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691708 CN1CC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CC1=O InChI=1S/C32H33ClFN5O4/c1-37-16-20(13-31(37)40)17-39-28-14-22(32(41)42)6-8-27(28)35-29(39)18-38-11-9-21(10-12-38)26-3-2-4-30(36-26)43-19-23-5-7-24(33)15-25(23)34/h2-8,14-15,20-21H,9-13,16-19H2,1H3,(H,41,42) DQLXQDYVAFRQKW-UHFFFAOYSA-N 349851 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-5-oxopyrrolidin-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-42 Glucagon-like peptide 1 receptor Human 190 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349851&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208625 386051608 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691709 Cn1cc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)cn1 InChI=1S/C31H30ClFN6O3/c1-37-16-20(15-34-37)17-39-28-13-22(31(40)41)6-8-27(28)35-29(39)18-38-11-9-21(10-12-38)26-3-2-4-30(36-26)42-19-23-5-7-24(32)14-25(23)33/h2-8,13-16,21H,9-12,17-19H2,1H3,(H,40,41) QWMCNVOPHJEKEE-UHFFFAOYSA-N 349852 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-pyrazol-4-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-43 Glucagon-like peptide 1 receptor Human 190 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349852&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208626 386051609 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691710 Cn1cc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)cn1 InChI=1S/C31H30ClFN6O3/c1-37-16-20(15-34-37)17-39-28-13-22(31(40)41)6-8-27(28)35-29(39)18-38-11-9-21(10-12-38)26-3-2-4-30(36-26)42-19-23-5-7-24(32)14-25(23)33/h2-8,13-16,21H,9-12,17-19H2,1H3,(H,40,41) QWMCNVOPHJEKEE-UHFFFAOYSA-N 349852 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-pyrazol-4-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-43 Glucagon-like peptide 1 receptor Human 3600 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349852&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208626 386051609 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691711 Cn1cc(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)nn1 InChI=1S/C31H31ClFN7O3/c1-38-17-24(36-37-38)11-14-40-28-15-21(31(41)42)6-8-27(28)34-29(40)18-39-12-9-20(10-13-39)26-3-2-4-30(35-26)43-19-22-5-7-23(32)16-25(22)33/h2-8,15-17,20H,9-14,18-19H2,1H3,(H,41,42) JEFQSZSRQHYFLV-UHFFFAOYSA-N 349853 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(1-methyl-1H-1,2,3-triazol-4-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-44 Glucagon-like peptide 1 receptor Human 210 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349853&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208627 386051610 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691712 COC[C@H](C)n1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19(17-39-2)36-27-14-21(30(37)38)7-9-26(27)33-28(36)16-35-12-10-20(11-13-35)25-4-3-5-29(34-25)40-18-22-6-8-23(31)15-24(22)32/h3-9,14-15,19-20H,10-13,16-18H2,1-2H3,(H,37,38)/t19-/m0/s1 WXMLCEJYRZLNNA-IBGZPJMESA-N 349854 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-1-methoxypropan-2-yl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-45 Glucagon-like peptide 1 receptor Human 290 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349854&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208628 386051611 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691713 COC[C@@H](C)n1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19(17-39-2)36-27-14-21(30(37)38)7-9-26(27)33-28(36)16-35-12-10-20(11-13-35)25-4-3-5-29(34-25)40-18-22-6-8-23(31)15-24(22)32/h3-9,14-15,19-20H,10-13,16-18H2,1-2H3,(H,37,38)/t19-/m1/s1 WXMLCEJYRZLNNA-LJQANCHMSA-N 349855 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2R)-1-methoxypropan-2-yl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-46 Glucagon-like peptide 1 receptor Human 300 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349855&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208629 386051612 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691714 Cc1cc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)on1 InChI=1S/C31H29ClFN5O4/c1-19-13-24(42-36-19)16-38-28-14-21(31(39)40)6-8-27(28)34-29(38)17-37-11-9-20(10-12-37)26-3-2-4-30(35-26)41-18-22-5-7-23(32)15-25(22)33/h2-8,13-15,20H,9-12,16-18H2,1H3,(H,39,40) NLGPUFRHRSFMBS-UHFFFAOYSA-N 349856 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3-methyl-1,2-oxazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-47 Glucagon-like peptide 1 receptor Human 320 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349856&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208630 386051613 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691715 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CC3CCCCO3)c2c1 InChI=1S/C32H34ClFN4O4/c33-24-9-7-23(26(34)17-24)20-42-31-6-3-5-27(36-31)21-11-13-37(14-12-21)19-30-35-28-10-8-22(32(39)40)16-29(28)38(30)18-25-4-1-2-15-41-25/h3,5-10,16-17,21,25H,1-2,4,11-15,18-20H2,(H,39,40) HXCMCEDTGKFJEJ-UHFFFAOYSA-N 349857 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydro-2H-pyran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-48 Glucagon-like peptide 1 receptor Human 350 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349857&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208631 386051614 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691716 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CC3CCOCC3)c2c1 InChI=1S/C32H34ClFN4O4/c33-25-6-4-24(26(34)17-25)20-42-31-3-1-2-27(36-31)22-8-12-37(13-9-22)19-30-35-28-7-5-23(32(39)40)16-29(28)38(30)18-21-10-14-41-15-11-21/h1-7,16-17,21-22H,8-15,18-20H2,(H,39,40) JJFNBFNFHFNXHQ-UHFFFAOYSA-N 349858 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-49 Glucagon-like peptide 1 receptor Human 380 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349858&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208632 386051615 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691717 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCN3CCOCC3)c2c1 InChI=1S/C32H35ClFN5O4/c33-25-6-4-24(26(34)19-25)21-43-31-3-1-2-27(36-31)22-8-10-38(11-9-22)20-30-35-28-7-5-23(32(40)41)18-29(28)39(30)13-12-37-14-16-42-17-15-37/h1-7,18-19,22H,8-17,20-21H2,(H,40,41) HIULSQBCVWHVBK-UHFFFAOYSA-N 349859 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(morpholin-4-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-50 Glucagon-like peptide 1 receptor Human 380 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349859&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208633 386051616 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691718 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CC3CC(F)(F)C3)c2c1 InChI=1S/C31H30ClF3N4O3/c32-23-6-4-22(24(33)13-23)18-42-29-3-1-2-25(37-29)20-8-10-38(11-9-20)17-28-36-26-7-5-21(30(40)41)12-27(26)39(28)16-19-14-31(34,35)15-19/h1-7,12-13,19-20H,8-11,14-18H2,(H,40,41) QTKKQALTXGDUTM-UHFFFAOYSA-N 349860 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3,3-difluorocyclobutyl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-51 Glucagon-like peptide 1 receptor Human 390 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349860&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208634 386051617 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691719 CC(c1nncn1C)n1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H31ClFN7O3/c1-19(30-37-34-18-38(30)2)40-27-14-21(31(41)42)7-9-26(27)35-28(40)16-39-12-10-20(11-13-39)25-4-3-5-29(36-25)43-17-22-6-8-23(32)15-24(22)33/h3-9,14-15,18-20H,10-13,16-17H2,1-2H3,(H,41,42) GJIHGLDHZWWCQL-UHFFFAOYSA-N 349861 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[1-(4-methyl-4H-1,2,4-triazol-3-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-52 Glucagon-like peptide 1 receptor Human 440 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349861&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208635 386051618 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691720 Cn1cnnc1CCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H31ClFN7O3/c1-38-19-34-37-28(38)11-14-40-27-15-21(31(41)42)6-8-26(27)35-29(40)17-39-12-9-20(10-13-39)25-3-2-4-30(36-25)43-18-22-5-7-23(32)16-24(22)33/h2-8,15-16,19-20H,9-14,17-18H2,1H3,(H,41,42) SMAMRSFVAKLCQD-UHFFFAOYSA-N 349862 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(4-methyl-4H-1,2,4-triazol-3-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-53 Glucagon-like peptide 1 receptor Human 450 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349862&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208636 386051619 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691721 Cn1cnnc1CCn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H31ClFN7O3/c1-38-19-34-37-28(38)11-14-40-27-15-21(31(41)42)6-8-26(27)35-29(40)17-39-12-9-20(10-13-39)25-3-2-4-30(36-25)43-18-22-5-7-23(32)16-24(22)33/h2-8,15-16,19-20H,9-14,17-18H2,1H3,(H,41,42) SMAMRSFVAKLCQD-UHFFFAOYSA-N 349862 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(4-methyl-4H-1,2,4-triazol-3-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-53 Glucagon-like peptide 1 receptor Human 5600 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349862&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208636 386051619 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691722 CCN1CCC[C@@H]1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C33H37ClFN5O3/c1-2-39-14-4-5-26(39)19-40-30-17-23(33(41)42)9-11-29(30)36-31(40)20-38-15-12-22(13-16-38)28-6-3-7-32(37-28)43-21-24-8-10-25(34)18-27(24)35/h3,6-11,17-18,22,26H,2,4-5,12-16,19-21H2,1H3,(H,41,42)/t26-/m1/s1 BEKWXCQGUFIUAU-AREMUKBSSA-N 349863 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[(2R)-1-ethylpyrrolidin-2-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-54 Glucagon-like peptide 1 receptor Human 500 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349863&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208637 386051620 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691723 Cc1nc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)c(C)o1 InChI=1S/C32H31ClFN5O4/c1-19-28(35-20(2)43-19)16-39-29-14-22(32(40)41)7-9-27(29)36-30(39)17-38-12-10-21(11-13-38)26-4-3-5-31(37-26)42-18-23-6-8-24(33)15-25(23)34/h3-9,14-15,21H,10-13,16-18H2,1-2H3,(H,40,41) KPSCTAFMSHBBBU-UHFFFAOYSA-N 349864 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2,5-dimethyl-1,3-oxazol-4-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-55 Glucagon-like peptide 1 receptor Human 520 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349864&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208638 386051621 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691724 COC1CCN(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CC1 InChI=1S/C34H39ClFN5O4/c1-44-27-11-15-39(16-12-27)17-18-41-31-19-24(34(42)43)6-8-30(31)37-32(41)21-40-13-9-23(10-14-40)29-3-2-4-33(38-29)45-22-25-5-7-26(35)20-28(25)36/h2-8,19-20,23,27H,9-18,21-22H2,1H3,(H,42,43) OMPURRNNLBAIAD-UHFFFAOYSA-N 349865 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(4-methoxypiperidin-1-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-56 Glucagon-like peptide 1 receptor Human 1100 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349865&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208639 386051622 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691725 Cc1cc(C)n(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1 InChI=1S/C33H34ClFN6O3/c1-21-16-22(2)41(38-21)15-14-40-30-17-24(33(42)43)7-9-29(30)36-31(40)19-39-12-10-23(11-13-39)28-4-3-5-32(37-28)44-20-25-6-8-26(34)18-27(25)35/h3-9,16-18,23H,10-15,19-20H2,1-2H3,(H,42,43) JILRNNZTJZQWBI-UHFFFAOYSA-N 349866 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-57 Glucagon-like peptide 1 receptor Human 1100 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349866&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208640 386051623 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691726 Cc1cc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)[nH]n1 InChI=1S/C31H30ClFN6O3/c1-19-13-24(37-36-19)16-39-28-14-21(31(40)41)6-8-27(28)34-29(39)17-38-11-9-20(10-12-38)26-3-2-4-30(35-26)42-18-22-5-7-23(32)15-25(22)33/h2-8,13-15,20H,9-12,16-18H2,1H3,(H,36,37)(H,40,41) YTHFAOWWPNVWSP-UHFFFAOYSA-N 349867 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3-methyl-1H-pyrazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-58 Glucagon-like peptide 1 receptor Human 1100 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349867&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208641 386051624 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691727 Cc1n[nH]c(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1 InChI=1S/C30H29ClFN7O3/c1-18-33-27(37-36-18)15-39-26-13-20(30(40)41)6-8-25(26)34-28(39)16-38-11-9-19(10-12-38)24-3-2-4-29(35-24)42-17-21-5-7-22(31)14-23(21)32/h2-8,13-14,19H,9-12,15-17H2,1H3,(H,40,41)(H,33,36,37) ZPDLPVKBMJMRCE-UHFFFAOYSA-N 349868 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(3-methyl-1H-1,2,4-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-59 Glucagon-like peptide 1 receptor Human 1400 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349868&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208642 386051625 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691728 CC(c1cnn(C)n1)n1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H31ClFN7O3/c1-19(27-16-34-38(2)37-27)40-28-14-21(31(41)42)7-9-26(28)35-29(40)17-39-12-10-20(11-13-39)25-4-3-5-30(36-25)43-18-22-6-8-23(32)15-24(22)33/h3-9,14-16,19-20H,10-13,17-18H2,1-2H3,(H,41,42) HXIZPDOHDVOSTL-UHFFFAOYSA-N 349869 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[1-(2-methyl-2H-1,2,3-triazol-4-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-60 Glucagon-like peptide 1 receptor Human 1600 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349869&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208643 386051626 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691729 Cc1ccc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)cn1 InChI=1S/C33H31ClFN5O3/c1-21-5-6-22(17-36-21)18-40-30-15-24(33(41)42)8-10-29(30)37-31(40)19-39-13-11-23(12-14-39)28-3-2-4-32(38-28)43-20-25-7-9-26(34)16-27(25)35/h2-10,15-17,23H,11-14,18-20H2,1H3,(H,41,42) PYQDWJOEJCDICQ-UHFFFAOYSA-N 349870 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(6-methylpyridin-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-61 Glucagon-like peptide 1 receptor Human 1900 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349870&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208644 386051627 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691730 COCc1cc(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)[nH]n1 InChI=1S/C32H32ClFN6O4/c1-43-19-25-15-24(37-38-25)16-40-29-13-21(32(41)42)6-8-28(29)35-30(40)17-39-11-9-20(10-12-39)27-3-2-4-31(36-27)44-18-22-5-7-23(33)14-26(22)34/h2-8,13-15,20H,9-12,16-19H2,1H3,(H,37,38)(H,41,42) NIRIJPAACIOYGQ-UHFFFAOYSA-N 349871 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[3-(methoxymethyl)-1H-pyrazol-5-yl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-62 Glucagon-like peptide 1 receptor Human 2200 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349871&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208645 386051628 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691731 CN1CCOC(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)C1 InChI=1S/C32H35ClFN5O4/c1-37-13-14-42-25(17-37)18-39-29-15-22(32(40)41)6-8-28(29)35-30(39)19-38-11-9-21(10-12-38)27-3-2-4-31(36-27)43-20-23-5-7-24(33)16-26(23)34/h2-8,15-16,21,25H,9-14,17-20H2,1H3,(H,40,41) GNYJUUQUQZNOCU-UHFFFAOYSA-N 349872 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4-methylmorpholin-2-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-63 Glucagon-like peptide 1 receptor Human 2500 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349872&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208646 386051629 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691732 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3n[nH]c(n3)C3CC3)c2c1 InChI=1S/C32H31ClFN7O3/c33-23-8-6-22(24(34)15-23)18-44-30-3-1-2-25(36-30)19-10-12-40(13-11-19)17-29-35-26-9-7-21(32(42)43)14-27(26)41(29)16-28-37-31(39-38-28)20-4-5-20/h1-3,6-9,14-15,19-20H,4-5,10-13,16-18H2,(H,42,43)(H,37,38,39) QHICXBUJWSIINB-UHFFFAOYSA-N 349873 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(5-cyclopropyl-1H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-64 Glucagon-like peptide 1 receptor Human 2900 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349873&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208647 386051630 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691733 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCC3CCOCC3)c2c1 InChI=1S/C33H36ClFN4O4/c34-26-6-4-25(27(35)19-26)21-43-32-3-1-2-28(37-32)23-9-13-38(14-10-23)20-31-36-29-7-5-24(33(40)41)18-30(29)39(31)15-8-22-11-16-42-17-12-22/h1-7,18-19,22-23H,8-17,20-21H2,(H,40,41) CLFKNWYMXKSDSM-UHFFFAOYSA-N 349874 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(tetrahydro-2H-pyran-4-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-65 Glucagon-like peptide 1 receptor Human 3100 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349874&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208648 386051631 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691734 Cc1n[nH]c(CCn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)n1 InChI=1S/C31H31ClFN7O3/c1-19-34-28(38-37-19)11-14-40-27-15-21(31(41)42)6-8-26(27)35-29(40)17-39-12-9-20(10-13-39)25-3-2-4-30(36-25)43-18-22-5-7-23(32)16-24(22)33/h2-8,15-16,20H,9-14,17-18H2,1H3,(H,41,42)(H,34,37,38) DGBCWOXGEQALTI-UHFFFAOYSA-N 349875 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[2-(3-methyl-1H-1,2,4-triazol-5-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-66 Glucagon-like peptide 1 receptor Human 4000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349875&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208649 386051632 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691735 CC(c1n[nH]c(C)n1)n1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O 349876 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[1-(5-methyl-1H-1,2,4-triazol-3-yl)ethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-67 Glucagon-like peptide 1 receptor Human 9300 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349876&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208650 386051633 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691736 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@H]3CCCO3)c2c1 InChI=1S/C31H32ClFN4O4/c32-23-8-6-22(25(33)16-23)19-41-30-5-1-4-26(35-30)20-10-12-36(13-11-20)18-29-34-27-9-7-21(31(38)39)15-28(27)37(29)17-24-3-2-14-40-24/h1,4-9,15-16,20,24H,2-3,10-14,17-19H2,(H,38,39)/t24-/m1/s1 BYYUOSXFZIZLGT-XMMPIXPASA-N 349877 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2R)-tetrahydrofuran-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-68 Glucagon-like peptide 1 receptor Human 63.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349877&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208651 386051634 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691737 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(C[C@H]3CCCO3)c2c1 InChI=1S/C31H32ClFN4O4/c32-23-8-6-22(25(33)16-23)19-41-30-5-1-4-26(35-30)20-10-12-36(13-11-20)18-29-34-27-9-7-21(31(38)39)15-28(27)37(29)17-24-3-2-14-40-24/h1,4-9,15-16,20,24H,2-3,10-14,17-19H2,(H,38,39)/t24-/m1/s1 BYYUOSXFZIZLGT-XMMPIXPASA-N 349877 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2R)-tetrahydrofuran-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-68 Glucagon-like peptide 1 receptor Human 2000 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349877&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208651 386051634 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691738 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ccon3)c2c1 InChI=1S/C30H27ClFN5O4/c31-22-6-4-21(24(32)15-22)18-40-29-3-1-2-25(34-29)19-8-11-36(12-9-19)17-28-33-26-7-5-20(30(38)39)14-27(26)37(28)16-23-10-13-41-35-23/h1-7,10,13-15,19H,8-9,11-12,16-18H2,(H,38,39) BRRNORBIEZMUJA-UHFFFAOYSA-N 349878 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,2-oxazol-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-69 Glucagon-like peptide 1 receptor Human 5.30 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349878&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208652 386051635 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691739 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(Cc3ccon3)c2c1 InChI=1S/C30H27ClFN5O4/c31-22-6-4-21(24(32)15-22)18-40-29-3-1-2-25(34-29)19-8-11-36(12-9-19)17-28-33-26-7-5-20(30(38)39)14-27(26)37(28)16-23-10-13-41-35-23/h1-7,10,13-15,19H,8-9,11-12,16-18H2,(H,38,39) BRRNORBIEZMUJA-UHFFFAOYSA-N 349878 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(1,2-oxazol-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-69 Glucagon-like peptide 1 receptor Human 21.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349878&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208652 386051635 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691740 Cn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H30ClFN6O3/c1-37-19-34-15-24(37)16-39-28-13-21(31(40)41)6-8-27(28)35-29(39)17-38-11-9-20(10-12-38)26-3-2-4-30(36-26)42-18-22-5-7-23(32)14-25(22)33/h2-8,13-15,19-20H,9-12,16-18H2,1H3,(H,40,41) XKYKSMAIJIVXDN-UHFFFAOYSA-N 349879 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-70 Glucagon-like peptide 1 receptor Human 0.700 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349879&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611057 386051636 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691741 Cn1cncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H30ClFN6O3/c1-37-19-34-15-24(37)16-39-28-13-21(31(40)41)6-8-27(28)35-29(39)17-38-11-9-20(10-12-38)26-3-2-4-30(36-26)42-18-22-5-7-23(32)14-25(22)33/h2-8,13-15,19-20H,9-12,16-18H2,1H3,(H,40,41) XKYKSMAIJIVXDN-UHFFFAOYSA-N 349879 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-70 Glucagon-like peptide 1 receptor Human 10.00 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349879&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611057 386051636 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691742 Cn1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN7O3/c1-37-18-33-36-28(37)16-39-26-13-20(30(40)41)6-8-25(26)34-27(39)15-38-11-9-19(10-12-38)24-3-2-4-29(35-24)42-17-21-5-7-22(31)14-23(21)32/h2-8,13-14,18-19H,9-12,15-17H2,1H3,(H,40,41) YEGMZHPMBRHBTL-UHFFFAOYSA-N 349880 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4-methyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-71 Glucagon-like peptide 1 receptor Human 30.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349880&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208653 386051637 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691743 Cn1cnnc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN7O3/c1-37-18-33-36-28(37)16-39-26-13-20(30(40)41)6-8-25(26)34-27(39)15-38-11-9-19(10-12-38)24-3-2-4-29(35-24)42-17-21-5-7-22(31)14-23(21)32/h2-8,13-14,18-19H,9-12,15-17H2,1H3,(H,40,41) YEGMZHPMBRHBTL-UHFFFAOYSA-N 349880 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(4-methyl-4H-1,2,4-triazol-3-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-71 Glucagon-like peptide 1 receptor Human 570 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349880&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208653 386051637 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691744 Cn1nncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN7O3/c1-37-23(15-33-36-37)16-39-27-13-20(30(40)41)6-8-26(27)34-28(39)17-38-11-9-19(10-12-38)25-3-2-4-29(35-25)42-18-21-5-7-22(31)14-24(21)32/h2-8,13-15,19H,9-12,16-18H2,1H3,(H,40,41) GAXPSCFJNIDMDR-UHFFFAOYSA-N 349881 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-1,2,3-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-72 Glucagon-like peptide 1 receptor Human 5.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349881&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611124 386051638 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691745 Cn1nncc1Cn1c(CN2CCC(CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H29ClFN7O3/c1-37-23(15-33-36-37)16-39-27-13-20(30(40)41)6-8-26(27)34-28(39)17-38-11-9-19(10-12-38)25-3-2-4-29(35-25)42-18-21-5-7-22(31)14-24(21)32/h2-8,13-15,19H,9-12,16-18H2,1H3,(H,40,41) GAXPSCFJNIDMDR-UHFFFAOYSA-N 349881 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(1-methyl-1H-1,2,3-triazol-5-yl)methyl]-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-72 Glucagon-like peptide 1 receptor Human 41.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349881&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611124 386051638 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691746 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCC(F)(F)F)c2c1 InChI=1S/C29H27ClF4N4O3/c30-21-6-4-20(22(31)15-21)17-41-27-3-1-2-23(36-27)18-8-11-37(12-9-18)16-26-35-24-7-5-19(28(39)40)14-25(24)38(26)13-10-29(32,33)34/h1-7,14-15,18H,8-13,16-17H2,(H,39,40) FTVJJRJLULFPAB-UHFFFAOYSA-N 349882 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(3,3,3-trifluoropropyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-73 Glucagon-like peptide 1 receptor Human 150 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349882&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208654 386051639 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691747 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)n(CCC(F)(F)F)c2c1 InChI=1S/C29H27ClF4N4O3/c30-21-6-4-20(22(31)15-21)17-41-27-3-1-2-23(36-27)18-8-11-37(12-9-18)16-26-35-24-7-5-19(28(39)40)14-25(24)38(26)13-10-29(32,33)34/h1-7,14-15,18H,8-13,16-17H2,(H,39,40) FTVJJRJLULFPAB-UHFFFAOYSA-N 349882 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(3,3,3-trifluoropropyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-73 Glucagon-like peptide 1 receptor Human 5300 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349882&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208654 386051639 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691748 COCC1(Cn2c(CN3CCC(CC3)c3cccc(OCc4ccc(Cl)cc4F)n3)nc3ccc(cc23)C(O)=O)CCC1 InChI=1S/C33H36ClFN4O4/c1-42-21-33(12-3-13-33)20-39-29-16-23(32(40)41)7-9-28(29)36-30(39)18-38-14-10-22(11-15-38)27-4-2-5-31(37-27)43-19-24-6-8-25(34)17-26(24)35/h2,4-9,16-17,22H,3,10-15,18-21H2,1H3,(H,40,41) JDZHYTGFLAYCAJ-UHFFFAOYSA-N 349883 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-{[1-(methoxymethyl)cyclobutyl]methyl}-1H-benzimidazole-6-carboxylic acid::US10208019, Example 11A-74 Glucagon-like peptide 1 receptor Human 560 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349883&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208655 386051640 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691749 COCCn1c(CN2CCN(CC2C(F)(F)F)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H28ClF4N5O4/c1-42-12-11-39-23-13-18(28(40)41)6-8-22(23)35-26(39)16-37-9-10-38(15-24(37)29(32,33)34)25-3-2-4-27(36-25)43-17-19-5-7-20(30)14-21(19)31/h2-8,13-14,24H,9-12,15-17H2,1H3,(H,40,41) DRKKUKDHSWFCNH-UHFFFAOYSA-N 349884 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)-2-(trifluoromethyl)piperazin-1-yl)methyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 12A-01::US10208019, Example 12A-02 Glucagon-like peptide 1 receptor Human >20000 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349884&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611226 386051641 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691750 COCCn1c(CN2CCN(CC2C(F)(F)F)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H28ClF4N5O4/c1-42-12-11-39-23-13-18(28(40)41)6-8-22(23)35-26(39)16-37-9-10-38(15-24(37)29(32,33)34)25-3-2-4-27(36-25)43-17-19-5-7-20(30)14-21(19)31/h2-8,13-14,24H,9-12,15-17H2,1H3,(H,40,41) DRKKUKDHSWFCNH-UHFFFAOYSA-N 349884 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)-2-(trifluoromethyl)piperazin-1-yl)methyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 12A-01::US10208019, Example 12A-02 Glucagon-like peptide 1 receptor Human 36.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349884&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611226 386051641 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691751 COCCn1c(CN2CCN(CC2C(F)(F)F)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H28ClF4N5O4/c1-42-12-11-39-23-13-18(28(40)41)6-8-22(23)35-26(39)16-37-9-10-38(15-24(37)29(32,33)34)25-3-2-4-27(36-25)43-17-19-5-7-20(30)14-21(19)31/h2-8,13-14,24H,9-12,15-17H2,1H3,(H,40,41) DRKKUKDHSWFCNH-UHFFFAOYSA-N 349884 2-((4-(6-((4-Chloro-2-fluorobenzyl)oxy)pyridin-2-yl)-2-(trifluoromethyl)piperazin-1-yl)methyl)-1-(2-methoxyethyl)-1H-benzo[d]imidazole-6-carboxylic acid::US10208019, Example 12A-01::US10208019, Example 12A-02 Glucagon-like peptide 1 receptor Human 1600 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349884&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611226 386051641 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691752 COCCn1c(CN2CCN(CC22CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H31ClFN5O4/c1-40-14-13-37-25-15-20(29(38)39)6-8-24(25)33-27(37)17-36-12-11-35(19-30(36)9-10-30)26-3-2-4-28(34-26)41-18-21-5-7-22(31)16-23(21)32/h2-8,15-16H,9-14,17-19H2,1H3,(H,38,39) UJTKMYRZOSUBNS-UHFFFAOYSA-N 349886 2-[(7-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-4,7-diazaspiro[2.5]oct-4-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-03 Glucagon-like peptide 1 receptor Human 600 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349886&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208656 386051642 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691753 COCCn1c(CN2CCN(C[C@@H]2C2CC2)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H33ClFN5O4/c1-41-14-13-38-26-15-21(31(39)40)8-10-25(26)34-29(38)18-36-11-12-37(17-27(36)20-5-6-20)28-3-2-4-30(35-28)42-19-22-7-9-23(32)16-24(22)33/h2-4,7-10,15-16,20,27H,5-6,11-14,17-19H2,1H3,(H,39,40)/t27-/m1/s1 HMUABVNXXZSVEJ-HHHXNRCGSA-N 349887 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-cyclopropylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-04 Glucagon-like peptide 1 receptor Human 250 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349887&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208657 386051643 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691754 COCCn1c(CN2CCN(C[C@@H]2C(C)C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C31H35ClFN5O4/c1-20(2)27-17-37(28-5-4-6-30(35-28)42-19-22-7-9-23(32)16-24(22)33)12-11-36(27)18-29-34-25-10-8-21(31(39)40)15-26(25)38(29)13-14-41-3/h4-10,15-16,20,27H,11-14,17-19H2,1-3H3,(H,39,40)/t27-/m1/s1 WLTNSTTXEDIKKP-HHHXNRCGSA-N 349888 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-(propan-2-yl)piperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-05 Glucagon-like peptide 1 receptor Human 1300 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349888&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208658 386051644 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691755 COCCn1c(CN2CCN(CC2(C)C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H33ClFN5O4/c1-30(2)19-35(26-5-4-6-28(34-26)41-18-21-7-9-22(31)16-23(21)32)11-12-36(30)17-27-33-24-10-8-20(29(38)39)15-25(24)37(27)13-14-40-3/h4-10,15-16H,11-14,17-19H2,1-3H3,(H,38,39) UTLGCTYGTFVJKR-UHFFFAOYSA-N 349889 2-[(4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2,2-dimethylpiperazin-1-yl)methyl]-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-06 Glucagon-like peptide 1 receptor Human 510 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349889&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208659 386051645 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691756 CC[C@H]1CN(CCN1Cc1nc2ccc(cc2n1CCOC)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H33ClFN5O4/c1-3-23-17-36(27-5-4-6-29(34-27)41-19-21-7-9-22(31)16-24(21)32)12-11-35(23)18-28-33-25-10-8-20(30(38)39)15-26(25)37(28)13-14-40-2/h4-10,15-16,23H,3,11-14,17-19H2,1-2H3,(H,38,39)/t23-/m0/s1 GPOOTDVRFDOBER-QHCPKHFHSA-N 349890 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-ethylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-07 Glucagon-like peptide 1 receptor Human 37.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349890&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208660 386051646 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691757 CC[C@H]1CN(CCN1Cc1nc2ccc(cc2n1CCOC)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1 InChI=1S/C30H33ClFN5O4/c1-3-23-17-36(27-5-4-6-29(34-27)41-19-21-7-9-22(31)16-24(21)32)12-11-35(23)18-28-33-25-10-8-20(30(38)39)15-26(25)37(28)13-14-40-2/h4-10,15-16,23H,3,11-14,17-19H2,1-2H3,(H,38,39)/t23-/m0/s1 GPOOTDVRFDOBER-QHCPKHFHSA-N 349890 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-ethylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-07 Glucagon-like peptide 1 receptor Human 1200 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349890&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208660 386051646 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691758 COCCn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(cc3)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32N6O4/c1-21-18-35(27-4-3-5-29(33-27)40-20-23-8-6-22(17-31)7-9-23)13-12-34(21)19-28-32-25-11-10-24(30(37)38)16-26(25)36(28)14-15-39-2/h3-11,16,21H,12-15,18-20H2,1-2H3,(H,37,38)/t21-/m0/s1 UXDMOGBSPKINQS-NRFANRHFSA-N 349891 2-{[(2S)-4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-08 Glucagon-like peptide 1 receptor Human 6.10 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349891&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611189 386051647 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691759 COCCn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(cc3)C#N)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32N6O4/c1-21-18-35(27-4-3-5-29(33-27)40-20-23-8-6-22(17-31)7-9-23)13-12-34(21)19-28-32-25-11-10-24(30(37)38)16-26(25)36(28)14-15-39-2/h3-11,16,21H,12-15,18-20H2,1-2H3,(H,37,38)/t21-/m0/s1 UXDMOGBSPKINQS-NRFANRHFSA-N 349891 2-{[(2S)-4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-08 Glucagon-like peptide 1 receptor Human 150 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349891&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611189 386051647 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691760 COCCn1c(CN2CCN(C[C@@H]2CO)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H31ClFN5O5/c1-40-12-11-36-25-13-19(29(38)39)6-8-24(25)32-27(36)16-34-9-10-35(15-22(34)17-37)26-3-2-4-28(33-26)41-18-20-5-7-21(30)14-23(20)31/h2-8,13-14,22,37H,9-12,15-18H2,1H3,(H,38,39)/t22-/m1/s1 HSQLTLCMDHWHLH-JOCHJYFZSA-N 349892 2-{[(2R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-(hydroxymethyl)piperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-09 Glucagon-like peptide 1 receptor Human 21.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349892&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208661 386051648 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691761 COCCn1c(CN2CCN(C[C@@H]2CO)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H31ClFN5O5/c1-40-12-11-36-25-13-19(29(38)39)6-8-24(25)32-27(36)16-34-9-10-35(15-22(34)17-37)26-3-2-4-28(33-26)41-18-20-5-7-21(30)14-23(20)31/h2-8,13-14,22,37H,9-12,15-18H2,1H3,(H,38,39)/t22-/m1/s1 HSQLTLCMDHWHLH-JOCHJYFZSA-N 349892 2-{[(2R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-(hydroxymethyl)piperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-09 Glucagon-like peptide 1 receptor Human 540 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349892&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208661 386051648 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691762 COCCn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H31ClFN5O4/c1-19-16-35(26-4-3-5-28(33-26)40-18-21-6-8-22(30)15-23(21)31)11-10-34(19)17-27-32-24-9-7-20(29(37)38)14-25(24)36(27)12-13-39-2/h3-9,14-15,19H,10-13,16-18H2,1-2H3,(H,37,38)/t19-/m0/s1 XDDYAMIFBDIOGM-IBGZPJMESA-N 349893 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-10 Glucagon-like peptide 1 receptor Human 6.90 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349893&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208662 386051649 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691763 COCCn1c(CN2CCN(C[C@@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C29H31ClFN5O4/c1-19-16-35(26-4-3-5-28(33-26)40-18-21-6-8-22(30)15-23(21)31)11-10-34(19)17-27-32-24-9-7-20(29(37)38)14-25(24)36(27)12-13-39-2/h3-9,14-15,19H,10-13,16-18H2,1-2H3,(H,37,38)/t19-/m0/s1 XDDYAMIFBDIOGM-IBGZPJMESA-N 349893 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 12A-10 Glucagon-like peptide 1 receptor Human 170 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349893&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208662 386051649 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691764 COCCn1c(CN2CCN(C[C@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccccc12 InChI=1S/C28H31ClFN5O2/c1-20-17-34(26-8-5-9-28(32-26)37-19-21-10-11-22(29)16-23(21)30)13-12-33(20)18-27-31-24-6-3-4-7-25(24)35(27)14-15-36-2/h3-11,16,20H,12-15,17-19H2,1-2H3/t20-/m1/s1 HIEXSWIXRWCLAD-HXUWFJFHSA-N 349894 2-{[(2R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-::US10208019, Example 12A-11 Glucagon-like peptide 1 receptor Human 54.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349894&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208663 386051650 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691765 COCCn1c(CN2CCN(C[C@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccccc12 InChI=1S/C28H31ClFN5O2/c1-20-17-34(26-8-5-9-28(32-26)37-19-21-10-11-22(29)16-23(21)30)13-12-33(20)18-27-31-24-6-3-4-7-25(24)35(27)14-15-36-2/h3-11,16,20H,12-15,17-19H2,1-2H3/t20-/m1/s1 HIEXSWIXRWCLAD-HXUWFJFHSA-N 349894 2-{[(2R)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-::US10208019, Example 12A-11 Glucagon-like peptide 1 receptor Human 2100 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349894&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208663 386051650 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691766 COCCn1c(CN2CCC(C[C@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19-14-20(25-4-3-5-29(34-25)40-18-22-6-8-23(31)16-24(22)32)10-11-35(19)17-28-33-26-9-7-21(30(37)38)15-27(26)36(28)12-13-39-2/h3-9,15-16,19-20H,10-14,17-18H2,1-2H3,(H,37,38)/t19-,20?/m1/s1 GTMWLWDYOZIYDR-FIWHBWSRSA-N 349895 2-{[4-{6-[(4-Chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 13A-01::US10208019, Example 13A-04 Glucagon-like peptide 1 receptor Human 1200 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349895&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208664 386051651 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691767 COCCn1c(CN2CCC(C[C@@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19-14-20(25-4-3-5-29(34-25)40-18-22-6-8-23(31)16-24(22)32)10-11-35(19)17-28-33-26-9-7-21(30(37)38)15-27(26)36(28)12-13-39-2/h3-9,15-16,19-20H,10-14,17-18H2,1-2H3,(H,37,38)/t19-,20?/m0/s1 GTMWLWDYOZIYDR-XJDOXCRVSA-N 349896 2-{[4-{6-[(4-Chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 13A-02 Glucagon-like peptide 1 receptor Human 420 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349896&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208665 386051652 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691768 COCCn1c(CN2CCC(CC2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19-14-20(25-4-3-5-29(34-25)40-18-22-6-8-23(31)16-24(22)32)10-11-35(19)17-28-33-26-9-7-21(30(37)38)15-27(26)36(28)12-13-39-2/h3-9,15-16,19-20H,10-14,17-18H2,1-2H3,(H,37,38) GTMWLWDYOZIYDR-UHFFFAOYSA-N 349897 2-{[4-{6-[(4-Chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 13A-03 Glucagon-like peptide 1 receptor Human 5.20 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349897&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611163 386051653 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691769 COCCn1c(CN2CCC(CC2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19-14-20(25-4-3-5-29(34-25)40-18-22-6-8-23(31)16-24(22)32)10-11-35(19)17-28-33-26-9-7-21(30(37)38)15-27(26)36(28)12-13-39-2/h3-9,15-16,19-20H,10-14,17-18H2,1-2H3,(H,37,38) GTMWLWDYOZIYDR-UHFFFAOYSA-N 349897 2-{[4-{6-[(4-Chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 13A-03 Glucagon-like peptide 1 receptor Human 120 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349897&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 134611163 386051653 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691770 COCCn1c(CN2CCC(C[C@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19-14-20(25-4-3-5-29(34-25)40-18-22-6-8-23(31)16-24(22)32)10-11-35(19)17-28-33-26-9-7-21(30(37)38)15-27(26)36(28)12-13-39-2/h3-9,15-16,19-20H,10-14,17-18H2,1-2H3,(H,37,38)/t19-,20?/m1/s1 GTMWLWDYOZIYDR-FIWHBWSRSA-N 349895 2-{[4-{6-[(4-Chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 13A-01::US10208019, Example 13A-04 Glucagon-like peptide 1 receptor Human 46.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349895&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208664 386051651 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691771 COCCn1c(CN2CCC(C[C@H]2C)c2cccc(OCc3ccc(Cl)cc3F)n2)nc2ccc(cc12)C(O)=O InChI=1S/C30H32ClFN4O4/c1-19-14-20(25-4-3-5-29(34-25)40-18-22-6-8-23(31)16-24(22)32)10-11-35(19)17-28-33-26-9-7-21(30(37)38)15-27(26)36(28)12-13-39-2/h3-9,15-16,19-20H,10-14,17-18H2,1-2H3,(H,37,38)/t19-,20?/m1/s1 GTMWLWDYOZIYDR-FIWHBWSRSA-N 349895 2-{[4-{6-[(4-Chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperidin-1-yl]methyl}-1-(2-methoxyethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 13A-01::US10208019, Example 13A-04 Glucagon-like peptide 1 receptor Human 1400 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349895&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208664 386051651 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691772 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4)C#N)n3)n(CC3CCCO3)c2c1 InChI=1S/C32H33N5O4/c33-18-22-6-8-23(9-7-22)21-41-31-5-1-4-27(35-31)24-12-14-36(15-13-24)20-30-34-28-11-10-25(32(38)39)17-29(28)37(30)19-26-3-2-16-40-26/h1,4-11,17,24,26H,2-3,12-16,19-21H2,(H,38,39) FWOZAWDCBQVUKK-UHFFFAOYSA-N 349899 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-01::US10208019, Example 14A-02 Glucagon-like peptide 1 receptor Human 5.60 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349899&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208666 386051654 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691773 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4)C#N)n3)n(CC3CCCO3)c2c1 InChI=1S/C32H33N5O4/c33-18-22-6-8-23(9-7-22)21-41-31-5-1-4-27(35-31)24-12-14-36(15-13-24)20-30-34-28-11-10-25(32(38)39)17-29(28)37(30)19-26-3-2-16-40-26/h1,4-11,17,24,26H,2-3,12-16,19-21H2,(H,38,39) FWOZAWDCBQVUKK-UHFFFAOYSA-N 349899 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-01::US10208019, Example 14A-02 Glucagon-like peptide 1 receptor Human 200 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349899&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208666 386051654 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691774 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4)C#N)n3)n(CC3CCCO3)c2c1 InChI=1S/C32H33N5O4/c33-18-22-6-8-23(9-7-22)21-41-31-5-1-4-27(35-31)24-12-14-36(15-13-24)20-30-34-28-11-10-25(32(38)39)17-29(28)37(30)19-26-3-2-16-40-26/h1,4-11,17,24,26H,2-3,12-16,19-21H2,(H,38,39) FWOZAWDCBQVUKK-UHFFFAOYSA-N 349899 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-01::US10208019, Example 14A-02 Glucagon-like peptide 1 receptor Human 94.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349899&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208666 386051654 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691775 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4)C#N)n3)n(CC3CCCO3)c2c1 InChI=1S/C32H33N5O4/c33-18-22-6-8-23(9-7-22)21-41-31-5-1-4-27(35-31)24-12-14-36(15-13-24)20-30-34-28-11-10-25(32(38)39)17-29(28)37(30)19-26-3-2-16-40-26/h1,4-11,17,24,26H,2-3,12-16,19-21H2,(H,38,39) FWOZAWDCBQVUKK-UHFFFAOYSA-N 349899 2-[(4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-01::US10208019, Example 14A-02 Glucagon-like peptide 1 receptor Human 1500 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349899&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208666 386051654 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691776 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4)C#N)n3)n(CC3CCCO3)c2c1 InChI=1S/C32H32FN5O4/c33-26-8-10-27(36-31(26)42-20-22-5-3-21(17-34)4-6-22)23-11-13-37(14-12-23)19-30-35-28-9-7-24(32(39)40)16-29(28)38(30)18-25-2-1-15-41-25/h3-10,16,23,25H,1-2,11-15,18-20H2,(H,39,40) RPVGGZOBMUVKRF-UHFFFAOYSA-N 349901 2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-03::US10208019, Example 14A-04 Glucagon-like peptide 1 receptor Human 6.30 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349901&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208667 386051655 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691777 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4)C#N)n3)n(CC3CCCO3)c2c1 InChI=1S/C32H32FN5O4/c33-26-8-10-27(36-31(26)42-20-22-5-3-21(17-34)4-6-22)23-11-13-37(14-12-23)19-30-35-28-9-7-24(32(39)40)16-29(28)38(30)18-25-2-1-15-41-25/h3-10,16,23,25H,1-2,11-15,18-20H2,(H,39,40) RPVGGZOBMUVKRF-UHFFFAOYSA-N 349901 2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-03::US10208019, Example 14A-04 Glucagon-like peptide 1 receptor Human 110 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349901&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208667 386051655 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691778 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4)C#N)n3)n(CC3CCCO3)c2c1 InChI=1S/C32H32FN5O4/c33-26-8-10-27(36-31(26)42-20-22-5-3-21(17-34)4-6-22)23-11-13-37(14-12-23)19-30-35-28-9-7-24(32(39)40)16-29(28)38(30)18-25-2-1-15-41-25/h3-10,16,23,25H,1-2,11-15,18-20H2,(H,39,40) RPVGGZOBMUVKRF-UHFFFAOYSA-N 349901 2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-03::US10208019, Example 14A-04 Glucagon-like peptide 1 receptor Human 100.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349901&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208667 386051655 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691779 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4)C#N)n3)n(CC3CCCO3)c2c1 InChI=1S/C32H32FN5O4/c33-26-8-10-27(36-31(26)42-20-22-5-3-21(17-34)4-6-22)23-11-13-37(14-12-23)19-30-35-28-9-7-24(32(39)40)16-29(28)38(30)18-25-2-1-15-41-25/h3-10,16,23,25H,1-2,11-15,18-20H2,(H,39,40) RPVGGZOBMUVKRF-UHFFFAOYSA-N 349901 2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-03::US10208019, Example 14A-04 Glucagon-like peptide 1 receptor Human 1100 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349901&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208667 386051655 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691780 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4)C#N)n3)n(CC3CCOC3)c2c1 InChI=1S/C32H32FN5O4/c33-26-6-8-27(36-31(26)42-20-22-3-1-21(16-34)2-4-22)24-9-12-37(13-10-24)18-30-35-28-7-5-25(32(39)40)15-29(28)38(30)17-23-11-14-41-19-23/h1-8,15,23-24H,9-14,17-20H2,(H,39,40) USPWGYWEYLZTSM-UHFFFAOYSA-N 349903 2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-05::US10208019, Example 14A-06 Glucagon-like peptide 1 receptor Human 28.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349903&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208668 386051656 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691781 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4)C#N)n3)n(CC3CCOC3)c2c1 InChI=1S/C32H32FN5O4/c33-26-6-8-27(36-31(26)42-20-22-3-1-21(16-34)2-4-22)24-9-12-37(13-10-24)18-30-35-28-7-5-25(32(39)40)15-29(28)38(30)17-23-11-14-41-19-23/h1-8,15,23-24H,9-14,17-20H2,(H,39,40) USPWGYWEYLZTSM-UHFFFAOYSA-N 349903 2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-05::US10208019, Example 14A-06 Glucagon-like peptide 1 receptor Human 350 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349903&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208668 386051656 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691782 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4)C#N)n3)n(CC3CCOC3)c2c1 InChI=1S/C32H32FN5O4/c33-26-6-8-27(36-31(26)42-20-22-3-1-21(16-34)2-4-22)24-9-12-37(13-10-24)18-30-35-28-7-5-25(32(39)40)15-29(28)38(30)17-23-11-14-41-19-23/h1-8,15,23-24H,9-14,17-20H2,(H,39,40) USPWGYWEYLZTSM-UHFFFAOYSA-N 349903 2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-05::US10208019, Example 14A-06 Glucagon-like peptide 1 receptor Human 4.20 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349903&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208668 386051656 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691783 OC(=O)c1ccc2nc(CN3CCC(CC3)c3ccc(F)c(OCc4ccc(cc4)C#N)n3)n(CC3CCOC3)c2c1 InChI=1S/C32H32FN5O4/c33-26-6-8-27(36-31(26)42-20-22-3-1-21(16-34)2-4-22)24-9-12-37(13-10-24)18-30-35-28-7-5-25(32(39)40)15-29(28)38(30)17-23-11-14-41-19-23/h1-8,15,23-24H,9-14,17-20H2,(H,39,40) USPWGYWEYLZTSM-UHFFFAOYSA-N 349903 2-[(4-{6-[(4-cyanobenzyl)oxy]-5-fluoropyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-05::US10208019, Example 14A-06 Glucagon-like peptide 1 receptor Human 77.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349903&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208668 386051656 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691784 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1CC1CCCO1)C(O)=O)c1cccc(OCc2ccc(cc2)C#N)n1 InChI=1S/C32H34N6O4/c1-22-18-37(29-5-2-6-31(35-29)42-21-24-9-7-23(17-33)8-10-24)14-13-36(22)20-30-34-27-12-11-25(32(39)40)16-28(27)38(30)19-26-4-3-15-41-26/h2,5-12,16,22,26H,3-4,13-15,18-21H2,1H3,(H,39,40)/t22-,26?/m0/s1 AZNQIZGQKNKPTK-CHQVSRGASA-N 349905 2-{[(2S)-4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-07::US10208019, Example 14A-08 Glucagon-like peptide 1 receptor Human 1.90 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349905&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208669 386051657 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691785 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1CC1CCCO1)C(O)=O)c1cccc(OCc2ccc(cc2)C#N)n1 InChI=1S/C32H34N6O4/c1-22-18-37(29-5-2-6-31(35-29)42-21-24-9-7-23(17-33)8-10-24)14-13-36(22)20-30-34-27-12-11-25(32(39)40)16-28(27)38(30)19-26-4-3-15-41-26/h2,5-12,16,22,26H,3-4,13-15,18-21H2,1H3,(H,39,40)/t22-,26?/m0/s1 AZNQIZGQKNKPTK-CHQVSRGASA-N 349905 2-{[(2S)-4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-07::US10208019, Example 14A-08 Glucagon-like peptide 1 receptor Human 55.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349905&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208669 386051657 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691786 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1CC1CCCO1)C(O)=O)c1cccc(OCc2ccc(cc2)C#N)n1 InChI=1S/C32H34N6O4/c1-22-18-37(29-5-2-6-31(35-29)42-21-24-9-7-23(17-33)8-10-24)14-13-36(22)20-30-34-27-12-11-25(32(39)40)16-28(27)38(30)19-26-4-3-15-41-26/h2,5-12,16,22,26H,3-4,13-15,18-21H2,1H3,(H,39,40)/t22-,26?/m0/s1 AZNQIZGQKNKPTK-CHQVSRGASA-N 349905 2-{[(2S)-4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-07::US10208019, Example 14A-08 Glucagon-like peptide 1 receptor Human 19.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349905&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208669 386051657 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691787 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1CC1CCCO1)C(O)=O)c1cccc(OCc2ccc(cc2)C#N)n1 InChI=1S/C32H34N6O4/c1-22-18-37(29-5-2-6-31(35-29)42-21-24-9-7-23(17-33)8-10-24)14-13-36(22)20-30-34-27-12-11-25(32(39)40)16-28(27)38(30)19-26-4-3-15-41-26/h2,5-12,16,22,26H,3-4,13-15,18-21H2,1H3,(H,39,40)/t22-,26?/m0/s1 AZNQIZGQKNKPTK-CHQVSRGASA-N 349905 2-{[(2S)-4-{6-[(4-cyanobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-07::US10208019, Example 14A-08 Glucagon-like peptide 1 receptor Human 380 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349905&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208669 386051657 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691788 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(CC3CCOC3)c2c1 InChI=1S/C32H32FN5O4/c33-26-14-21(16-34)4-5-25(26)20-42-31-3-1-2-27(36-31)23-8-11-37(12-9-23)18-30-35-28-7-6-24(32(39)40)15-29(28)38(30)17-22-10-13-41-19-22/h1-7,14-15,22-23H,8-13,17-20H2,(H,39,40) NINPGBYQOIGTQN-UHFFFAOYSA-N 349907 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-09::US10208019, Example 14A-10 Glucagon-like peptide 1 receptor Human 3.30 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349907&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208670 386051658 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691789 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(CC3CCOC3)c2c1 InChI=1S/C32H32FN5O4/c33-26-14-21(16-34)4-5-25(26)20-42-31-3-1-2-27(36-31)23-8-11-37(12-9-23)18-30-35-28-7-6-24(32(39)40)15-29(28)38(30)17-22-10-13-41-19-22/h1-7,14-15,22-23H,8-13,17-20H2,(H,39,40) NINPGBYQOIGTQN-UHFFFAOYSA-N 349907 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-09::US10208019, Example 14A-10 Glucagon-like peptide 1 receptor Human 54.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349907&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208670 386051658 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691790 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(CC3CCOC3)c2c1 InChI=1S/C32H32FN5O4/c33-26-14-21(16-34)4-5-25(26)20-42-31-3-1-2-27(36-31)23-8-11-37(12-9-23)18-30-35-28-7-6-24(32(39)40)15-29(28)38(30)17-22-10-13-41-19-22/h1-7,14-15,22-23H,8-13,17-20H2,(H,39,40) NINPGBYQOIGTQN-UHFFFAOYSA-N 349907 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-09::US10208019, Example 14A-10 Glucagon-like peptide 1 receptor Human 12.0 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349907&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208670 386051658 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691791 OC(=O)c1ccc2nc(CN3CCC(CC3)c3cccc(OCc4ccc(cc4F)C#N)n3)n(CC3CCOC3)c2c1 InChI=1S/C32H32FN5O4/c33-26-14-21(16-34)4-5-25(26)20-42-31-3-1-2-27(36-31)23-8-11-37(12-9-23)18-30-35-28-7-6-24(32(39)40)15-29(28)38(30)17-22-10-13-41-19-22/h1-7,14-15,22-23H,8-13,17-20H2,(H,39,40) NINPGBYQOIGTQN-UHFFFAOYSA-N 349907 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-(tetrahydrofuran-3-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-09::US10208019, Example 14A-10 Glucagon-like peptide 1 receptor Human 270 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349907&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208670 386051658 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691792 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1CC1CCCO1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C32H33FN6O4/c1-21-17-38(29-5-2-6-31(36-29)43-20-24-8-7-22(16-34)14-26(24)33)12-11-37(21)19-30-35-27-10-9-23(32(40)41)15-28(27)39(30)18-25-4-3-13-42-25/h2,5-10,14-15,21,25H,3-4,11-13,17-20H2,1H3,(H,40,41)/t21-,25?/m0/s1 XDDRIFCSPGYKPN-BWDMCYIDSA-N 349909 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-11::US10208019, Example 14A-12 Glucagon-like peptide 1 receptor Human 7.00 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349909&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208671 386051659 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691793 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1CC1CCCO1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C32H33FN6O4/c1-21-17-38(29-5-2-6-31(36-29)43-20-24-8-7-22(16-34)14-26(24)33)12-11-37(21)19-30-35-27-10-9-23(32(40)41)15-28(27)39(30)18-25-4-3-13-42-25/h2,5-10,14-15,21,25H,3-4,11-13,17-20H2,1H3,(H,40,41)/t21-,25?/m0/s1 XDDRIFCSPGYKPN-BWDMCYIDSA-N 349909 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-11::US10208019, Example 14A-12 Glucagon-like peptide 1 receptor Human 140 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349909&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208671 386051659 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691794 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1CC1CCCO1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C32H33FN6O4/c1-21-17-38(29-5-2-6-31(36-29)43-20-24-8-7-22(16-34)14-26(24)33)12-11-37(21)19-30-35-27-10-9-23(32(40)41)15-28(27)39(30)18-25-4-3-13-42-25/h2,5-10,14-15,21,25H,3-4,11-13,17-20H2,1H3,(H,40,41)/t21-,25?/m0/s1 XDDRIFCSPGYKPN-BWDMCYIDSA-N 349909 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-11::US10208019, Example 14A-12 Glucagon-like peptide 1 receptor Human 1.40 US Patent 10.7270/Q2WH2S4X aid1797417 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349909&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208671 386051659 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669 691795 C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1CC1CCCO1)C(O)=O)c1cccc(OCc2ccc(cc2F)C#N)n1 InChI=1S/C32H33FN6O4/c1-21-17-38(29-5-2-6-31(36-29)43-20-24-8-7-22(16-34)14-26(24)33)12-11-37(21)19-30-35-27-10-9-23(32(40)41)15-28(27)39(30)18-25-4-3-13-42-25/h2,5-10,14-15,21,25H,3-4,11-13,17-20H2,1H3,(H,40,41)/t21-,25?/m0/s1 XDDRIFCSPGYKPN-BWDMCYIDSA-N 349909 2-{[(2S)-4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 14A-11::US10208019, Example 14A-12 Glucagon-like peptide 1 receptor Human 20.0 US Patent 10.7270/Q2WH2S4X aid1797418 US10208019 Aspnes, GE; Bagley, SW; Curto, JM; Dowling, MS; Edmonds, D; Flanagan, ME; Futatsugi, K; Griffith, DA; Huard, K; Ingle, G; Jiao, W; Limberakis, C; Mathiowetz, AM; Piotrowski, DW; Ruggeri, RB 2/19/2019 9/21/2019 Pfizer Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=349909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7978&target=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=349909&enzyme=Glucagon-like+peptide+1+receptor&column=ki&startPg=0&Increment=50&submit=Search 139208671 386051659 1 MAGAPGPLRLALLLLGMVGRAGPRPQGATVSLWETVQKWREYRRQCQRSLTEDPPPATDLFCNRTFDEYACWPDGEPGSFVNVSCPWYLPWASSVPQGHVYRFCTAEGLWLQKDNSSLPWRDLSECEESKRGERSSPEEQLLFLYIIYTVGYALSFSALVIASAILLGFRHLHCTRNYIHLNLFASFILRALSVFIKDAALKWMYSTAAQQHQWDGLLSYQDSLSCRLVFLLMQYCVAANYYWLLVEGVYLYTLLAFSVLSEQWIFRLYVSIGWGVPLLFVVPWGIVKYLYEDEGCWTRNSNMNYWLIIRLPILFAIGVNFLIFVRVICIVVSKLKANLMCKTDIKCRLAKSTLTLIPLLGTHEVIFAFVMDEHARGTLRFIKLFTELSFTSFQGLMVAILYCFVNNEVQLEFRKSWERWRLEHLHIQRDSSMKPLKCPTSSLSSGATAGSSMYTATCQASCS 3C59,3C5T,3IOL,4ZGM,5E94,5OTT,5OTU,5OTV,5OTW,5OTX,6GB1,7DUQ,7DUR,7E14,7EVM,7FIM,7VBH,7VBI Glucagon-like peptide 1 receptor GLP1R_HUMAN P43220 Q2M229 Q99669